[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, a synonym for Acrokeratosis paraneoplastica is Bazex's syndrome.",
    "llama-2-13b-chat-hf_fact_raw": "1. Acrokeratosis paraneoplastica is also known as Bazex's syndrome.",
    "llama-2-13b-chat-hf_fact": [
      "Acrokeratosis paraneoplastica is also known as Bazex's syndrome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Weaver syndrome and Sotos syndrome are related but distinct conditions. Both conditions are characterized by childhood overgrowth, advanced bone age, and developmental delay, but Weaver syndrome has a distinctive facial appearance that is different from Sotos syndrome. The study found that intragenic mutations of the NSD1 gene are the major cause of Sotos syndrome and account for some Weaver syndrome cases, but rarely occur in other childhood overgrowth phenotypes. Therefore, while there is some overlap between the two conditions, they are not the same thing.",
    "llama-2-13b-chat-hf_fact_raw": "1. Weaver syndrome and Sotos syndrome are characterized by childhood overgrowth.\n2. Both Weaver syndrome and Sotos syndrome have advanced bone age and developmental delay as characteristics.\n3. Weaver syndrome has a facial appearance that is distinct from Sotos syndrome.\n4. Intragenic mutations of the NSD1 gene are the major cause of Sotos syndrome.\n5. Intragenic mutations of the NSD1 gene account for some Weaver syndrome cases.",
    "llama-2-13b-chat-hf_fact": [
      "Weaver syndrome and Sotos syndrome are characterized by childhood overgrowth.",
      "Both Weaver syndrome and Sotos syndrome have advanced bone age and developmental delay as characteristics.",
      "Weaver syndrome has a facial appearance that is distinct from Sotos syndrome.",
      "Intragenic mutations of the NSD1 gene are the major cause of Sotos syndrome.",
      "Intragenic mutations of the NSD1 gene account for some Weaver syndrome cases."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Weaver syndrome is typically caused by mutations in the EZH2 gene, not the NSD1 gene.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here are the releases of the JASPAR database:\n1. The fourth major release, which is the largest expansion of the core database to date, with 457 non-redundant, curated profiles. This release includes the first batch of profiles derived from ChIP-seq and ChIP-chip whole-genome binding experiments, and 177 yeast TF binding profiles.\nNote that the database now uses versioning of matrices, with 12% of the older models updated to improved versions. Additionally, a curated catalog of mammalian TFs is provided, extending the use of the JASPAR profiles to additional TFs belonging to the same structural family.",
    "llama-2-13b-chat-hf_fact_raw": "1. The fourth major release of the JASPAR database included 457 non-redundant, curated profiles.\n2. The fourth major release of the JASPAR database was the largest expansion of the core database to that date.\n3. The release added profiles derived from ChIP-seq and ChIP-chip whole-genome binding experiments.\n4. The release included 177 yeast transcription factor (TF) binding profiles.\n5. The JASPAR database employs versioning of matrices, with 12% of the older models updated to improved versions in the mentioned release.",
    "llama-2-13b-chat-hf_fact": [
      "The fourth major release of the JASPAR database included 457 non-redundant, curated profiles.",
      "The fourth major release of the JASPAR database was the largest expansion of the core database to that date.",
      "The release added profiles derived from ChIP-seq and ChIP-chip whole-genome binding experiments.",
      "The release included 177 yeast transcription factor (TF) binding profiles.",
      "The JASPAR database employs versioning of matrices, with 12% of the older models updated to improved versions in the mentioned release."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: The exact number of non-redundant, curated profiles included in the fourth major release of the JASPAR database requires specific reference information that is not provided in the statement.\n2. UNKNOWN: The statement about the fourth major release being the largest expansion of the core database to that date cannot be confirmed or denied without a reference to the actual data or a historical record of the database's releases.\n3. UNKNOWN: The addition of profiles derived from ChIP-seq and ChIP-chip whole-genome binding experiments in the release lacks context and specific reference information to ascertain the truthfulness of the statement.\n4. UNKNOWN: The inclusion of 177 yeast transcription factor (TF) binding profiles in the release requires specific knowledge about the contents of this release which is not available in the statement.\n5. UNKNOWN: The statement regarding the versioning of matrices and the percentage of older models updated is very specific and cannot be verified without additional data or references.\n\nWithout specific knowledge or reference to the contents and features of the JASPAR database's fourth major release, it is not possible to confirm or correct any of the statements accurately.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the function of the viral KP4 protein is to regulate PIV5 gene expression through sumoylation. The K254 residue of the P protein is within a consensus sumoylation motif, and mutation of this residue to arginine (P-K254R) reduces PIV5 minigenome activity and viral growth. The study suggests that sumoylation of the P protein at K254 is important for PIV5 growth and regulates PIV5 gene expression through a host protein.",
    "llama-2-13b-chat-hf_fact_raw": "1. The viral KP4 protein functions to regulate PIV5 gene expression through sumoylation.\n2. The K254 residue of the P protein is within a consensus sumoylation motif.\n3. A mutation of the K254 residue to arginine (P-K254R) reduces PIV5 minigenome activity and viral growth.\n4. Sumoylation of the P protein at K254 is important for PIV5 growth.\n5. Sumoylation at K254 regulates PIV5 gene expression through a host protein.",
    "llama-2-13b-chat-hf_fact": [
      "The viral KP4 protein functions to regulate PIV5 gene expression through sumoylation.",
      "The K254 residue of the P protein is within a consensus sumoylation motif.",
      "A mutation of the K254 residue to arginine (P-K254R) reduces PIV5 minigenome activity and viral growth.",
      "Sumoylation of the P protein at K254 is important for PIV5 growth.",
      "Sumoylation at K254 regulates PIV5 gene expression through a host protein."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nReasoning: The details provided refer to specific scientific findings involving molecular biology and virology. Without access to the specific research or publication from which these statements are extracted, I cannot verify the accuracy of the statements regarding the KP4 protein, the K254 residue, the effects of mutating this residue, the process of sumoylation, or its role in PIV5 gene expression and viral growth. Such statements would require specialized knowledge and access to the relevant scientific literature for verification.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog that has been shown to have beneficial effects in experimental and clinical studies. Specifically, DITPA has been found to stimulate weight loss in overweight mammals, lower triglycerides, and improve metabolic abnormalities in humans with a body mass index (BMI) > 25. The patent application mentions two human clinical studies that have employed DITPA, one of which showed significant body weight reduction and improvement in metabolic abnormalities in obese adults. Therefore, the answer to the user's question is:\nYes, DITPA is a thyroid hormone analog that has been utilized in experimental and clinical studies for its potential benefits in weight loss, triglyceride reduction, and improvement of metabolic abnormalities in humans with obesity.",
    "llama-2-13b-chat-hf_fact_raw": "1. DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog.\n2. DITPA has been used in experimental and clinical studies.\n3. DITPA has been found to stimulate weight loss in overweight mammals.\n4. DITPA has been shown to lower triglycerides.\n5. In humans with a BMI > 25, DITPA has been used to improve metabolic abnormalities.",
    "llama-2-13b-chat-hf_fact": [
      "DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog.",
      "DITPA has been used in experimental and clinical studies.",
      "DITPA has been found to stimulate weight loss in overweight mammals.",
      "DITPA has been shown to lower triglycerides.",
      "In humans with a BMI > 25, DITPA has been used to improve metabolic abnormalities."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the COUGER tool is a device used for sharpening scalers and curettes. Specifically, it is a powered rotary stone that is used to grind the sides of the blade and remove edge burrs. The authors of the document recommend a regular sharpening schedule to simplify the process and extend the useful life of the armamentarium.",
    "llama-2-13b-chat-hf_fact_raw": "1. The COUGER tool is a device used for sharpening scalers and curettes.\n2. It is a powered rotary stone that grinds the sides of the blade.\n3. The tool is used to remove edge burrs.\n4. A regular sharpening schedule is recommended to extend the useful life of the tools it sharpens.",
    "llama-2-13b-chat-hf_fact": [
      "The COUGER tool is a device used for sharpening scalers and curettes.",
      "It is a powered rotary stone that grinds the sides of the blade.",
      "The tool is used to remove edge burrs.",
      "A regular sharpening schedule is recommended to extend the useful life of the tools it sharpens."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n\nNote: The truth value of statements 1 and 2 cannot be determined due to the lack of specific information on a device named COUGER tool. Without additional context or information confirming the existence and function of such a tool, their accuracy cannot be assessed. Statement 3 describes a true characteristic of a general sharpening process, and statement 4 is generally true as regular sharpening is recommended for maintaining the effectiveness of cutting tools.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is a drug called cytoflavin that has been suggested for the pathogenetic treatment of neuroinfections, including tick-borne encephalitis. The drug has been found to have a modifying effect on nitric oxide (NO) metabolites, which are involved in the immune inflammation development in the central nervous system. In a study of patients with tick-borne encephalitis, those who received cytoflavin experienced a significantly rapid reduction in general brain, focal brain, and neuropsychological disorders, as well as a decrease in endogenous NO metabolites. The recommended dosage of cytoflavin is 10.0 ml once a day intravenously in drops for 7-10 days.",
    "llama-2-13b-chat-hf_fact_raw": "1. Cytoflavin has been suggested for the pathogenetic treatment of tick-borne encephalitis.\n2. Cytoflavin has a modifying effect on nitric oxide (NO) metabolites related to immune inflammation development in the central nervous system.\n3. In a study, patients with tick-borne encephalitis who received cytoflavin experienced a rapid reduction in general brain, focal brain, and neuropsychological disorders.\n4. Patients treated with cytoflavin also experienced a decrease in endogenous NO metabolites.\n5. The recommended dosage of cytoflavin for tick-borne encephalitis is 10.0 ml intravenously once a day for 7-10 days.",
    "llama-2-13b-chat-hf_fact": [
      "Cytoflavin has been suggested for the pathogenetic treatment of tick-borne encephalitis.",
      "Cytoflavin has a modifying effect on nitric oxide (NO) metabolites related to immune inflammation development in the central nervous system.",
      "In a study, patients with tick-borne encephalitis who received cytoflavin experienced a rapid reduction in general brain, focal brain, and neuropsychological disorders.",
      "Patients treated with cytoflavin also experienced a decrease in endogenous NO metabolites.",
      "The recommended dosage of cytoflavin for tick-borne encephalitis is 10.0 ml intravenously once a day for 7-10 days."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are very specific to medical treatment and outcomes concerning tick-borne encephalitis and the effects of Cytoflavin. Determining the truth of these claims requires specialized knowledge in medicine and access to the particular studies or clinical data on which these statements are based, which is not available within my capabilities. Without the relevant scientific or medical literature, it's not possible to accurately verify these statements. It's recommended to consult medical literature or a healthcare professional for accurate information about medical treatments and drug effects.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the University of California, Santa Cruz Genome Browser Database is a genomic database that contains DNA shape annotations for various species, including vertebrates and invertebrates. The database includes a wide range of annotations, such as assembly data, genes and gene predictions, mRNA and EST alignments, and comparative genomics, regulation, expression, and variation data. The database is optimized for fast interactive performance and provides powerful visualization and querying capabilities. Additionally, the database includes new features such as VisiGene, phyloGif, and expanded SNP annotation track. Therefore, the answer to the user's question is that the University of California, Santa Cruz Genome Browser Database is a available genome browser database for DNA shape annotations.",
    "llama-2-13b-chat-hf_fact_raw": "1. The University of California, Santa Cruz Genome Browser Database contains DNA shape annotations.\n2. This database includes data for various species, including both vertebrates and invertebrates.\n3. The UCSC Genome Browser Database provides a variety of annotations, including assembly data, genes and gene predictions, and mRNA and EST alignments. \n4. The database features comparative genomics, regulation, expression, and variation data.\n5. The UCSC Genome Browser Database is designed for fast interactive performance with visualization and querying capabilities.",
    "llama-2-13b-chat-hf_fact": [
      "The University of California, Santa Cruz Genome Browser Database contains DNA shape annotations.",
      "This database includes data for various species, including both vertebrates and invertebrates.",
      "The UCSC Genome Browser Database provides a variety of annotations, including assembly data, genes and gene predictions, and mRNA and EST alignments.",
      "The database features comparative genomics, regulation, expression, and variation data.",
      "The UCSC Genome Browser Database is designed for fast interactive performance with visualization and querying capabilities."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach of the statements is consistent with the known capabilities and features of the UCSC Genome Browser Database, which is a widely-used platform for genomic research that includes a variety of data and annotations for multiple species, and is designed for efficient interactive use with powerful visualization and querying tools.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the syndromes associated with mutations in the EZH2 gene are Weaver syndrome.",
    "llama-2-13b-chat-hf_fact_raw": "1. Mutations in the EZH2 gene are associated with Weaver syndrome.",
    "llama-2-13b-chat-hf_fact": [
      "Mutations in the EZH2 gene are associated with Weaver syndrome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, human pregnancy zone protein (PZP) is a protein that undergoes a dimer-to-tetramer transition. The transition is triggered by the binding of proteinases such as chymotrypsin (CT) or methylamine (MA), which causes the cleavage of internal thiol esters in the molecule. This leads to the formation of different conformational states of PZP, including dimeric, tetrameric, and CT- or MA-bound forms. The reactivity of selected monoclonal antibodies against PZP towards the three PZP derivatives demonstrated differences in the reactivity pattern, indicating that at least three different conformational states exist for PZP and its derivatives. Therefore, the answer to the question \"List human proteins that are subject to a dimer-to-tetramer transition\" is:\n1. Human pregnancy zone protein (PZP)",
    "llama-2-13b-chat-hf_fact_raw": "1. Human pregnancy zone protein (PZP) undergoes a dimer-to-tetramer transition.\n2. The dimer-to-tetramer transition of PZP is triggered by the binding of proteinases such as chymotrypsin (CT) or methylamine (MA).\n3. The binding of proteinases to PZP causes the cleavage of internal thiol esters in the molecule.\n4. Different conformational states of PZP include dimeric, tetrameric, and CT- or MA-bound forms.\n5. Reactivity differences of selected monoclonal antibodies against PZP indicate the existence of at least three different conformational states for PZP and its derivatives.",
    "llama-2-13b-chat-hf_fact": [
      "Human pregnancy zone protein (PZP) undergoes a dimer-to-tetramer transition.",
      "The dimer-to-tetramer transition of PZP is triggered by the binding of proteinases such as chymotrypsin (CT) or methylamine (MA).",
      "The binding of proteinases to PZP causes the cleavage of internal thiol esters in the molecule.",
      "Different conformational states of PZP include dimeric, tetrameric, and CT- or MA-bound forms.",
      "Reactivity differences of selected monoclonal antibodies against PZP indicate the existence of at least three different conformational states for PZP and its derivatives."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE\n\nThe statements 1, 2, and 3 require specific biochemical knowledge or access to the relevant scientific literature about the characteristics and behavior of Human pregnancy zone protein (PZP). Without that specific information, these statements cannot be accurately verified.\n\nHowever, statements 4 and 5 could be true, assuming the statements reflect the complexity of PZP structure and its interaction with different molecules or conditions that cause conformational changes. The presentation of different conformations like dimeric, tetrameric, and complex-bound forms suggests a protein that undergoes structural changes, and the reactivity difference of monoclonal antibodies supports the notion of multiple conformations.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is SERCA2a. The interaction between PLN and SERCA2a was found to occur through a direct protein-protein interaction, and the affinity of the binding was determined to be 0.70 microM. The association was inhibited by cAMP-dependent phosphorylation of the PLN fusion protein and by usage of anti-PLN monoclonal antibody. These results suggest that PLN can bind SERCA2a in the absence of the membrane domains and that the modifications of the cytoplasmic domain of PLN that activate SERCA2a parallel the disruption of the association between the two fusion proteins.",
    "llama-2-13b-chat-hf_fact_raw": "1. SERCA2a is a protein known to interact with phospholamban (PLN).\n2. The binding affinity between PLN and SERCA2a was determined to be 0.70 microM.\n3. cAMP-dependent phosphorylation of the PLN fusion protein inhibits the association between PLN and SERCA2a.\n4. The use of anti-PLN monoclonal antibody also inhibits the interaction between PLN and SERCA2a.\n5. Modifications of the cytoplasmic domain of PLN activate SERCA2a and disrupt the association between PLN and SERCA2a.",
    "llama-2-13b-chat-hf_fact": [
      "SERCA2a is a protein known to interact with phospholamban (PLN).",
      "The binding affinity between PLN and SERCA2a was determined to be 0.70 microM.",
      "cAMP-dependent phosphorylation of the PLN fusion protein inhibits the association between PLN and SERCA2a.",
      "The use of anti-PLN monoclonal antibody also inhibits the interaction between PLN and SERCA2a.",
      "Modifications of the cytoplasmic domain of PLN activate SERCA2a and disrupt the association between PLN and SERCA2a."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: cAMP-dependent phosphorylation of the PLN reduces its inhibitory effect, thus enhancing the association between PLN and SERCA2a.\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, there is no evidence to suggest that vitamin D supplementation reduces the incidence of falls in older people in clinical trials. The document states that regular exercise reduced the incidence of falls resulting in injury, but routine vitamin D supplementation did not have this effect. Therefore, based on this information, it can be concluded that vitamin D supplementation does not appear to be effective in reducing the incidence of falls in older people.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is no evidence that vitamin D supplementation reduces the incidence of falls in older people in clinical trials.\n2. Regular exercise reduced the incidence of falls resulting in injury.\n3. Routine vitamin D supplementation did not reduce the incidence of falls in older people.",
    "llama-2-13b-chat-hf_fact": [
      "There is no evidence that vitamin D supplementation reduces the incidence of falls in older people in clinical trials.",
      "Regular exercise reduced the incidence of falls resulting in injury.",
      "Routine vitamin D supplementation did not reduce the incidence of falls in older people."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: There is evidence that vitamin D supplementation can reduce the incidence of falls in older people, particularly those who have low vitamin D levels or who are at increased risk for falls.\n2. TRUE\n3. FALSE [correction]: Some clinical trials have shown that routine vitamin D supplementation can reduce the incidence of falls in older people, especially among those with vitamin D deficiency. However, the effect may vary depending on various factors such as dosage, population, and study design.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is an association between Jarid2 and miR-155 in Th17 cells in the context of TNBS-induced colitis. The study found that miR-155 inhibition reduced the proportion of Th17 cells in spleens and mesenteric lymph nodes, and decreased the levels of Th17 cell-associated cytokines in colon tissues. Additionally, the study found that Jarid2 was significantly elevated by miR-155 inhibition, and notch1 expression was inversely correlated with Jarid2. These findings suggest that miR-155 regulates the differentiation and function of Th17 cells by targeting Jarid2, which in turn affects the expression of notch1.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is an association between Jarid2 and miR-155 in Th17 cells.\n2. miR-155 inhibition reduced the proportion of Th17 cells in spleens and mesenteric lymph nodes.\n3. miR-155 inhibition decreased the levels of Th17 cell-associated cytokines in colon tissues.\n4. Jarid2 was significantly elevated by miR-155 inhibition.\n5. Notch1 expression was inversely correlated with Jarid2.",
    "llama-2-13b-chat-hf_fact": [
      "There is an association between Jarid2 and miR-155 in Th17 cells.",
      "miR-155 inhibition reduced the proportion of Th17 cells in spleens and mesenteric lymph nodes.",
      "miR-155 inhibition decreased the levels of Th17 cell-associated cytokines in colon tissues.",
      "Jarid2 was significantly elevated by miR-155 inhibition.",
      "Notch1 expression was inversely correlated with Jarid2."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: Without specific data or findings referenced, it is impossible to confirm or refute the association between Jarid2 and miR-155 in Th17 cells.\n2. UNKNOWN: The statement about the effect of miR-155 inhibition on Th17 cells in spleens and mesenteric lymph nodes cannot be verified without specific experimental evidence.\n3. UNKNOWN: Similarly, the statement about the impact of miR-155 inhibition on cytokine levels cannot be determined as true or false without the context of a study or data supporting it.\n4. FALSE [correction]: Typically, inhibition of a microRNA would not increase the levels of its target genes/proteins. If Jarid2 is a target of miR-155, one would generally expect Jarid2 levels to increase when miR-155 is inhibited.\n5. UNKNOWN: Without specific scientific data, it is not possible to confirm or dispute the claimed inverse correlation between Notch1 expression and Jarid2.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the human hoxD cluster contains four genes.",
    "llama-2-13b-chat-hf_fact_raw": "1. The human hoxD cluster contains four genes.",
    "llama-2-13b-chat-hf_fact": [
      "The human hoxD cluster contains four genes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are some phosphorylation consensus motifs for Casein Kinase 1 (CK1):\n1. Serine/threonine-proline-serine/threonine (S/T-P-S/T) motif: This is the most common phosphorylation consensus motif recognized by CK1, and it is found in many of its substrates, including proteins involved in cell signaling, metabolism, and cytoskeleton organization.\n2. Serine/threonine-proline-arginine/lysine (S/T-P-R/K) motif: This motif is also recognized by CK1 and is found in some of its substrates, particularly those involved in cell signaling and transcription regulation.\n3. Serine/threonine-glutamine-serine/threonine (S/T-Q-S/T) motif: This motif is less well-studied than the first two, but it has been identified as a CK1 phosphorylation site in some proteins, including the protein kinase CK2.\nThese consensus motifs are based on the crystal structures of CK1 and its inhibitors, as well as previous biochemical and cellular studies. However, it is important to note that not all CK1 substrates contain these consensus motifs, and other motifs may also be recognized by the kinase. Additionally, the specificity of CK1 for these motifs may vary depending on the context of the protein and the cellular environment.",
    "llama-2-13b-chat-hf_fact_raw": "1. Casein Kinase 1 (CK1) recognizes a phosphorylation consensus motif consisting of serine/threonine-proline-serine/threonine (S/T-P-S/T).\n2. Casein Kinase 1 (CK1) also recognizes the consensus motif serine/threonine-proline-arginine/lysine (S/T-P-R/K).\n3. Another phosphorylation consensus motif for CK1 is serine/threonine-glutamine-serine/threonine (S/T-Q-S/T).\n4. The protein kinase CK2 has been identified as containing the CK1 phosphorylation site consistent with the S/T-Q-S/T motif.\n5. The specificity of CK1 for recognized consensus motifs may vary depending on the context of the protein and the cellular environment.",
    "llama-2-13b-chat-hf_fact": [
      "Casein Kinase 1 (CK1) recognizes a phosphorylation consensus motif consisting of serine/threonine-proline-serine/threonine (S/T-P-S/T).",
      "Casein Kinase 1 (CK1) also recognizes the consensus motif serine/threonine-proline-arginine/lysine (S/T-P-R/K).",
      "Another phosphorylation consensus motif for CK1 is serine/threonine-glutamine-serine/threonine (S/T-Q-S/T).",
      "The protein kinase CK2 has been identified as containing the CK1 phosphorylation site consistent with the S/T-Q-S/T motif.",
      "The specificity of CK1 for recognized consensus motifs may vary depending on the context of the protein and the cellular environment."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Casein Kinase 1 (CK1) typically does not recognize the consensus motif serine/threonine-proline-arginine/lysine (S/T-P-R/K). CK1 usually targets sequences that are S/T-X-X-S/T (where X can be any amino acid) and does not have a basic amino acid like arginine (R) or lysine (K) typically directly following the proline.\n3. UNKNOWN\n4. FALSE [correction]: The specificity mentioned for protein kinase CK2 is incorrect; CK2 typically recognizes a consensus sequence characterized by S/T preceded by acidic amino acids (Asp or Glu), not the S/T-Q-S/T motif associated with CK1.\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the different proteins/isoforms encoded by the ASPH (aspartate beta-hydroxylase) gene in humans are:\n1. hAspH (human aspartyl beta-hydroxylase): This is the main isoform of the gene, which is encoded by a 4.3-kb cDNA and has a deduced amino acid sequence of 757 aa (85 kDa).\n2. N-terminally truncated hAspH: This is a shorter isoform of hAspH, which is formed through posttranslational cleavage of the catalytic C terminus in the lumen of the endoplasmic reticulum. The exact size of this isoform was not specified in the information provided.\nTherefore, there are two isoforms of the ASPH gene in humans: the full-length hAspH and the N-terminally truncated hAspH.",
    "llama-2-13b-chat-hf_fact_raw": "1. The ASPH gene in humans encodes the main isoform known as hAspH (human aspartyl beta-hydroxylase).\n2. The hAspH isoform is encoded by a 4.3-kb cDNA.\n3. The deduced amino acid sequence of hAspH is comprised of 757 amino acids (aa).\n4. The hAspH protein has an approximate molecular weight of 85 kDa.\n5. There exists an N-terminally truncated isoform of hAspH that is created via posttranslational cleavage of the catalytic C terminus in the endoplasmic reticulum.",
    "llama-2-13b-chat-hf_fact": [
      "The ASPH gene in humans encodes the main isoform known as hAspH (human aspartyl beta-hydroxylase).",
      "The hAspH isoform is encoded by a 4.3-kb cDNA.",
      "The deduced amino acid sequence of hAspH is comprised of 757 amino acids (aa).",
      "The hAspH protein has an approximate molecular weight of 85 kDa.",
      "There exists an N-terminally truncated isoform of hAspH that is created via posttranslational cleavage of the catalytic C terminus in the endoplasmic reticulum."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE - The deduced amino acid sequence of hAspH consists of 758 amino acids, not 757. The slight discrepancy in number could be due to different sources or updates in research that might have led to reevaluation of the amino acid count. Given the precision required for such information and the potential for updates in genomic databases, this response assumes the most accurate information available up to the knowledge cutoff in early 2023.\n4. FALSE [correction]: The hAspH protein has an approximate molecular weight of 86 kDa, not 85 kDa. Protein molecular weights can be rounded differently, but a commonly accepted value for hAspH is closer to 86 kDa.\n5. FALSE [correction]: The known N-terminally truncated isoform of hAspH results from alternative splicing, which removes part of the N-terminus containing the proline-rich region, not from posttranslational cleavage.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, empagliflozin was FDA approved on December 18, 2014.",
    "llama-2-13b-chat-hf_fact_raw": "1. Empagliflozin was FDA approved on December 18, 2014.",
    "llama-2-13b-chat-hf_fact": [
      "Empagliflozin was FDA approved on December 18, 2014."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the results of loss of the protein Lon1 in the plant Arabidopsis are:\n1. Protein half-lives vary from several hours to several months, with different proteins having different degradation rates.\n2. Protein complex membership and specific protein domains are strong predictors of degradation rate, while N-end amino acid, hydrophobicity, or aggregation propensity of proteins are not.\n3. Rapidly degrading subunits were found in a variety of protein complexes in plastids.\n4. The degradation rate of certain proteins changes in different leaves of the rosette and correlates with leaf growth rate.\n5. The protein turnover energy costs in different leaves and their key determinants within the proteome have been calculated.\nIn other words, the study found that the degradation rate of proteins in Arabidopsis is highly variable and is influenced by the protein's complex membership and specific domains, but not by its N-end amino acid, hydrophobicity, or aggregation propensity. The study also identified rapidly degrading subunits in plastids and found that the degradation rate of certain proteins changes in different leaves of the rosette and correlates with leaf growth rate. Finally, the study calculated the protein turnover energy costs in different leaves and identified the key determinants within the proteome.",
    "llama-2-13b-chat-hf_fact_raw": "1. Protein half-lives in the plant Arabidopsis vary from several hours to several months.\n2. Protein complex membership and specific protein domains are strong predictors of protein degradation rate in Arabidopsis.\n3. Rapidly degrading protein subunits were identified in a variety of protein complexes in Arabidopsis plastids.\n4. The degradation rate of certain proteins in Arabidopsis changes in different leaves of the rosette and correlates with leaf growth rate.\n5. The study calculated the protein turnover energy costs in different leaves of Arabidopsis and identified key determinants within the proteome.",
    "llama-2-13b-chat-hf_fact": [
      "Protein half-lives in the plant Arabidopsis vary from several hours to several months.",
      "Protein complex membership and specific protein domains are strong predictors of protein degradation rate in Arabidopsis.",
      "Rapidly degrading protein subunits were identified in a variety of protein complexes in Arabidopsis plastids.",
      "The degradation rate of certain proteins in Arabidopsis changes in different leaves of the rosette and correlates with leaf growth rate.",
      "The study calculated the protein turnover energy costs in different leaves of Arabidopsis and identified key determinants within the proteome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Protein half-lives can indeed vary significantly in organisms, including plants such as Arabidopsis. This range from hours to months is plausible.\n2. TRUE: Protein complex membership and specific protein domains are known factors that can affect the degradation rate of proteins. These are strong predictors as they can determine the protein's stability, localization, and interaction with other molecules that can lead to its degradation.\n3. TRUE: It is reasonable that rapidly degrading protein subunits could be identified in a variety of protein complexes, including those found in Arabidopsis plastids, because different protein complexes can exhibit varying stability and degradation rates.\n4. UNKNOWN: Without specific research data, it's unclear whether the degradation rate of certain proteins in Arabidopsis changes in different leaves of the rosette and whether this correlates with leaf growth rate. This would need supportive data from a study.\n5. UNKNOWN: Calculating the protein turnover energy costs in different leaves of Arabidopsis and identifying key determinants within the proteome is specific and requires particular data to be known as true. Without confirmation from the relevant study, we cannot verify the accuracy of this statement.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct answer to the question of whether a linker histone exists in the yeast genome. However, the information does mention that the study explored the regulation of linker histone binding in the yeast, Saccharomyces cerevisiae. Additionally, the study found that increased expression of Hho1, the yeast linker histone, resulted in a severe growth defect, despite only subtle changes in chromatin structure. This suggests that linker histones do play a role in the regulation of chromatin structure in yeast, but the exact nature of their presence or absence in the yeast genome is not explicitly stated in the provided information.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is a study that explored the regulation of linker histone binding in Saccharomyces cerevisiae.\n2. Increased expression of Hho1, which is the yeast linker histone, can result in a severe growth defect in yeast.\n3. Changes in chromatin structure were observed to be subtle despite the increased expression of Hho1 in yeast.",
    "llama-2-13b-chat-hf_fact": [
      "There is a study that explored the regulation of linker histone binding in Saccharomyces cerevisiae.",
      "Increased expression of Hho1, which is the yeast linker histone, can result in a severe growth defect in yeast.",
      "Changes in chromatin structure were observed to be subtle despite the increased expression of Hho1 in yeast."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, there is no evidence that tomato juice lowers cholesterol levels. The study found that there was a significant reduction in total cholesterol and LDL-C only in the control group at the end of the study, but this reduction was not observed in the experimental group that consumed polyphenol-enriched tomato juice. The study suggests that tomato juice may have favorable effects on lipid metabolism, but the addition of polyphenols to the juice does not provide additional beneficial cardiovascular effects.",
    "llama-2-13b-chat-hf_fact_raw": "1. Document-0 indicates no evidence that tomato juice lowers cholesterol levels.\n2. A study found a significant reduction in total cholesterol and LDL-C in the control group only.\n3. The experimental group in the study consumed polyphenol-enriched tomato juice.\n4. Tomato juice may have favorable effects on lipid metabolism.\n5. Adding polyphenols to tomato juice does not provide additional beneficial cardiovascular effects.",
    "llama-2-13b-chat-hf_fact": [
      "Document-0 indicates no evidence that tomato juice lowers cholesterol levels.",
      "A study found a significant reduction in total cholesterol and LDL-C in the control group only.",
      "The experimental group in the study consumed polyphenol-enriched tomato juice.",
      "Tomato juice may have favorable effects on lipid metabolism.",
      "Adding polyphenols to tomato juice does not provide additional beneficial cardiovascular effects."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: If there was a significant reduction in total cholesterol and LDL-C found, it would not be in the control group only as the control group is usually the group receiving no treatment or standard treatment, not the one receiving the experimental treatment.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Hsp70 and Hsp110 can affect mRNA stability by interacting with AU-rich elements (AREs) in the 3' untranslated regions (3'UTRs) of mRNAs. Hsp70 forms direct, high-affinity complexes with ARE substrates, recognizing U-rich sequences in the AREs, and stabilizes endogenous ARE-containing mRNAs, such as those encoding vascular endothelial growth factor (VEGF) and Cox-2. This mRNA-stabilizing role of Hsp70 is novel and may contribute to the cytoprotective effects of Hsp70 following cellular stress. Hsp110, another heat shock protein, has also been shown to interact with AREs and stabilize mRNAs. However, the specific mechanisms by which Hsp110 affects mRNA stability may differ from those of Hsp70. Overall, the binding and stabilization of selected ARE-containing mRNAs by Hsp70 and Hsp110 may play a role in protecting cells from stress and may also contribute to the development of aggressive neoplastic phenotypes.",
    "llama-2-13b-chat-hf_fact_raw": "1. Hsp70 interacts with AU-rich elements (AREs) in the 3' untranslated regions (3'UTRs) of mRNAs.\n2. Hsp70 stabilizes endogenous ARE-containing mRNAs.\n3. The mRNAs stabilized by Hsp70 include those encoding for vascular endothelial growth factor (VEGF) and Cox-2.\n4. Hsp110, similarly to Hsp70, has been shown to stabilize mRNAs by interacting with AREs.\n5. The mRNA-stabilizing role of Hsp70 may contribute to cytoprotective effects following cellular stress.",
    "llama-2-13b-chat-hf_fact": [
      "Hsp70 interacts with AU-rich elements (AREs) in the 3' untranslated regions (3'UTRs) of mRNAs.",
      "Hsp70 stabilizes endogenous ARE-containing mRNAs.",
      "The mRNAs stabilized by Hsp70 include those encoding for vascular endothelial growth factor (VEGF) and Cox-2.",
      "Hsp110, similarly to Hsp70, has been shown to stabilize mRNAs by interacting with AREs.",
      "The mRNA-stabilizing role of Hsp70 may contribute to cytoprotective effects following cellular stress."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe specificity of the information provided in these statements requires authoritative knowledge of molecular biology, specifically concerning the functions of the Hsp70 protein family and the interactions with AU-rich elements (AREs) within the 3' untranslated regions (3'UTRs) of mRNAs. Additionally, the statements about Hsp110's interaction with AREs and the role of Hsp70 in mRNA stability and cytoprotection after cellular stress require specialized knowledge or access to specific scientific studies or data. Without the particular passage or scientific evidence necessary to verify these claims, it is not possible to determine the truthfulness of these statements. Therefore, they are marked as UNKNOWN.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that there is only one deiodinase present in skeletal muscle, and that is type 2 deiodinase (D2). The information states that D2 is expressed in human skeletal muscle, and that it is a low K(m) iodothyronine deiodinase that catalyzes the removal of a single iodine from the phenolic ring of T4 or rT3.",
    "llama-2-13b-chat-hf_fact_raw": "1. Type 2 deiodinase (D2) is present in human skeletal muscle.\n2. Type 2 deiodinase (D2) is a low K(m) iodothyronine deiodinase.\n3. Type 2 deiodinase (D2) catalyzes the removal of a single iodine from the phenolic ring of T4 or rT3.",
    "llama-2-13b-chat-hf_fact": [
      "Type 2 deiodinase (D2) is present in human skeletal muscle.",
      "Type 2 deiodinase (D2) is a low K(m) iodothyronine deiodinase.",
      "Type 2 deiodinase (D2) catalyzes the removal of a single iodine from the phenolic ring of T4 or rT3."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in the document, the following are inflammatory caspase proteins:\n1. Caspase-1\n2. Caspase-12\nThese caspases are essential effectors of inflammation and cell death in the gut, and play a bimodal role in regulating intestinal homeostasis, inflammation, and tumorigenesis. Caspase-1 is involved in the induction of inflammation after tissue injury, while caspase-12 is involved in the regulation of the inflammasome and the repair of mucosal tissue.",
    "llama-2-13b-chat-hf_fact_raw": "1. Caspase-1 is categorized as an inflammatory caspase protein.\n2. Caspase-12 is categorized as an inflammatory caspase protein.\n3. Caspase-1 is involved in the induction of inflammation after tissue injury.\n4. Caspase-12 is involved in the regulation of the inflammasome.\n5. Caspase-12 plays a role in the repair of mucosal tissue.",
    "llama-2-13b-chat-hf_fact": [
      "Caspase-1 is categorized as an inflammatory caspase protein.",
      "Caspase-12 is categorized as an inflammatory caspase protein.",
      "Caspase-1 is involved in the induction of inflammation after tissue injury.",
      "Caspase-12 is involved in the regulation of the inflammasome.",
      "Caspase-12 plays a role in the repair of mucosal tissue."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Caspase-12 is categorized as a non-inflammatory caspase protein that may be involved in the inhibition of inflammatory responses.\n3. TRUE\n4. FALSE [correction]: Caspase-12 is generally thought to act as a negative regulator of the inflammasome, rather than directly regulating it.\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct link between the aurora B kinase and the polycomb protein ring1B. The document discusses the Aurora C splicing variant (Aurora C-SV) and its role in chromosome segregation and cytokinesis, but does not mention polycomb protein ring1B. However, both Aurora C-SV and ring1B are involved in regulating chromosome segregation and cytokinesis, suggesting that they may have related functions in these processes.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is no direct link between the aurora B kinase and the polycomb protein ring1B according to the provided information.\n2. The Aurora C splicing variant (Aurora C-SV) is involved in chromosome segregation and cytokinesis.\n3. The document mentioned does not discuss the polycomb protein ring1B when referring to aurora B kinase.\n4. The polycomb protein ring1B is involved in regulating chromosome segregation and cytokinesis.\n\n(Note: These statements are based on the information provided in the answer and assume the document being referred to is accurate; external verification would be required to confirm these claims.)",
    "llama-2-13b-chat-hf_fact": [
      "There is no direct link between the aurora B kinase and the polycomb protein ring1B according to the provided information.",
      "The Aurora C splicing variant (Aurora C-SV) is involved in chromosome segregation and cytokinesis.",
      "The document mentioned does not discuss the polycomb protein ring1B when referring to aurora B kinase.",
      "The polycomb protein ring1B is involved in regulating chromosome segregation and cytokinesis.",
      "ote: These statements are based on the information provided in the answer and assume the document being referred to is accurate; external verification would be required to confirm these claims.)"
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: Without the actual provided information or document to reference, it is impossible to accurately determine the truthfulness of these statements related to the aurora kinases and polycomb proteins. External verification with the relevant documents or scientific literature is necessary.]",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are:\n1. Overlapping donor and acceptor sites: These are the most abundant type of non-canonical motifs, with a site shift of four nucleotides being the most common. Overlapping sites may clash with consensus requirements and can introduce frameshifts in the protein-coding region, leading to different functional roles for the alternative splicing of these sites.\n2. Alternative donor sites: These sites are more frequently conserved in other mammalian genomes and can lead to frameshifts and nonsense-mediated decay-inducing mRNA isoforms, which are likely involved in regulated unproductive splicing pathways.\n3. Alternative acceptor sites: These sites can lead to microvariations in protein sequences and may have different functional roles than overlapping donor sites.\nIt is important to note that the usage of these non-canonical motifs is uneven and can vary between different mammalian genomes. Additionally, the functional roles of these motifs can be different, with alternative donor sites leading to frameshifts and nonsense-mediated decay-inducing mRNA isoforms, while alternative acceptor sites may lead to microvariations in protein sequences.",
    "llama-2-13b-chat-hf_fact_raw": "1. Overlapping donor and acceptor splice sites with a site shift of four nucleotides are the most abundant type of non-canonical motifs in vertebrates.\n2. Overlapping splice sites can introduce frameshifts in the protein-coding region.\n3. Alternative donor sites are more frequently conserved in other mammalian genomes.\n4. Alternative donor sites can lead to frameshifts and nonsense-mediated decay-inducing mRNA isoforms.\n5. Alternative acceptor sites can lead to microvariations in protein sequences.",
    "llama-2-13b-chat-hf_fact": [
      "Overlapping donor and acceptor splice sites with a site shift of four nucleotides are the most abundant type of non-canonical motifs in vertebrates.",
      "Overlapping splice sites can introduce frameshifts in the protein-coding region.",
      "Alternative donor sites are more frequently conserved in other mammalian genomes.",
      "Alternative donor sites can lead to frameshifts and nonsense-mediated decay-inducing mRNA isoforms.",
      "Alternative acceptor sites can lead to microvariations in protein sequences."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: The specific abundance of non-canonical motifs such as overlapping donor and acceptor splice sites with a site shift of four nucleotides in vertebrates would need backing from a specific scientific study or dataset, which is not provided.\n2. TRUE: Overlapping splice sites can indeed introduce frameshifts in the coding region of a gene, altering the open reading frame which may result in different proteins being produced or leading to nonfunctional proteins.\n3. UNKNOWN: Conservation of alternative splice sites across mammalian genomes is a topic for empirical study. Without specific data or references, this statements veracity cannot be confidently assessed.\n4. TRUE: Use of alternative donor sites can lead to the introduction of premature stop codons or shifts in the reading frame, which can result in mRNA isoforms that are targets for nonsense-mediated decay.\n5. TRUE: Usage of alternative acceptor splice sites can lead to inclusion or exclusion of certain amino acids, thereby causing microvariations in the protein sequences encoded by the mRNA.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the event that results in the acetylation of S6K1 is growth factor stimulation.",
    "llama-2-13b-chat-hf_fact_raw": "1. The acetylation of S6K1 is a consequence of growth factor stimulation.",
    "llama-2-13b-chat-hf_fact": [
      "The acetylation of S6K1 is a consequence of growth factor stimulation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the cause of episodic ataxia type 6 (EA6) is not yet fully understood, as the molecular basis of late-onset EA2 is unclear. However, the case report described in the provided document suggests that genetically induced reduction in calcium channel function may be associated with late-onset EA2. Specifically, the first multiple-base pair insertion in the CACNA1A gene, which codes for a calcium channel, was found to be associated with late-onset EA2 in one individual. Further research is needed to determine the underlying genetic causes of EA6 and to better understand the relationship between calcium channel function and the development of EA6.",
    "llama-2-13b-chat-hf_fact_raw": "1. The cause of episodic ataxia type 6 (EA6) is not yet fully understood.\n2. A reduction in calcium channel function might be associated with late-onset episodic ataxia type 2 (EA2).\n3. The first multiple-base pair insertion in the CACNA1A gene is associated with late-onset EA2 in one individual.\n4. The CACNA1A gene codes for a calcium channel.\n5. Further research is needed to determine the underlying genetic causes of EA6.",
    "llama-2-13b-chat-hf_fact": [
      "The cause of episodic ataxia type 6 (EA6) is not yet fully understood.",
      "A reduction in calcium channel function might be associated with late-onset episodic ataxia type 2 (EA2).",
      "The first multiple-base pair insertion in the CACNA1A gene is associated with late-onset EA2 in one individual.",
      "The CACNA1A gene codes for a calcium channel.",
      "Further research is needed to determine the underlying genetic causes of EA6."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, chromomethylases are not present in animal genomes, including the genome of Bactrocera dorsalis. The study focused on chitinases (Chts) and chitin deacetylases (CDAs) in B. dorsalis, and the analysis did not reveal the presence of chromomethylases. The study did show that the 12 Cht-related genes and 6 CDA genes in B. dorsalis were clustered into different groups based on their conserved sequences and phylogenetic relationships, and that these genes had different expression patterns among eggs, larvae, pupae, and adults, as well as among different tissues of larvae and adults.",
    "llama-2-13b-chat-hf_fact_raw": "1. Chromomethylases are not present in animal genomes.\n2. The genome of Bactrocera dorsalis does not contain chromomethylases.\n3. The study on Bactrocera dorsalis focused on chitinases (Chts) and chitin deacetylases (CDAs).\n4. In Bactrocera dorsalis, 12 Cht-related genes and 6 CDA genes were identified.\n5. The identified Cht-related and CDA genes in Bactrocera dorsalis were found to have different expression patterns among various developmental stages and tissues.",
    "llama-2-13b-chat-hf_fact": [
      "Chromomethylases are not present in animal genomes.",
      "The genome of Bactrocera dorsalis does not contain chromomethylases.",
      "The study on Bactrocera dorsalis focused on chitinases (Chts) and chitin deacetylases (CDAs).",
      "In Bactrocera dorsalis, 12 Cht-related genes and 6 CDA genes were identified.",
      "The identified Cht-related and CDA genes in Bactrocera dorsalis were found to have different expression patterns among various developmental stages and tissues."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Chromomethylases are typically found in plant genomes, and they are not generally present in animal genomes.\n2. TRUE: Given that chromomethylases are not present in animal genomes and Bactrocera dorsalis is a species of fruit fly, it follows that its genome would not contain chromomethylases.\n3. TRUE: The context implies that the study on Bactrocera dorsalis indeed focused on chitinases (Chts) and chitin deacetylases (CDAs), which are enzymes involved in chitin metabolism.\n4. UNKNOWN: Without specific information from the study, the exact number of Cht-related genes and CDA genes identified in Bactrocera dorsalis cannot be confirmed as true or false.\n5. TRUE: It is common for such studies to find that genes related to development and metabolic pathways have different expression patterns in various developmental stages and tissues, so this statement is plausible. However, without the specific results of the study, this statement is taken to be true based on typical findings in genomic studies.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, here are some packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis:\n1. TFBSTools: This package provides a toolkit for handling TFBS profile matrices, scanning sequences and alignments, and querying the JASPAR database. It also includes advanced statistical analysis, data visualization, and data integration capabilities.\n2. GenomicRangeSample (GRS): This package provides a flexible and efficient method for identifying overlapping genomic ranges that are enriched for a given set of features, such as TFBSs.\n3. HISAT2: This package is a spliced aligner that can be used to align RNA-seq reads to a reference genome, and can also be used to identify TFBSs.\n4. STAR: This package is a high-performance spliced aligner that can be used to align RNA-seq reads to a reference genome, and can also be used to identify TFBSs.\n5. HMMER: This package is a tool for searching for specific protein sequences (such as transcription factors) in a given DNA or protein sequence. It can be used to identify TFBSs in a genomic sequence.\n6. RSAT: This package provides a set of tools for the analysis of ChIP-seq data, including peak calling and motif analysis, which can be used to identify TFBSs.\n7. MACS: This package is a collection of tools for the analysis of ChIP-seq data, including peak calling and motif analysis, which can be used to identify TFBSs.\n8. DeepTools: This package provides a set of tools for the analysis of deep-sequencing data, including peak calling and motif analysis, which can be used to identify TFBSs.\nAll of these packages are available under the GPL-2 license and can be downloaded from the Bioconductor website (http://bioconductor.org/). For more information, you can contact the author at ge.tan09@imperial.ac.uk.\nI hope this helps! Let me know if you have any other questions.",
    "llama-2-13b-chat-hf_fact_raw": "1. TFBSTools is an R/Bioconductor package for handling transcription factor binding site profile matrices and querying the JASPAR database.\n2. GenomicRangeSample (GRS) is an R/Bioconductor package for identifying overlapping genomic ranges enriched for features like TFBSs.\n3. HISAT2 is an R/Bioconductor spliced aligner that can also be used to identify transcription factor binding sites.\n4. STAR is an R/Bioconductor high-performance spliced aligner useful for identifying TFBSs.\n5. HMMER is an R/Bioconductor tool for searching specific protein sequences and can be employed to identify TFBSs in genomic sequences.",
    "llama-2-13b-chat-hf_fact": [
      "TFBSTools is an R/Bioconductor package for handling transcription factor binding site profile matrices and querying the JASPAR database.",
      "GenomicRangeSample (GRS) is an R/Bioconductor package for identifying overlapping genomic ranges enriched for features like TFBSs.",
      "HISAT2 is an R/Bioconductor spliced aligner that can also be used to identify transcription factor binding sites.",
      "STAR is an R/Bioconductor high-performance spliced aligner useful for identifying TFBSs.",
      "HMMER is an R/Bioconductor tool for searching specific protein sequences and can be employed to identify TFBSs in genomic sequences."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: GenomicRanges is an R/Bioconductor package for representing and handling genomic intervals and annotations. \"GenomicRangeSample\" is not a recognized package, and the correct functioning should be ascribed to GenomicRanges or one of its companion packages (not specifically for TFBSs, though).\n3. FALSE [correction]: HISAT2 is a fast and sensitive spliced aligner for mapping RNA-Seq reads, but it is not part of the R/Bioconductor suite, nor is it specifically designed to identify transcription factor binding sites (TFBSs).\n4. FALSE [correction]: STAR (Spliced Transcripts Alignment to a Reference) is also a fast and widely-used spliced read aligner for RNA-Seq data, but it is not an R/Bioconductor package, and its primary function is not to identify TFBSs.\n5. FALSE [correction]: HMMER is a suite of tools for searching sequence databases for homologs of protein sequences using hidden Markov model (HMM) profiles. It is not part of R/Bioconductor, nor is it typically used to identify TFBSs in genomic sequences.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are some clinical trials for the prevention of sarcopenia:\n1. The Sarcopenia Prevention by Resistance Training (SPORT) trial, which is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n2. The Physical Activity and Sarcopenia Trial (PAST), which is a randomized controlled trial that aims to determine the effectiveness of a physical activity intervention in preventing sarcopenia in older adults.\n3. The Sarcopenia Intervention by Diet and Exercise (SIDE) trial, which is a randomized controlled trial that aims to determine the effectiveness of a diet and exercise intervention in preventing sarcopenia in older adults.\n4. The Multidisciplinary Approach to the Prevention of Sarcopenia (MAPS) trial, which is a randomized controlled trial that aims to determine the effectiveness of a multidisciplinary intervention in preventing sarcopenia in older adults.\n5. The Sarcopenia Prevention through Exercise and Nutrition (SPEN) trial, which is a randomized controlled trial that aims to determine the effectiveness of an exercise and nutrition intervention in preventing sarcopenia in older adults.\nThese clinical trials are based on the recommendations made by the international task force of academic and industry leaders in sarcopenia research, and they are designed to evaluate the effectiveness of different interventions in preventing sarcopenia in older adults.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Sarcopenia Prevention by Resistance Training (SPORT) trial is a randomized controlled trial.\n2. The Physical Activity and Sarcopenia Trial (PAST) focuses on the effectiveness of physical activity in preventing sarcopenia in older adults.\n3. The Sarcopenia Intervention by Diet and Exercise (SIDE) trial examines the effectiveness of a diet and exercise intervention in preventing sarcopenia.\n4. The Multidisciplinary Approach to the Prevention of Sarcopenia (MAPS) trial is designed to test a multidisciplinary intervention for sarcopenia prevention.\n5. The Sarcopenia Prevention through Exercise and Nutrition (SPEN) trial is a study on the prevention of sarcopenia through exercise and nutrition interventions.",
    "llama-2-13b-chat-hf_fact": [
      "The Sarcopenia Prevention by Resistance Training (SPORT) trial is a randomized controlled trial.",
      "The Physical Activity and Sarcopenia Trial (PAST) focuses on the effectiveness of physical activity in preventing sarcopenia in older adults.",
      "The Sarcopenia Intervention by Diet and Exercise (SIDE) trial examines the effectiveness of a diet and exercise intervention in preventing sarcopenia.",
      "The Multidisciplinary Approach to the Prevention of Sarcopenia (MAPS) trial is designed to test a multidisciplinary intervention for sarcopenia prevention.",
      "The Sarcopenia Prevention through Exercise and Nutrition (SPEN) trial is a study on the prevention of sarcopenia through exercise and nutrition interventions."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout additional details or access to current academic databases and literature to verify the specifics of these trials, it is not possible for me to determine the truthfulness of the statements about the various sarcopenia trials mentioned. These statements appear to reflect typical naming conventions for clinical trials and research studies, but their existence and the specifics of their design would need to be confirmed with research papers or clinical trial registries.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the database of molecular recognition features in membrane proteins is called \"mpMoRFsDB\". It is a publicly available MySQL database with a user-friendly web interface and a Jmol applet for structure visualization. The database contains information on molecular recognition features (MoRFs) in transmembrane and peripheral membrane proteins, including their secondary structure and position in the protein. The database is available at the website http://bioinformatics.biol.uoa.gr/mpMoRFsDB.",
    "llama-2-13b-chat-hf_fact_raw": "1. The database of molecular recognition features in membrane proteins is called \"mpMoRFsDB\".\n2. mpMoRFsDB is a publicly available MySQL database.\n3. mpMoRFsDB includes a user-friendly web interface.\n4. The database features a Jmol applet for structure visualization.\n5. The database provides information on molecular recognition features in transmembrane and peripheral membrane proteins.",
    "llama-2-13b-chat-hf_fact": [
      "The database of molecular recognition features in membrane proteins is called \"mpMoRFsDB\".",
      "mpMoRFsDB is a publicly available MySQL database.",
      "mpMoRFsDB includes a user-friendly web interface.",
      "The database features a Jmol applet for structure visualization.",
      "The database provides information on molecular recognition features in transmembrane and peripheral membrane proteins."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, yes, rivaroxaban is metabolized in the kidneys. The document states that rivaroxaban is excreted via the kidneys, and the PBPK model developed in the study took into account the role of the kidneys in rivaroxaban's pharmacokinetics. Additionally, the study found that age, renal, and hepatic clearance are important factors affecting rivaroxaban pharmacokinetics, which further supports the idea that the kidneys play a role in the metabolism of rivaroxaban.",
    "llama-2-13b-chat-hf_fact_raw": "1. Rivaroxaban is metabolized in the kidneys.\n2. Rivaroxaban is excreted via the kidneys.\n3. A PBPK model has been developed that considers the role of the kidneys in rivaroxaban's pharmacokinetics.\n4. Age, renal, and hepatic clearance are important factors affecting rivaroxaban pharmacokinetics.",
    "llama-2-13b-chat-hf_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "Rivaroxaban is excreted via the kidneys.",
      "A PBPK model has been developed that considers the role of the kidneys in rivaroxaban's pharmacokinetics.",
      "Age, renal, and hepatic clearance are important factors affecting rivaroxaban pharmacokinetics."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized in the liver.\n2. TRUE\n3. TRUE: A physiologically based pharmacokinetic (PBPK) model for rivaroxaban would likely consider the role of the kidneys in its pharmacokinetics due to its importance in drug excretion.\n4. TRUE: Age, renal function, and hepatic function are important factors affecting the pharmacokinetics of rivaroxaban.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the genes regulated by TRalpha2 in the heart are:\n1. TRalpha2 itself, as it is expressed in the apex and its expression is increased by AM.\n2. T3-regulated genes, as the changes in their expression are reminiscent of foetal reprogramming.\nThe study found that AM and Dron have similar effects on the expression of TR isoforms in the right atrium, but AM has a more profound effect on TR- and T3-dependent gene expression in the left ventricle, suggesting that AM may have a greater impact on foetal reprogramming in this region.",
    "llama-2-13b-chat-hf_fact_raw": "1. TRalpha2 is expressed in the apex of the heart.\n2. The expression of TRalpha2 is increased by a molecule referred to as AM.\n3. T3-regulated genes are affected by TRalpha2 in the heart and undergo changes in expression reflective of foetal reprogramming.\n4. AM and Dron have similar effects on the expression of TR isoforms in the right atrium.\n5. AM has a more profound effect on TR- and T3-dependent gene expression in the left ventricle than Dron.",
    "llama-2-13b-chat-hf_fact": [
      "TRalpha2 is expressed in the apex of the heart.",
      "The expression of TRalpha2 is increased by a molecule referred to as AM.",
      "T3-regulated genes are affected by TRalpha2 in the heart and undergo changes in expression reflective of foetal reprogramming.",
      "AM and Dron have similar effects on the expression of TR isoforms in the right atrium.",
      "AM has a more profound effect on TR- and T3-dependent gene expression in the left ventricle than Dron."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are too specific and seem to refer to the results of particular research studies or scientific knowledge related to thyroid hormone receptors (TRs) like TRalpha2, AM (potentially an acronym for a molecule or compound in this context), and a substance or condition referred to as \"Dron.\" Without access to the specific research or scientific literature in question, it's impossible to verify the accuracy of these statements. Therefore, they all fall under \"UNKNOWN\" unless further context or evidence is provided.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-13b-chat-hf_response": "Certainly! Based on the information provided, here are some available biomedical question answering systems:\n1. Mayo Clinic's AskMayoExpert: This is a machine learning-based system that provides evidence-based answers to clinical questions. It uses a knowledge graph to store and retrieve information from a large database of medical literature.\n2. IBM Watson for Oncology: This is a machine learning-based system that uses natural language processing and machine learning algorithms to answer questions related to cancer diagnosis and treatment. It has been trained on a large dataset of medical literature and clinical trials.\n3. Microsoft Healthcare NLP: This is a set of natural language processing tools and resources for the healthcare industry. It includes a question answering system that can be trained on specific domains of medical knowledge.\n4. Stanford Natural Language Processing Group's Biomedical Question Answering System: This is a machine learning-based system that uses a combination of natural language processing and machine learning algorithms to answer biomedical questions. It has been trained on a large dataset of biomedical literature.\n5. University of Utah's Biomedical Question Answering System: This is a machine learning-based system that uses a combination of natural language processing and machine learning algorithms to answer biomedical questions. It has been trained on a large dataset of biomedical literature and clinical trials.\n6. OpenBiolink: This is an open-source question answering system that uses natural language processing and machine learning algorithms to answer biomedical questions. It has been trained on a large dataset of biomedical literature and clinical trials.\n7. BioASQ: This is a machine learning-based system that uses natural language processing and machine learning algorithms to answer biomedical questions. It has been trained on a large dataset of biomedical literature and clinical trials.\n8. MedQA: This is a machine learning-based system that uses natural language processing and machine learning algorithms to answer biomedical questions. It has been trained on a large dataset of biomedical literature and clinical trials.\nThese are just a few examples of available biomedical question answering systems. There are many other systems and resources available, and the field is constantly evolving as new technologies and approaches are developed.\nIn terms of your specific question analysis component, you may want to consider exploring the",
    "llama-2-13b-chat-hf_fact_raw": "1. Mayo Clinic's AskMayoExpert is a machine learning-based system designed to provide evidence-based answers to clinical questions.\n2. IBM Watson for Oncology is a system developed to assist with cancer diagnosis and treatment questions, using natural language processing and machine learning.\n3. Microsoft Healthcare NLP offers natural language processing tools and resources that include a question answering capability for the healthcare industry.\n4. The Stanford Natural Language Processing Group has developed a machine learning-based Biomedical Question Answering System trained on biomedical literature.\n5. BioASQ is a biomedical question answering system that uses natural language processing and machine learning, and it is trained on a dataset of medical literature and clinical trials.",
    "llama-2-13b-chat-hf_fact": [
      "Mayo Clinic's AskMayoExpert is a machine learning-based system designed to provide evidence-based answers to clinical questions.",
      "IBM Watson for Oncology is a system developed to assist with cancer diagnosis and treatment questions, using natural language processing and machine learning.",
      "Microsoft Healthcare NLP offers natural language processing tools and resources that include a question answering capability for the healthcare industry.",
      "The Stanford Natural Language Processing Group has developed a machine learning-based Biomedical Question Answering System trained on biomedical literature.",
      "BioASQ is a biomedical question answering system that uses natural language processing and machine learning, and it is trained on a dataset of medical literature and clinical trials."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Mayo Clinic's AskMayoExpert is an online clinical knowledge management system designed to provide evidence-based answers to clinical questions, but there is no specific mention that it is machine learning-based.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the trancription factor that activates the betalain pathway is not directly mentioned. However, the article discusses the role of beta-arrestin2 in the signaling pathway activated by the biased agonist PTH-betaarr. Therefore, it can be inferred that beta-arrestin2 is a key transcription factor that activates the betalain pathway.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the preferred technologies for the enrichment of phosphorylated peptides in global quantitative phosphoproteomics analyses are:\n1. TiO2 phosphopeptide pre-enrichment: This method uses titanium dioxide (TiO2) to selectively adsorb phosphopeptides, which are then eluted and concentrated for further analysis.\n2. IMAC (SIMAC) fractionation: This method uses immobilized metal affinity chromatography (IMAC) to separate phosphopeptides based on their phosphorylation state. In this study, sequential elution from IMAC (SIMAC) was used to separate multi- and mono-phosphorylated peptides.\n3. Hydrophilic interaction liquid chromatography (HILIC): This method separates peptides based on their hydrophilicity. In this study, HILIC was used to separate the mono-phosphorylated peptides.\nThese technologies were combined in a multi-dimensional phosphoproteomics strategy, which includes the TiO2 phosphopeptide pre-enrichment step, followed by post-fractionation using sequential elution from IMAC (SIMAC) and HILIC. This strategy has several advantages, including high specificity, reduced sample preparation workload, and low adsorptive losses.",
    "llama-2-13b-chat-hf_fact_raw": "1. Titanium dioxide (TiO2) is used to selectively adsorb phosphopeptides in TiO2 phosphopeptide pre-enrichment technology.\n2. Immobilized metal affinity chromatography (IMAC) is used to separate phosphopeptides based on their phosphorylation state.\n3. Sequential elution from IMAC (SIMAC) can separate multi- and mono-phosphorylated peptides.\n4. Hydrophilic interaction liquid chromatography (HILIC) is used to separate peptides based on their hydrophilicity, particularly mono-phosphorylated peptides.\n5. A multi-dimensional phosphoproteomics strategy can include TiO2 pre-enrichment, followed by post-fractionation using SIMAC and HILIC.",
    "llama-2-13b-chat-hf_fact": [
      "Titanium dioxide (TiO2) is used to selectively adsorb phosphopeptides in TiO2 phosphopeptide pre-enrichment technology.",
      "Immobilized metal affinity chromatography (IMAC) is used to separate phosphopeptides based on their phosphorylation state.",
      "Sequential elution from IMAC (SIMAC) can separate multi- and mono-phosphorylated peptides.",
      "Hydrophilic interaction liquid chromatography (HILIC) is used to separate peptides based on their hydrophilicity, particularly mono-phosphorylated peptides.",
      "A multi-dimensional phosphoproteomics strategy can include TiO2 pre-enrichment, followed by post-fractionation using SIMAC and HILIC."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the disorder described in the document is rated by Palmini classification as X-linked intellectual disability with spastic paraplegia and palmo-plantar hyperkeratosis (OMIM 309500).",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, there is no conclusive evidence to suggest that viruses are involved in the etiology of human subacute thyroiditis. The document reports on the isolation of unclassified viruses from patients with subacute thyroiditis, but does not provide any definitive evidence of a causal link between the viruses and the disease. Further research is needed to determine the potential role of these viruses in human health disorders.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is no conclusive evidence to suggest that viruses are involved in the etiology of human subacute thyroiditis.\n2. Unclassified viruses have been isolated from patients with subacute thyroiditis.\n3. There is no definitive evidence of a causal link between the isolated viruses and subacute thyroiditis.\n4. Document-0 indicates that further research is needed to determine the role of these viruses in human health disorders.",
    "llama-2-13b-chat-hf_fact": [
      "There is no conclusive evidence to suggest that viruses are involved in the etiology of human subacute thyroiditis.",
      "Unclassified viruses have been isolated from patients with subacute thyroiditis.",
      "There is no definitive evidence of a causal link between the isolated viruses and subacute thyroiditis.",
      "Document-0 indicates that further research is needed to determine the role of these viruses in human health disorders."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: No unclassified viruses have been isolated from patients with subacute thyroiditis that are conclusively linked to the condition.\n3. TRUE\n4. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that STAT3 is involved in the suppression of autophagy through its interaction with the eIF2 kinase 2 EIF2AK2 (also known as protein kinase R (PKR)). The study found that pharmacological and genetic inhibition of STAT3 stimulated the activating phosphorylation of PKR and consequent eIF2 hyperphosphorylation, which inhibits autophagy. Additionally, the study found that PKR depletion inhibited autophagy, and that STAT3-targeting chemicals and palmitate caused the disruption of inhibitory STAT3-PKR interactions, leading to PKR-dependent eIF2 phosphorylation and autophagy induction. Therefore, the answer to the question is yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
    "llama-2-13b-chat-hf_fact_raw": "1. STAT3 interacts with the eIF2 kinase 2 EIF2AK2.\n2. Inhibition of STAT3 stimulates the activating phosphorylation of PKR (protein kinase R).\n3. Pharmacological and genetic inhibition of STAT3 leads to eIF2 hyperphosphorylation, which inhibits autophagy.\n4. PKR depletion inhibited autophagy according to the study.\n5. STAT3-targeting chemicals and palmitate disrupt the inhibitory STAT3-PKR interactions, leading to PKR-dependent eIF2 phosphorylation and autophagy induction.",
    "llama-2-13b-chat-hf_fact": [
      "STAT3 interacts with the eIF2 kinase 2 EIF2AK2.",
      "Inhibition of STAT3 stimulates the activating phosphorylation of PKR (protein kinase R).",
      "Pharmacological and genetic inhibition of STAT3 leads to eIF2 hyperphosphorylation, which inhibits autophagy.",
      "PKR depletion inhibited autophagy according to the study.",
      "STAT3-targeting chemicals and palmitate disrupt the inhibitory STAT3-PKR interactions, leading to PKR-dependent eIF2 phosphorylation and autophagy induction."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: STAT3 (Signal Transducer and Activator of Transcription 3) is a protein known to interact with various other proteins, including kinases. It can interact with eIF2 kinase 2 (also known as EIF2AK2 or PKR).\n2. UNKNOWN: Without more specific details from the provided passage, it's impossible to verify if the inhibition of STAT3 stimulates the activating phosphorylation of PKR.\n3. UNKNOWN: The statement regarding pharmacological and genetic inhibition of STAT3 leading to eIF2 hyperphosphorylation and subsequent inhibition of autophagy is specific and would require referencing literature to confirm.\n4. UNKNOWN: Whether PKR depletion inhibited autophagy is another specific claim which cannot be validated as true or false without additional context or access to the study that produced these findings.\n5. UNKNOWN: The statement about STAT3-targeting chemicals and palmitate disrupting STAT3-PKR interactions, leading to PKR-dependent eIF2 phosphorylation and autophagy induction, would need to be referenced against specific studies or scientific literature to be confirmed as true or false.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Theatre is a web-based software tool for genomic analysis that allows users to compare and analyze genomic sequences, particularly with respect to motifs that may be involved in gene expression regulation. The tool provides an interface to commonly used sequence analysis tools and biological sequence databases, and can determine or predict the positions of coding regions, repetitive sequences, and transcription factor binding sites in families of DNA sequences.\nTheatre can produce both web-based output and publication-quality color hardcopies showing predicted features in aligned genomic sequences. The tool can be accessed online at http://www.hgmp.mrc.ac.uk/Registered/Webapp/theatre/.\nIn a case study, Theatre was used to compare the p53 promoter region of four mammalian species and two fish species. The results revealed differences in the p53 promoter region between the mammalian species and the fish species, with the promoter regions in the fish species not having been previously predicted or characterized.\nOverall, Theatre is a useful tool for researchers working in the field of genomics and gene expression regulation, as it provides an easy-to-use interface for comparing and analyzing genomic sequences and predicting the presence of specific motifs and features.",
    "llama-2-13b-chat-hf_fact_raw": "1. Theatre is a web-based software tool for genomic analysis.\n2. Theatre allows users to analyze genomic sequences, especially regarding motifs involved in gene expression regulation.\n3. The software provides access to sequence analysis tools and biological sequence databases.\n4. Theatre can determine or predict the positions of coding regions, repetitive sequences, and transcription factor binding sites in DNA sequences.\n5. Theatre was used in a case study to compare the p53 promoter region in mammalian and fish species, revealing differences between these species.",
    "llama-2-13b-chat-hf_fact": [
      "Theatre is a web-based software tool for genomic analysis.",
      "Theatre allows users to analyze genomic sequences, especially regarding motifs involved in gene expression regulation.",
      "The software provides access to sequence analysis tools and biological sequence databases.",
      "Theatre can determine or predict the positions of coding regions, repetitive sequences, and transcription factor binding sites in DNA sequences.",
      "Theatre was used in a case study to compare the p53 promoter region in mammalian and fish species, revealing differences between these species."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The correct name of a web-based software tool for genomic analysis is GALAXY, not Theatre.\n2. FALSE [correction]: Since the true name of the software is GALAXY (correcting from the first statement), the statement regarding its features should also refer to GALAXY.\n3. TRUE (assuming \"Theatre\" is a typo for GALAXY, which does provide access to analysis tools and databases)\n4. TRUE (again assuming \"Theatre\" is a typo for GALAXY, as GALAXY is known to perform such analyses)\n5. UNKNOWN (without specific publication or case study details, it cannot be determined if GALAXY (or a software mistakenly called Theatre) was used for such a comparative analysis)",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is approximately 21.4 GCUPS (gigafloating-point operations per second) when implemented on an NVIDIA GTX 275 graphics card, as reported in the paper.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, FLVCR1 is a member of the SLC22 family of membrane transporters.",
    "llama-2-13b-chat-hf_fact_raw": "1. FLVCR1 is a member of the SLC22 family of membrane transporters.",
    "llama-2-13b-chat-hf_fact": [
      "FLVCR1 is a member of the SLC22 family of membrane transporters."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: FLVCR1 is not a member of the SLC22 family of membrane transporters; it is part of the Major Facilitator Superfamily (MFS).",
    "llama-2-13b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are the GATA-1 interacting partners that have been discovered using the biotinylation tagging approach:\n1. Other transcription factors\n2. Chromatin remodeling cofactors\nThese interacting partners were identified through the direct binding of biotinylated GATA-1 to streptavidin in nuclear extracts, followed by mass spectrometry analysis. The biotinylation tagging approach has proven to be an efficient method for the direct capture and characterization of transcription factor complexes, including GATA-1 complexes.",
    "llama-2-13b-chat-hf_fact_raw": "1. GATA-1 interacting partners have been discovered using the biotinylation tagging approach.\n2. These interacting partners include other transcription factors.\n3. Chromatin remodeling cofactors are also identified as GATA-1 interacting partners.\n4. Biotinylated GATA-1 directly binds to streptavidin in nuclear extracts for interaction partner identification.\n5. Mass spectrometry analysis is employed following the binding to streptavidin to characterize GATA-1 complexes.",
    "llama-2-13b-chat-hf_fact": [
      "GATA-1 interacting partners have been discovered using the biotinylation tagging approach.",
      "These interacting partners include other transcription factors.",
      "Chromatin remodeling cofactors are also identified as GATA-1 interacting partners.",
      "Biotinylated GATA-1 directly binds to streptavidin in nuclear extracts for interaction partner identification.",
      "Mass spectrometry analysis is employed following the binding to streptavidin to characterize GATA-1 complexes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided about GATA-1 interacting partners indicate a series of procedures that are plausible in a molecular biology context. Biotinylation tagging is a common method for studying protein interactions. Transcription factors, chromatin remodeling cofactors, and the use of mass spectrometry to identify the components of protein complexes are all standard techniques and discoveries in the field. However, without a specific passage or more detailed information, it is not possible to verify the factual accuracy of the specific research findings in these statements. The responses are based on the assumption that the statements accurately reflect the content of the given passage.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the outcome of TAF10 interacting with the GATA1 transcription factor is a differentiation block accompanied by deregulated GATA1 target genes in erythroid cells. This is suggested by the observation that ablating TAF10 specifically in erythroid cells in vivo leads to a block in differentiation and deregulation of GATA1 target genes, including Gata1 itself. Additionally, the interaction between TAF10 and GATA1 is direct, and TAF10 is enriched on the GATA1 locus in human fetal erythroid cells.",
    "llama-2-13b-chat-hf_fact_raw": "1. TAF10 interaction with the GATA1 transcription factor results in a differentiation block in erythroid cells.\n2. The interaction also causes deregulation of GATA1 target genes.\n3. Ablating TAF10 in erythroid cells in vivo leads to a block in differentiation.\n4. Ablating TAF10 in erythroid cells results in deregulation of GATA1 target genes, including Gata1 itself.\n5. TAF10 directly interacts with GATA1.",
    "llama-2-13b-chat-hf_fact": [
      "TAF10 interaction with the GATA1 transcription factor results in a differentiation block in erythroid cells.",
      "The interaction also causes deregulation of GATA1 target genes.",
      "Ablating TAF10 in erythroid cells in vivo leads to a block in differentiation.",
      "Ablating TAF10 in erythroid cells results in deregulation of GATA1 target genes, including Gata1 itself.",
      "TAF10 directly interacts with GATA1."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout the specific text from the original passage or expert knowledge on the interactions between TAF10 and GATA1 in erythroid cells, its impossible to confirm the accuracy of these statements. They contain specific scientific information that requires specialized knowledge or a reliable source to verify.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are decision support systems for chronic pain management. The study described in the provided document found that a computer-based decision support system (CBDS) improved the ability of primary care physicians (PCPs) to manage chronic pain. The system provided structured summaries for 50 chronic pain patients and recommended appropriate pain therapies based on a pain specialist's assessment. The PCPs using the system \"prescribed\" additional pain therapy in 85% of evaluations, with a medical appropriateness score of 5.5/10. Additionally, only 25% of the patients were subsequently re-referred to the pain clinic within one year, suggesting that the use of a CBDS system may improve the management of chronic pain and facilitate screening of consults to optimize specialist utilization.",
    "llama-2-13b-chat-hf_fact_raw": "1. A computer-based decision support system (CBDS) has been developed to assist primary care physicians in managing chronic pain.\n2. The CBDS system provides structured summaries and recommended pain therapies based on a pain specialist's assessment.\n3. Primary care physicians using the CBDS system increased their prescription of additional pain therapy in 85% of evaluations.\n4. The medical appropriateness score for the additional pain therapy prescribed by primary care physicians using the CBDS was 5.5 out of 10.\n5. After using the CBDS system, only 25% of chronic pain patients were re-referred to the pain clinic within one year.",
    "llama-2-13b-chat-hf_fact": [
      "A computer-based decision support system (CBDS) has been developed to assist primary care physicians in managing chronic pain.",
      "The CBDS system provides structured summaries and recommended pain therapies based on a pain specialist's assessment.",
      "Primary care physicians using the CBDS system increased their prescription of additional pain therapy in 85% of evaluations.",
      "The medical appropriateness score for the additional pain therapy prescribed by primary care physicians using the CBDS was 5.5 out of 10.",
      "After using the CBDS system, only 25% of chronic pain patients were re-referred to the pain clinic within one year."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: The statement may be true, but without specific context or reference to the development of such a system, it is not possible to verify the accuracy of the statement.\n2. UNKNOWN: Similar to the first statement, without additional context or reference, we cannot verify the accuracy of the claims about the features of the CBDS system.\n3. UNKNOWN: This statement could be true, but again, it requires data or a study result for confirmation, which has not been provided.\n4. UNKNOWN: As with the previous statements, without specific data or reference to a study mentioning this score, the accuracy of the statement cannot be confirmed.\n5. UNKNOWN: The success rate of the CBDS system in preventing re-referrals to a pain clinic is unverifiable without data or reference to a specific study or report.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the subcellular localization of the protein angiogenin is the perinuclear region and the cytoplasm.",
    "llama-2-13b-chat-hf_fact_raw": "1. Angiogenin localizes to the perinuclear region.\n2. Angiogenin is found in the cytoplasm.",
    "llama-2-13b-chat-hf_fact": [
      "Angiogenin localizes to the perinuclear region.",
      "Angiogenin is found in the cytoplasm."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n\nAngiogenin, a protein with angiogenic properties, can be found in various cellular compartments, including the perinuclear region and the cytoplasm. It is involved in the process of angiogenesis and can be localized to different parts of the cell depending on its functional state and the cell type.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, ranolazine affects kinase signaling activation in the heart by increasing the phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) in both nondiabetic and diabetic infarcted hearts. Additionally, ranolazine increases the ratio of sarcoplasmic Ca(2+)-ATPase/phospholamban and phosphorylated calcium-regulated adenosine monophosphate-activated protein kinase (AMPK) in diabetic hearts. These changes in kinase signaling activation are associated with improved cardiac function in diabetic rats following myocardial infarction.",
    "llama-2-13b-chat-hf_fact_raw": "1. Ranolazine increases phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) in nondiabetic and diabetic infarcted hearts.\n2. Ranolazine affects the ratio of sarcoplasmic Ca(2+)-ATPase/phospholamban in diabetic hearts.\n3. Ranolazine increases phosphorylated calcium-regulated adenosine monophosphate-activated protein kinase (AMPK) in diabetic hearts.\n4. Changes in kinase signaling activation by ranolazine are associated with improved cardiac function in diabetic rats after myocardial infarction.",
    "llama-2-13b-chat-hf_fact": [
      "Ranolazine increases phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) in nondiabetic and diabetic infarcted hearts.",
      "Ranolazine affects the ratio of sarcoplasmic Ca(2+)-ATPase/phospholamban in diabetic hearts.",
      "Ranolazine increases phosphorylated calcium-regulated adenosine monophosphate-activated protein kinase (AMPK) in diabetic hearts.",
      "Changes in kinase signaling activation by ranolazine are associated with improved cardiac function in diabetic rats after myocardial infarction."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nThe provided statements regarding Ranolazine and its effects on kinase signaling and cardiac function in diabetic rats appear consistent with pharmacological actions and outcomes that could be expected based on scientific studies concerning this drug. However, without specific details or references to confirm these claims, these responses assume that the statements reflect accurate scientific knowledge up to the knowledge cutoff date. If the statements are from a credible scientific source, they are likely to be true.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the regulation of Vsr endonuclease does not appear to be independent of the growth phase of bacteria. The document suggests that Vsr endonuclease may play a role in regulating mutation in stationary-phase cells, and that overexpression of Vsr can increase the stationary-phase reversion of a Lac-frameshift allele. However, the absence of Vsr does not have any effect, indicating that Vsr has no regulatory role in stationary-phase mutation. Therefore, the regulation of Vsr endonuclease is not independent of the growth phase of bacteria.",
    "llama-2-13b-chat-hf_fact_raw": "1. The regulation of Vsr endonuclease is not independent of the growth phase of bacteria.\n2. Vsr endonuclease may play a role in regulating mutation in stationary-phase cells.\n3. Overexpression of Vsr can increase the stationary-phase reversion of a Lac-frameshift allele.\n4. The absence of Vsr does not have an effect on stationary-phase mutation.\n5. Vsr endonuclease does not have a regulatory role in stationary-phase mutation without its presence.",
    "llama-2-13b-chat-hf_fact": [
      "The regulation of Vsr endonuclease is not independent of the growth phase of bacteria.",
      "Vsr endonuclease may play a role in regulating mutation in stationary-phase cells.",
      "Overexpression of Vsr can increase the stationary-phase reversion of a Lac-frameshift allele.",
      "The absence of Vsr does not have an effect on stationary-phase mutation.",
      "Vsr endonuclease does not have a regulatory role in stationary-phase mutation without its presence."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The absence of Vsr likely has an effect on stationary-phase mutation, given the implication that its regulation plays a role in this process.\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the computational tools for the prediction of beta-barrel transmembrane proteins are:\n1. transFold: A novel method that uses pairwise interstrand residue statistical potentials derived from globular proteins to predict the supersecondary structure of transmembrane beta-barrel proteins. It employs a generalized hidden Markov model to describe potential beta-barrel supersecondary structures and computes the minimum free energy beta-barrel structure by dynamic programming.\nThis approach does not require a training phase on known TMB structures and can capture long-range interactions, making it a useful tool for predicting the structure of beta-barrel transmembrane proteins. Additionally, a Web server running transFold is available that outputs contact predictions and locations for sequences predicted to form TMBs.",
    "llama-2-13b-chat-hf_fact_raw": "1. transFold is a computational tool used for predicting the supersecondary structure of transmembrane beta-barrel proteins.\n2. transFold uses pairwise interstrand residue statistical potentials derived from globular proteins.\n3. The method employs a generalized hidden Markov model for potential beta-barrel supersecondary structures.\n4. transFold computes the minimum free energy beta-barrel structure through dynamic programming.\n5. A Web server for transFold is available that outputs contact predictions and locations for sequences predicted to form transmembrane beta-barrel proteins (TMBs).",
    "llama-2-13b-chat-hf_fact": [
      "transFold is a computational tool used for predicting the supersecondary structure of transmembrane beta-barrel proteins.",
      "transFold uses pairwise interstrand residue statistical potentials derived from globular proteins.",
      "The method employs a generalized hidden Markov model for potential beta-barrel supersecondary structures.",
      "transFold computes the minimum free energy beta-barrel structure through dynamic programming.",
      "A Web server for transFold is available that outputs contact predictions and locations for sequences predicted to form transmembrane beta-barrel proteins (TMBs)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: transFold uses pairwise interstrand residue statistical potentials derived from membrane proteins, not globular proteins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Galassi classification is used for bipolar affective disorder.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are some common features of Shapiro syndrome:\n1. Recurrent spontaneous hypothermia: The patient experiences episodes of hypothermia, which are not related to environmental factors.\n2. Hyperhidrosis: The patient experiences excessive sweating, which is not related to environmental factors.\n3. Agenesis of the corpus callosum: The patient is born without a complete corpus callosum, a part of the brain that connects the two hemispheres.\n4. Hypotonia: The patient experiences low muscle tone, which can lead to impaired muscle strength and coordination.\n5. Impaired consciousness: The patient may experience impaired consciousness or altered states of consciousness during episodes.\n6. Rhythmic low- to medium-voltage theta waves on EEG: The patient may exhibit a specific type of brain wave pattern on electroencephalography (EEG) called theta waves, which are associated with deep relaxation and drowsiness.\n7. Normal brain MRI: Imaging studies such as magnetic resonance imaging (MRI) of the brain may be normal or may show only minor abnormalities.\nIt is important to note that Shapiro syndrome is a rare condition, and these features may not be present in all cases. A healthcare professional should be consulted for proper diagnosis and treatment.",
    "llama-2-13b-chat-hf_fact_raw": "1. Patients with Shapiro syndrome experience recurrent spontaneous hypothermia not due to environmental factors.\n2. Hyperhidrosis, or excessive sweating not related to environmental factors, is a common feature of Shapiro syndrome.\n3. Shapiro syndrome may include agenesis of the corpus callosum, where the patient is born without a complete corpus callosum.\n4. Hypotonia, indicating low muscle tone, can be a symptom of Shapiro syndrome.\n5. Patients with Shapiro syndrome may show normal brain MRI results or only minor abnormalities.",
    "llama-2-13b-chat-hf_fact": [
      "Patients with Shapiro syndrome experience recurrent spontaneous hypothermia not due to environmental factors.",
      "Hyperhidrosis, or excessive sweating not related to environmental factors, is a common feature of Shapiro syndrome.",
      "Shapiro syndrome may include agenesis of the corpus callosum, where the patient is born without a complete corpus callosum.",
      "Hypotonia, indicating low muscle tone, can be a symptom of Shapiro syndrome.",
      "Patients with Shapiro syndrome may show normal brain MRI results or only minor abnormalities."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the disease linked to mutations within BRAG1 is Congenital Central Hypoventilation Syndrome (CCHS).",
    "llama-2-13b-chat-hf_fact_raw": "1. Congenital Central Hypoventilation Syndrome (CCHS) is linked to mutations within the BRAG1 gene.",
    "llama-2-13b-chat-hf_fact": [
      "Congenital Central Hypoventilation Syndrome (CCHS) is linked to mutations within the BRAG1 gene."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Congenital Central Hypoventilation Syndrome (CCHS) is linked to mutations within the PHOX2B gene, not the BRAG1 gene.",
    "llama-2-13b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the main inhibitor of protein phosphatase 1 (PP1) is protein phosphatase inhibitor-1 (PPI-1).",
    "llama-2-13b-chat-hf_fact_raw": "1. Protein phosphatase inhibitor-1 (PPI-1) is the main inhibitor of protein phosphatase 1 (PP1).",
    "llama-2-13b-chat-hf_fact": [
      "Protein phosphatase inhibitor-1 (PPI-1) is the main inhibitor of protein phosphatase 1 (PP1)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the mechanisms underlying adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis involve at least two genes involved in the regulation of post-exponential phase prokaryotic differentiation, specifically comA and comK. The presence of a functional RecA protein is not required for this type of mutagenesis. The phenomenon of adaptive mutagenesis in B. subtilis suggests the existence of a hypermutable subpopulation(s) within the bacterial culture, which raises important considerations for the study of evolution, mutation development, bacterial populations, and inter-bacterial communication in ecological niches.",
    "llama-2-13b-chat-hf_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis involves genes associated with post-exponential phase prokaryotic differentiation.\n2. The genes comA and comK are involved in the regulation of adaptive mutagenesis in Bacillus subtilis.\n3. A functional RecA protein is not required for stationary-phase mutagenesis in Bacillus subtilis.\n4. Adaptive mutagenesis in B. subtilis suggests the existence of a hypermutable subpopulation within the bacterial culture. \n5. The study of adaptive mutagenesis in Bacillus subtilis has implications for understanding evolution, mutation development, and inter-bacterial communication.",
    "llama-2-13b-chat-hf_fact": [
      "Adaptive mutagenesis in Bacillus subtilis involves genes associated with post-exponential phase prokaryotic differentiation.",
      "The genes comA and comK are involved in the regulation of adaptive mutagenesis in Bacillus subtilis.",
      "A functional RecA protein is not required for stationary-phase mutagenesis in Bacillus subtilis.",
      "Adaptive mutagenesis in B. subtilis suggests the existence of a hypermutable subpopulation within the bacterial culture.",
      "The study of adaptive mutagenesis in Bacillus subtilis has implications for understanding evolution, mutation development, and inter-bacterial communication."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Adaptive mutagenesis in Bacillus subtilis is linked to conditions such as the post-exponential phase, which is associated with prokaryotic differentiation and stress responses.\n2. TRUE: The genes comA and comK are known to be involved in competence development in Bacillus subtilis, which can relate to processes such as transformation and potentially influence mutagenesis.\n3. FALSE [correction]: A functional RecA protein is typically required for recombinational repair and for stationary-phase mutagenesis in Bacillus subtilis, as RecA is central to DNA repair and homologous recombination in bacteria.\n4. TRUE: Studies on adaptive mutagenesis often discuss the possibility or existence of a hypermutable subpopulation within a bacterial culture that may contribute to mutation development under stress.\n5. TRUE: The study of adaptive mutagenesis in Bacillus subtilis indeed provides insights into evolutionary processes, the mechanisms of mutation development, and aspects of inter-bacterial communication such as transformation and competence.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, erucism is caused by the venom-containing spines of the gum leaf skeletoniser (Uraba lugens). This insect is not an indigenous caterpillar, but its presence in the Auckland region should be considered by medical practitioners in the differential diagnosis of contact dermatitis. Exposure to U. lugens can cause symptoms such as a stinging sensation, itching, and the formation of wheals.",
    "llama-2-13b-chat-hf_fact_raw": "1. Erucism is caused by venom-containing spines of the gum leaf skeletoniser (Uraba lugens).\n2. The gum leaf skeletoniser (Uraba lugens) is not indigenous.\n3. Medical practitioners in Auckland should consider Uraba lugens in the differential diagnosis of contact dermatitis.\n4. Exposure to Uraba lugens can cause symptoms such as a stinging sensation, itching, and the formation of wheals.",
    "llama-2-13b-chat-hf_fact": [
      "Erucism is caused by venom-containing spines of the gum leaf skeletoniser (Uraba lugens).",
      "The gum leaf skeletoniser (Uraba lugens) is not indigenous.",
      "Medical practitioners in Auckland should consider Uraba lugens in the differential diagnosis of contact dermatitis.",
      "Exposure to Uraba lugens can cause symptoms such as a stinging sensation, itching, and the formation of wheals."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The gum leaf skeletoniser (Uraba lugens) is indigenous to Australia.\n3. TRUE\n4. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the indications for hydrochlorothiazide (HCTZ) are for the treatment of hypertension. This is stated in the document-0, which describes HCTZ as a diuretic used to treat hypertension and belonging to class IV of the Biopharmaceutics Classification System.",
    "llama-2-13b-chat-hf_fact_raw": "1. Hydrochlorothiazide is indicated for the treatment of hypertension.\n2. Hydrochlorothiazide is a diuretic.\n3. It belongs to class IV of the Biopharmaceutics Classification System.",
    "llama-2-13b-chat-hf_fact": [
      "Hydrochlorothiazide is indicated for the treatment of hypertension.",
      "Hydrochlorothiazide is a diuretic.",
      "It belongs to class IV of the Biopharmaceutics Classification System."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Hydrochlorothiazide belongs to class I of the Biopharmaceutics Classification System, which denotes high solubility and high permeability.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nYes, silicon has been used in the treatment of incontinence.\nThe document provided describes a study where transurethral submucosal injection therapy using polydimethylsiloxane (PDS) was used to treat severe post-operative incontinence after radical prostatectomy (RP). The study found that five out of six patients who underwent the treatment were dry after a mean follow-up of 15.5 months, with minimal side effects. The study concludes that transurethral injection therapy using silicone particles is a justifiable procedure for treating incontinence after RP.",
    "llama-2-13b-chat-hf_fact_raw": "1. Silicon, in the form of polydimethylsiloxane (PDS), has been used in the treatment of incontinence.\n2. The treatment was used specifically for severe post-operative incontinence after radical prostatectomy (RP).\n3. In a study, five out of six patients treated with transurethral submucosal injection therapy using PDS were dry after a mean follow-up of 15.5 months.\n4. The study reported minimal side effects from the treatment with polydimethylsiloxane.\n5. The study concludes that transurethral injection therapy using silicone particles can be justifiable for treating incontinence after radical prostatectomy.",
    "llama-2-13b-chat-hf_fact": [
      "Silicon, in the form of polydimethylsiloxane (PDS), has been used in the treatment of incontinence.",
      "The treatment was used specifically for severe post-operative incontinence after radical prostatectomy (RP).",
      "In a study, five out of six patients treated with transurethral submucosal injection therapy using PDS were dry after a mean follow-up of 15.5 months.",
      "The study reported minimal side effects from the treatment with polydimethylsiloxane.",
      "The study concludes that transurethral injection therapy using silicone particles can be justifiable for treating incontinence after radical prostatectomy."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Silicon, in the form of polydimethylsiloxane (PDMS), not PDS, has been used in the treatment of incontinence.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n(Note: Without the specific study or research data referenced, it is difficult to accurately determine the truth of statements related to its findings. Therefore, the responses to statements 3, 4, and 5 are unknown.)",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, there is an association between the moon cycle and the risk of rupture of intracranial aneurysms. Specifically, the study found that there was a peak incidence of aneurysm rupture during the phase of the new moon, which was statistically significant (p < 0.001). However, no seasonal variation in the incidence of aneurysmal subarachnoid hemorrhage (SAH) was observed. This suggests that the lunar cycle may have a specific effect on the risk of aneurysm rupture, but not on the overall incidence of SAH.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is an association between the moon cycle and the risk of rupture of intracranial aneurysms.\n2. A peak incidence of aneurysm rupture occurred during the phase of the new moon.\n3. The observed peak incidence during the new moon phase was statistically significant, with a p-value less than 0.001.\n4. No seasonal variation in the incidence of aneurysmal subarachnoid hemorrhage (SAH) was noted in the study.\n5. The lunar cycle may affect the risk of aneurysm rupture, but not the overall incidence of subarachnoid hemorrhage (SAH).",
    "llama-2-13b-chat-hf_fact": [
      "There is an association between the moon cycle and the risk of rupture of intracranial aneurysms.",
      "A peak incidence of aneurysm rupture occurred during the phase of the new moon.",
      "The observed peak incidence during the new moon phase was statistically significant, with a p-value less than 0.001.",
      "No seasonal variation in the incidence of aneurysmal subarachnoid hemorrhage (SAH) was noted in the study.",
      "The lunar cycle may affect the risk of aneurysm rupture, but not the overall incidence of subarachnoid hemorrhage (SAH)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Explanation]: There is not enough context provided to verify or refute the specific claims about the moon cycle's association with intracranial aneurysm rupture, the statistical significance of the peak incidence in relation to the lunar phase, or any seasonal variations in the incidence of subarachnoid hemorrhage (SAH). These statements would require access to specific scientific studies or medical data to confirm their accuracy.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that HuR protein does regulate the splicing process. The document states that HuR protein modulates mRNA splicing, which is a process that removes introns (non-coding regions) and joins exons (coding regions) together to form a mature mRNA molecule. The document also mentions that HuR protein interacts with thousands of cellular transcripts, including non-coding RNAs, and that it serves as a model of RNA-protein interactions. Additionally, the document states that HuR protein recognizes specific RNA targets composed of short primary sequence patterns, and that secondary structures of 66-75 nucleotides enhance HuR's recognition of these targets. Overall, the information suggests that HuR protein plays a role in regulating the splicing process by interacting with specific RNA targets and modulating mRNA splicing.",
    "llama-2-13b-chat-hf_fact_raw": "1. HuR protein modulates mRNA splicing.\n2. mRNA splicing involves the removal of introns and the joining of exons to form a mature mRNA molecule.\n3. HuR protein interacts with thousands of cellular transcripts, including non-coding RNAs.\n4. HuR protein serves as a model for RNA-protein interactions.\n5. HuR protein recognizes specific RNA targets composed of short primary sequence patterns and is influenced by secondary structures of 66-75 nucleotides.",
    "llama-2-13b-chat-hf_fact": [
      "HuR protein modulates mRNA splicing.",
      "mRNA splicing involves the removal of introns and the joining of exons to form a mature mRNA molecule.",
      "HuR protein interacts with thousands of cellular transcripts, including non-coding RNAs.",
      "HuR protein serves as a model for RNA-protein interactions.",
      "HuR protein recognizes specific RNA targets composed of short primary sequence patterns and is influenced by secondary structures of 66-75 nucleotides."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: HuR protein primarily modulates mRNA stability and translation, rather than splicing.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the known functions of the prothymosin alpha c-terminal peptide are:\n1. Nuclear localization: The c-terminal peptide of prothymosin alpha has been shown to be responsible for targeting the protein to the nucleus. The basic cluster of amino acids at the carboxyl terminus, TKKQKT, has been identified as the nuclear targeting signal.\n2. Sequestration of thymosin alpha 1: Prothymosin alpha was once thought to be a precursor for thymosin alpha 1, a putative peptide hormone secreted by the thymus. The c-terminal peptide of prothymosin alpha may play a role in sequestering thymosin alpha 1 and preventing its secretion.\nIt is important to note that these functions are based on the information provided in the given document, and further research may reveal additional functions for the prothymosin alpha c-terminal peptide.",
    "llama-2-13b-chat-hf_fact_raw": "1. The c-terminal peptide of prothymosin alpha is responsible for targeting the protein to the nucleus.\n2. The amino acid sequence TKKQKT at the carboxyl terminus of prothymosin alpha is identified as the nuclear targeting signal.\n3. Prothymosin alpha was once thought to be a precursor for thymosin alpha 1.\n4. The c-terminal peptide of prothymosin alpha may sequester thymosin alpha 1, possibly preventing its secretion.",
    "llama-2-13b-chat-hf_fact": [
      "The c-terminal peptide of prothymosin alpha is responsible for targeting the protein to the nucleus.",
      "The amino acid sequence TKKQKT at the carboxyl terminus of prothymosin alpha is identified as the nuclear targeting signal.",
      "Prothymosin alpha was once thought to be a precursor for thymosin alpha 1.",
      "The c-terminal peptide of prothymosin alpha may sequester thymosin alpha 1, possibly preventing its secretion."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The amino acid sequence KKEKET at the carboxyl terminus of prothymosin alpha is identified as the nuclear localization signal.\n3. TRUE\n4. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the peptide that plays a pivotal role in human cystatin C (HCC) fibrillization is (47)LQVVR(51). This peptide was identified using the AmylPred algorithm as an \"aggregation-prone\" peptide within the HCC sequence, and subsequent experiments have confirmed its role in HCC fibrillization.",
    "llama-2-13b-chat-hf_fact_raw": "1. The peptide (47)LQVVR(51) plays a pivotal role in human cystatin C fibrillization.\n2. The peptide (47)LQVVR(51) was identified as \"aggregation-prone\" within the human cystatin C sequence.\n3. The identification of the peptide (47)LQVVR(51) was accomplished using the AmylPred algorithm.\n4. Experiments have confirmed the role of peptide (47)LQVVR(51) in human cystatin C fibrillization.",
    "llama-2-13b-chat-hf_fact": [
      "The peptide (47)LQVVR(51) plays a pivotal role in human cystatin C fibrillization.",
      "The peptide (47)LQVVR(51) was identified as \"aggregation-prone\" within the human cystatin C sequence.",
      "The identification of the peptide (47)LQVVR(51) was accomplished using the AmylPred algorithm.",
      "Experiments have confirmed the role of peptide (47)LQVVR(51) in human cystatin C fibrillization."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: The peptide (47)LQVVR(51) is known for its role in human cystatin C fibrillization, and mutations within this region have been linked to hereditary cerebral amyloid angiopathy.\n2. TRUE: The peptide (47)LQVVR(51) has been identified as \"aggregation-prone\" within the human cystatin C sequence, supporting its role in amyloid fibril formation.\n3. UNKNOWN: Without specific evidence from the provided statements, it is unclear whether the AmylPred algorithm was used to identify the peptide (47)LQVVR(51). AmylPred is a tool for predicting amyloidogenic regions, but there's no direct information stating it was used in this particular identification.\n4. TRUE: There have been experiments and studies that confirm the role of peptide (47)LQVVR(51) in human cystatin C fibrillization through the investigation of its aggregation properties and the effects mutations have in this region.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that the concentration of protein HIF-1 does increase after the administration of the cytoprotective prodrug amifostine (ethyol). The study found that incubation of cell lines with amifostine resulted in HIF1 induction, and in vivo experiments with Wistar rats showed increased HIF1 accumulation in normal tissues after amifostine administration. Therefore, the answer to the user's question is yes, the concentration of HIF-1 does increase after amifostine administration.",
    "llama-2-13b-chat-hf_fact_raw": "1. The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug amifostine (ethyol).\n2. Incubation of cell lines with amifostine resulted in the induction of HIF1.\n3. In vivo experiments with Wistar rats showed increased HIF1 accumulation in normal tissues after amifostine administration.",
    "llama-2-13b-chat-hf_fact": [
      "The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug amifostine (ethyol).",
      "Incubation of cell lines with amifostine resulted in the induction of HIF1.",
      "In vivo experiments with Wistar rats showed increased HIF1 accumulation in normal tissues after amifostine administration."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n\nPlease note that without specific scientific references or the passage from which these statements are derived, it's not possible to verify these claims with absolute certainty. These responses are based on the information typically discussed in scientific literature regarding HIF-1 and the effects of the prodrug amifostine. If the passage contains data that contradict these statements, the answers could be different.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Set7 deposits histone H4 Lys 20 methylation.",
    "llama-2-13b-chat-hf_fact_raw": "1. Set7 is responsible for the methylation of histone H4 on Lysine 20.",
    "llama-2-13b-chat-hf_fact": [
      "Set7 is responsible for the methylation of histone H4 on Lysine 20."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Set8, also known as PR-Set7 or SETD8, is responsible for the methylation of histone H4 on Lysine 20 (H4K20). Set7, also known as SETD7, typically methylates histone H3 on Lysine 4 (H3K4).",
    "llama-2-13b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the protein hepcidin has 4 disulfide bridges.",
    "llama-2-13b-chat-hf_fact_raw": "1. The protein hepcidin has 4 disulfide bridges.",
    "llama-2-13b-chat-hf_fact": [
      "The protein hepcidin has 4 disulfide bridges."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the localization of the protein encoded by the gene DNAJC11 is diffusely distributed in the cytoplasm.",
    "llama-2-13b-chat-hf_fact_raw": "1. The protein encoded by the gene DNAJC11 is localized in the cytoplasm.",
    "llama-2-13b-chat-hf_fact": [
      "The protein encoded by the gene DNAJC11 is localized in the cytoplasm."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n\nRationale: The statement about the localization of the protein encoded by the DNAJC11 gene requires specific biological knowledge, and without additional context or access to current scientific data, it's not possible to determine the veracity of this statement. Protein localization can sometimes be determined by specific databases or recent scientific publications, but such information is not provided here.",
    "llama-2-13b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs) in the human genome. The depletion of UCEs from CNVs is observed in both recent large-scale human CNV datasets and newly formed de novo CNVs, indicating that this phenomenon is not limited to a specific type of CNV or genetic context. However, CNVs arising in cancer cells are not significantly depleted for UCEs, suggesting that the depletion of UCEs from CNVs may be related to the diseased state. Additionally, somatic CNVs that are not associated with disease are depleted for UCEs, further supporting the idea that the depletion of UCEs from CNVs is a result of selection against UCE-disrupting CNVs.",
    "llama-2-13b-chat-hf_fact_raw": "1. Ultraconserved elements (UCEs) are depleted among copy number variants (CNVs) in the human genome.\n2. The depletion of UCEs from CNVs is observed in both recent large-scale human CNV datasets and newly formed de novo CNVs.\n3. Copy number variants (CNVs) arising in cancer cells are not significantly depleted for UCEs.\n4. Somatic CNVs that are not associated with disease are depleted for UCEs.",
    "llama-2-13b-chat-hf_fact": [
      "Ultraconserved elements (UCEs) are depleted among copy number variants (CNVs) in the human genome.",
      "The depletion of UCEs from CNVs is observed in both recent large-scale human CNV datasets and newly formed de novo CNVs.",
      "Copy number variants (CNVs) arising in cancer cells are not significantly depleted for UCEs.",
      "Somatic CNVs that are not associated with disease are depleted for UCEs."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Ultraconserved elements (UCEs) are indeed relatively depleted among copy number variants (CNVs) in the human genome, indicating their potential importance in maintaining genomic stability and function.\n\n2. TRUE: The statement is consistent with research findings that have shown UCEs to be depleted in CNVs observed in large-scale human datasets, including those that have formed de novo, suggesting that UCEs have a conserved genomic structure less likely to be altered by CNV events.\n\n3. TRUE: This statement reflects the observation that CNVs arising in cancer cells often exhibit different characteristics compared to germline CNVs. In cancer, there may not be a significant depletion of UCEs within CNVs because cancer genomes can exhibit a high degree of genomic instability and can tolerate disruptions in these regions.\n\n4. TRUE: Somatic CNVs that are not associated with disease also tend to be depleted for UCEs, similar to germline CNVs, which reinforce the idea that UCEs are typically conserved and less subject to structural variations across the genome in both healthy and diseased states.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the substrate of the haspin kinase during mitosis is histone H3.",
    "llama-2-13b-chat-hf_fact_raw": "1. Haspin kinase has a substrate during mitosis.\n2. The substrate of haspin kinase during mitosis is histone H3.",
    "llama-2-13b-chat-hf_fact": [
      "Haspin kinase has a substrate during mitosis.",
      "The substrate of haspin kinase during mitosis is histone H3."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the mechanism of viroid replication is through a rolling circle mechanism that is exclusively RNA-dependent. This mechanism involves the identification of a universal initiation site on the PLMVd molecule, which is shared by a relatively wide repertoire of viroid variants. The initiation site is delineated by a conserved CAGACG box, which is found in the vicinity of the PLMVd initiation sites. This conserved sequence contributes to the initiation of replication and provides an explanation for the presence of a specific universal initiation site on the PLMVd molecule.",
    "llama-2-13b-chat-hf_fact_raw": "1. Viroid replication occurs through a rolling circle mechanism that is RNA-dependent.\n2. There is a universal initiation site on the PLMVd (Peach latent mosaic viroid) molecule for replication.\n3. A wide range of viroid variants share this universal initiation site.\n4. The initiation site is characterized by a conserved CAGACG box sequence.\n5. The conserved CAGACG box sequence is found in the vicinity of the PLMVd initiation sites.",
    "llama-2-13b-chat-hf_fact": [
      "Viroid replication occurs through a rolling circle mechanism that is RNA-dependent.",
      "There is a universal initiation site on the PLMVd (Peach latent mosaic viroid) molecule for replication.",
      "A wide range of viroid variants share this universal initiation site.",
      "The initiation site is characterized by a conserved CAGACG box sequence.",
      "The conserved CAGACG box sequence is found in the vicinity of the PLMVd initiation sites."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no universal initiation site on PLMVd (Peach latent mosaic viroid) molecules for replication. Initiation sites can vary among different viroids and even among variants of the same viroid.\n3. FALSE [correction]: Due to the lack of a universal initiation site, it is incorrect to say that a wide range of viroid variants share this initiation site.\n4. UNKNOWN\n5. UNKNOWN\n\nNote: Specific details about the conserved sequences in viroids and initiation sites for replication can be quite technical and require expert knowledge in molecular biology or virology. Therefore, without the precise context or a reference, statements 4 and 5 can't be accurately validated.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nYes, fibronectin can be used as a serum biomarker for Duchenne muscular dystrophy (DMD).\nThe study found that there was a significant increase in fibronectin levels in DMD patients compared to age-matched controls, and this increase was observed in both longitudinal and cross-sectional studies. Additionally, fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels, suggesting that the elevation of fibronectin levels is specific to DMD.\nTherefore, fibronectin can be used as a serum biomarker to monitor disease progression in DMD patients.",
    "llama-2-13b-chat-hf_fact_raw": "1. Fibronectin can be used as a serum biomarker for Duchenne muscular dystrophy (DMD).\n2. There was a significant increase in fibronectin levels in DMD patients compared to age-matched controls.\n3. The increase in fibronectin levels was observed in both longitudinal and cross-sectional studies.\n4. Fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels.\n5. The elevation of fibronectin levels is specific to Duchenne muscular dystrophy (DMD).",
    "llama-2-13b-chat-hf_fact": [
      "Fibronectin can be used as a serum biomarker for Duchenne muscular dystrophy (DMD).",
      "There was a significant increase in fibronectin levels in DMD patients compared to age-matched controls.",
      "The increase in fibronectin levels was observed in both longitudinal and cross-sectional studies.",
      "Fibronectin levels in patients with Becker muscular dystrophy, Bethlem myopathy, or myasthenia gravis were comparable to control levels.",
      "The elevation of fibronectin levels is specific to Duchenne muscular dystrophy (DMD)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Fibronectin has been studied as a potential serum biomarker for Duchenne muscular dystrophy (DMD).\n2. TRUE: Studies have shown that there is a significant increase in fibronectin levels in DMD patients compared to age-matched controls.\n3. UNKNOWN: Without specific studies to reference, we cannot confirm or refute that the increase in fibronectin levels was observed in both longitudinal and cross-sectional studies.\n4. UNKNOWN: Without specific data, it is impossible to verify the levels of fibronectin in patients with other muscular disorders compared to control levels.\n5. FALSE [correction]: The elevation of fibronectin levels may not be specific to Duchenne muscular dystrophy (DMD) since biomarkers can sometimes be elevated in various muscular disorders and their specificity can vary. Specificity would need to be confirmed by studies comparing fibronectin levels across different neuromuscular conditions.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here is the answer to the user's question:\nThe DeepBlue epigenomic data server contains data from four major epigenome projects, namely ENCODE, ROADMAP, BLUEPRINT, and DEEP.",
    "llama-2-13b-chat-hf_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE project.\n2. The DeepBlue epigenomic data server contains data from the ROADMAP project.\n3. The DeepBlue epigenomic data server contains data from the BLUEPRINT project.\n4. The DeepBlue epigenomic data server contains data from the DEEP project.",
    "llama-2-13b-chat-hf_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project.",
      "The DeepBlue epigenomic data server contains data from the ROADMAP project.",
      "The DeepBlue epigenomic data server contains data from the BLUEPRINT project.",
      "The DeepBlue epigenomic data server contains data from the DEEP project."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nThe DeepBlue epigenomic data server contains data from various epigenomic research projects, including ENCODE, ROADMAP, BLUEPRINT, and DEEP. These are large-scale consortia projects that have contributed to the understanding of the functional elements of the human genome and the role of epigenetics in health and disease.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the tool that employs self-organizing maps for analyzing synonymous codon usage is the PBIL Web server (http://pbil.univ-lyon1.fr/datasets/charif04/). This tool is available for genomic studies and can be accessed through the Pole Bioinformatique Lyonnais (PBIL) Web server. The tool uses within-group correspondence analysis to analyze synonymous codon usage variability, and is available under a GPL licence. For more information, you can contact the PBIL team at http://pbil.univ-lyon1.fr/members/lobry.",
    "llama-2-13b-chat-hf_fact_raw": "1. The PBIL Web server uses self-organizing maps for analyzing synonymous codon usage.\n2. The tool is available for genomic studies.\n3. It can be accessed through the Pole Bioinformatique Lyonnais (PBIL) Web server.\n4. The tool employs within-group correspondence analysis for analyzing synonymous codon usage variability.\n5. The tool is available under a GPL licence.",
    "llama-2-13b-chat-hf_fact": [
      "The PBIL Web server uses self-organizing maps for analyzing synonymous codon usage.",
      "The tool is available for genomic studies.",
      "It can be accessed through the Pole Bioinformatique Lyonnais (PBIL) Web server.",
      "The tool employs within-group correspondence analysis for analyzing synonymous codon usage variability.",
      "The tool is available under a GPL licence."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe correctness of statements 1, 4, and 5 would require specific knowledge about the features of the PBIL Web server and its licensing. Without access to current, detailed information about the PBIL Web server's analytical tools and licensing, I cannot verify the accuracy of these statements.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, MINDY-1 is a gene that plays a crucial role in regulating energy metabolism and mitochondrial biogenesis in mammals. The gene is homologous to the Indy gene found in Drosophila and C. elegans, which has been shown to prolong lifespan and augment mitochondrial biogenesis in those organisms. In mammals, the homolog of Indy is known as SLC13A5, and it is referred to as mIndy.\nThe study found that deletion of the mIndy gene in mice (mINDY(-/-) mice) leads to several changes in energy metabolism and mitochondrial biogenesis that protect the mice from adiposity and insulin resistance that evolve with high-fat feeding and aging. Specifically, mINDY(-/-) mice have reduced hepatocellular ATP/ADP ratio, activated hepatic AMPK, increased PGC-1, inhibited ACC-2, and reduced SREBP-1c levels. These changes promote hepatic mitochondrial biogenesis, lipid oxidation, and energy expenditure and attenuate hepatic de novo lipogenesis.\nOverall, the study suggests that mIndy is a key regulator of energy metabolism and mitochondrial biogenesis in mammals and that modulating its activity may be a potential therapeutic target for the treatment of obesity and type 2 diabetes.",
    "llama-2-13b-chat-hf_fact_raw": "1. MINDY-1 is a gene that regulates energy metabolism and mitochondrial biogenesis in mammals.\n2. MINDY-1 is homologous to the Indy gene found in Drosophila and C. elegans.\n3. The homolog of Indy in mammals is known as SLC13A5 and referred to as mIndy.\n4. Deletion of the mIndy gene in mice leads to changes that protect them from adiposity and insulin resistance from high-fat feeding and aging.\n5. Mice with the mIndy gene deleted have shown changes such as reduced hepatocellular ATP/ADP ratio and activated hepatic AMPK which promote hepatic mitochondrial biogenesis and energy expenditure.",
    "llama-2-13b-chat-hf_fact": [
      "MINDY-1 is a gene that regulates energy metabolism and mitochondrial biogenesis in mammals.",
      "MINDY-1 is homologous to the Indy gene found in Drosophila and C. elegans.",
      "The homolog of Indy in mammals is known as SLC13A5 and referred to as mIndy.",
      "Deletion of the mIndy gene in mice leads to changes that protect them from adiposity and insulin resistance from high-fat feeding and aging.",
      "Mice with the mIndy gene deleted have shown changes such as reduced hepatocellular ATP/ADP ratio and activated hepatic AMPK which promote hepatic mitochondrial biogenesis and energy expenditure."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN (There's no broad consensus on the existence or role of a gene named \"MINDY-1,\" and if it refers to a specific gene, it would require a reference to scientific literature for verification.)\n2. UNKNOWN (Without a clear referent for \"MINDY-1,\" the claim about its homology to the Indy gene in these species remains unverifiable.)\n3. TRUE (The mammalian homolog of the Indy (I'm Not Dead Yet) gene is indeed known as SLC13A5 and is sometimes referred to as mIndy.)\n4. TRUE (Deletion of the mIndy gene in mice, corresponding to the human SLC13A5 gene, has been shown in studies to lead to metabolic changes that protect from certain negative effects of high-fat diets and aging.)\n5. TRUE (Research has indicated that mice with the mIndy gene deletion exhibit such metabolic and cellular changes, which are associated with increased mitochondrial biogenesis and energy expenditure.)",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the software package available for the analysis of conserved genomic loci is Molecular Evolutionary Genetics Analysis (Mega) software. The latest version of Mega is optimized for use on 64-bit computing systems and provides advanced tools for phylogenomics and phylomedicine, including an advanced wizard for building timetrees and automatic prediction of gene duplication events. Both the graphical user interface (GUI) and command line versions of Mega are available for free download from the website www.megasoftware.net.",
    "llama-2-13b-chat-hf_fact_raw": "1. Molecular Evolutionary Genetics Analysis (Mega) software is available for the analysis of conserved genomic loci.\n2. The latest version of Molecular Evolutionary Genetics Analysis (Mega) software is optimized for 64-bit computing systems. \n3. Mega software offers advanced tools for phylogenomics and phylomedicine.\n4. Mega software includes an advanced wizard for building timetrees and predicting gene duplication events.\n5. Both the graphical user interface (GUI) and command line versions of Mega software are available for free download from www.megasoftware.net.",
    "llama-2-13b-chat-hf_fact": [
      "Molecular Evolutionary Genetics Analysis (Mega) software is available for the analysis of conserved genomic loci.",
      "The latest version of Molecular Evolutionary Genetics Analysis (Mega) software is optimized for 64-bit computing systems.",
      "Mega software offers advanced tools for phylogenomics and phylomedicine.",
      "Mega software includes an advanced wizard for building timetrees and predicting gene duplication events.",
      "Both the graphical user interface (GUI) and command line versions of Mega software are available for free download from www.megasoftware.net."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here are three diseases associated with the PIEZO2 gene:\n1. Distal arthrogryposis 3 (DA3)\n2. Distal arthrogryposis 5 (DA5)\n3. Marden-Walker syndrome (MWKS)\nThese diseases are caused by heterozygous gain-of-function missense mutations in the PIEZO2 gene, which lead to dominant negative effects and disrupt proper proprioception, resulting in contractures of hands and feet, scoliosis, ophthalmoplegia, and ptosis.",
    "llama-2-13b-chat-hf_fact_raw": "1. Distal arthrogryposis 3 (DA3) is associated with the PIEZO2 gene.\n2. Distal arthrogryposis 5 (DA5) is associated with the PIEZO2 gene.\n3. Marden-Walker syndrome (MWKS) is associated with the PIEZO2 gene.",
    "llama-2-13b-chat-hf_fact": [
      "Distal arthrogryposis 3 (DA3) is associated with the PIEZO2 gene.",
      "Distal arthrogryposis 5 (DA5) is associated with the PIEZO2 gene.",
      "Marden-Walker syndrome (MWKS) is associated with the PIEZO2 gene."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Distal arthrogryposis 5 (DA5) is not typically associated with the PIEZO2 gene. It is associated with the ECEL1 gene.\n3. FALSE [correction]: Marden-Walker syndrome (MWKS) is typically associated with the PIEZO1 gene, not the PIEZO2 gene.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, ERAP1-ERAP2 dimerization promotes the production of final epitopes presented by MHC class I molecules. The dimerization of ERAP1 and ERAP2 enhances the trimming of epitope precursor peptides, and physical interaction between the two enzymes changes the basic enzymatic parameters of ERAP1, improving its substrate-binding affinity. This results in the creation of complexes with superior peptide-trimming efficacy, which are likely to enhance Ag presentation by cells displaying coordinated expression of the two enzymes.",
    "llama-2-13b-chat-hf_fact_raw": "1. ERAP1-ERAP2 dimerization promotes the production of final epitopes presented by MHC class I molecules.\n2. The dimerization enhances the trimming of epitope precursor peptides.\n3. The physical interaction between ERAP1 and ERAP2 changes the enzymatic parameters of ERAP1.\n4. The interaction improves ERAP1's substrate-binding affinity.\n5. Dimerization results in complexes with improved peptide-trimming efficacy, which enhances antigen presentation by cells expressing both enzymes.",
    "llama-2-13b-chat-hf_fact": [
      "ERAP1-ERAP2 dimerization promotes the production of final epitopes presented by MHC class I molecules.",
      "The dimerization enhances the trimming of epitope precursor peptides.",
      "The physical interaction between ERAP1 and ERAP2 changes the enzymatic parameters of ERAP1.",
      "The interaction improves ERAP1's substrate-binding affinity.",
      "Dimerization results in complexes with improved peptide-trimming efficacy, which enhances antigen presentation by cells expressing both enzymes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided appear to be specific scientific claims which are likely based on research findings. Unless provided with contradictory scientific evidence, these statements are assumed true as they are written with a level of specificity that suggests they are informed by specialized knowledge in the field of immunology.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, R-spondin 1 and noggin are not directly involved in the function of non-damaged gallbladders. The information provided in the document discusses the role of prostaglandins in regulating gallbladder mucus release, and the effect of prostaglandin E2 on the volume of glycoprotein granules in the gallbladder epithelium.\nR-spondin 1 and noggin are both secreted proteins that have been implicated in the regulation of stem cell self-renewal and differentiation, particularly in the context of embryonic development and tissue regeneration. However, there is no direct evidence to suggest that these proteins are involved in the function of non-damaged gallbladders.\nTherefore, the answer to the user's question based on the given information is: R-spondin 1 and noggin do not play a direct role in the function of non-damaged gallbladders.",
    "llama-2-13b-chat-hf_fact_raw": "1. R-spondin 1 and noggin are secreted proteins.\n2. R-spondin 1 and noggin have been implicated in the regulation of stem cell self-renewal and differentiation.\n3. R-spondin 1 and noggin are involved in embryonic development and tissue regeneration.\n4. Prostaglandins regulate gallbladder mucus release.\n5. Prostaglandin E2 affects the volume of glycoprotein granules in the gallbladder epithelium.",
    "llama-2-13b-chat-hf_fact": [
      "R-spondin 1 and noggin are secreted proteins.",
      "R-spondin 1 and noggin have been implicated in the regulation of stem cell self-renewal and differentiation.",
      "R-spondin 1 and noggin are involved in embryonic development and tissue regeneration.",
      "Prostaglandins regulate gallbladder mucus release.",
      "Prostaglandin E2 affects the volume of glycoprotein granules in the gallbladder epithelium."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll statements appear consistent with the current understanding of these biological processes. R-spondin 1 and noggin are indeed secreted proteins involved in the regulation of stem cell activities and tissue development/regeneration. Prostaglandins, including Prostaglandin E2, are known to be involved in various physiological processes including the regulation of mucus secretion in various parts of the body.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, NADPH oxidase 5 does require a subunit for function. The document states that the heterodimeric cytochrome b558 in the neutrophil oxidase complex is composed of two subunits, and that the photoaffinity probe [3H]azido-NADPH behaved as a competitive inhibitor of NADPH oxidase with a Ki of 6 microM, indicating that the oxidase requires the presence of a subunit for function. Additionally, the photolabeling of the oxidase with [3H]azido-NADPH inactivated the enzyme, and the immunoblot analysis revealed a predominant photolabeled protein band of 80-100 kDa, which coincided with the large subunit (beta) of cytochrome b558. This suggests that the beta subunit is a critical component of the NADPH oxidase complex and is necessary for its function.",
    "llama-2-13b-chat-hf_fact_raw": "1. NADPH oxidase 5 requires a subunit for its function.\n2. The heterodimeric cytochrome b558 in the neutrophil oxidase complex is composed of two subunits.\n3. [3H]azido-NADPH acts as a competitive inhibitor of NADPH oxidase with a Ki of 6 microM.\n4. Photolabeling of the oxidase with [3H]azido-NADPH inactivates the enzyme.\n5. The immunoblot analysis identified a predominant photolabeled protein band of 80-100 kDa, corresponding to the beta subunit of cytochrome b558.",
    "llama-2-13b-chat-hf_fact": [
      "NADPH oxidase 5 requires a subunit for its function.",
      "The heterodimeric cytochrome b558 in the neutrophil oxidase complex is composed of two subunits.",
      "[3H]azido-NADPH acts as a competitive inhibitor of NADPH oxidase with a Ki of 6 microM.",
      "Photolabeling of the oxidase with [3H]azido-NADPH inactivates the enzyme.",
      "The immunoblot analysis identified a predominant photolabeled protein band of 80-100 kDa, corresponding to the beta subunit of cytochrome b558."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Photolabeling with [3H]azido-NADPH typically results in the labeling of active sites on enzymes, which does not necessarily inactivate them, but this statement cannot be confirmed as true or false without specific biochemical context.\n5. FALSE [correction]: The beta subunit of cytochrome b558 is approximately 22 kDa; the 80-100 kDa band would more likely correspond to the gp91phox (or NOX2) component of the oxidase complex.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is a direct connection between furin and hepcidin. Furin is a prohormone convertase that mediates the posttranslational processing of hepcidin. The processing of prohepcidin to hepcidin is not regulated by iron-transferrin or the HIF pathway, but rather by furin. In other words, furin is responsible for the cleavage of prohepcidin to produce the active form of hepcidin.",
    "llama-2-13b-chat-hf_fact_raw": "1. Furin is a prohormone convertase.\n2. Furin mediates the posttranslational processing of hepcidin.\n3. Furin is responsible for the cleavage of prohepcidin to produce active hepcidin.\n4. The processing of prohepcidin to hepcidin is not regulated by iron-transferrin.\n5. The processing of prohepcidin to hepcidin is not regulated by the HIF pathway.",
    "llama-2-13b-chat-hf_fact": [
      "Furin is a prohormone convertase.",
      "Furin mediates the posttranslational processing of hepcidin.",
      "Furin is responsible for the cleavage of prohepcidin to produce active hepcidin.",
      "The processing of prohepcidin to hepcidin is not regulated by iron-transferrin.",
      "The processing of prohepcidin to hepcidin is not regulated by the HIF pathway."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Furin mediates the posttranslational processing of various proteins but not specifically hepcidin. The prohormone convertase that mediates the processing of hepcidin is not commonly referred to as furin.\n3. FALSE [correction]: Furin is responsible for the cleavage of many precursor proteins to their mature forms, but prohepcidin is cleaved by a different convertase, not by furin, to produce active hepcidin.\n4. FALSE [correction]: The processing of prohepcidin to hepcidin is regulated by iron-transferrin through the BMP/SMAD pathway, among other factors.\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the largest metabolic gene cluster in yeast is the GAL cluster.",
    "llama-2-13b-chat-hf_fact_raw": "1. The GAL cluster is the largest metabolic gene cluster in yeast.",
    "llama-2-13b-chat-hf_fact": [
      "The GAL cluster is the largest metabolic gene cluster in yeast."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the role of LIMT lncRNA is to inhibit extracellular matrix invasion of mammary cells and tumor metastasis in vivo. It is a highly conserved lncRNA that is depleted in basal-like and HER2-positive tumors, and low expression of which predicts poor patient prognosis. Additionally, EGF rapidly downregulates LIMT expression by enhancing histone deacetylation at the respective promoter.",
    "llama-2-13b-chat-hf_fact_raw": "1. LIMT lncRNA inhibits extracellular matrix invasion of mammary cells.\n2. LIMT lncRNA inhibits tumor metastasis in vivo.\n3. LIMT lncRNA is highly conserved and often depleted in basal-like and HER2-positive tumors.\n4. Low expression of LIMT lncRNA predicts poor patient prognosis.\n5. EGF downregulates LIMT expression by enhancing histone deacetylation at the respective promoter.",
    "llama-2-13b-chat-hf_fact": [
      "LIMT lncRNA inhibits extracellular matrix invasion of mammary cells.",
      "LIMT lncRNA inhibits tumor metastasis in vivo.",
      "LIMT lncRNA is highly conserved and often depleted in basal-like and HER2-positive tumors.",
      "Low expression of LIMT lncRNA predicts poor patient prognosis.",
      "EGF downregulates LIMT expression by enhancing histone deacetylation at the respective promoter."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout the specific scientific context or a reference to the study or data supporting these statements, it is not possible to verify the accuracy of the statements related to LIMT lncRNA and its functions, conservation status, association with certain types of tumors, prognostic value, or its regulation by EGF. The statements might be true if they are supported by scientific research, but without that information, their veracity cannot be determined.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the R/Bioconductor package used for performing SNP enrichment analysis is TEQC (Target Enrichment Quality Control).",
    "llama-2-13b-chat-hf_fact_raw": "1. The R/Bioconductor package TEQC is used for performing SNP enrichment analysis.",
    "llama-2-13b-chat-hf_fact": [
      "The R/Bioconductor package TEQC is used for performing SNP enrichment analysis."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The R/Bioconductor package TEQC is used for quality control and preprocessing of targeted sequencing data, not for SNP enrichment analysis.",
    "llama-2-13b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the key players in radial glial specification to ependymal cells are:\n1. Adult ependymal cells: These cells are postmitotic and highly differentiated, and they can divide and transform into radial glial cells after stroke.\n2. Radial glial cells: These cells are neurogenic precursors that are found in the subventricular zone (SVZ) and can support neuron migration after stroke.\n3. Stroke: The acute stimulation of adult ependymal cell proliferation after stroke leads to the transformation of ependymal cells into radial glial cells.\nTherefore, the key players in radial glial specification to ependymal cells are the adult ependymal cells, radial glial cells, and stroke.",
    "llama-2-13b-chat-hf_fact_raw": "1. Adult ependymal cells can divide and transform into radial glial cells after a stroke.\n2. Radial glial cells are neurogenic precursors that are found in the subventricular zone (SVZ).\n3. Radial glial cells can support neuron migration after a stroke.\n4. The acute stimulation of adult ependymal cell proliferation after a stroke leads to the transformation of ependymal cells into radial glial cells.",
    "llama-2-13b-chat-hf_fact": [
      "Adult ependymal cells can divide and transform into radial glial cells after a stroke.",
      "Radial glial cells are neurogenic precursors that are found in the subventricular zone (SVZ).",
      "Radial glial cells can support neuron migration after a stroke.",
      "The acute stimulation of adult ependymal cell proliferation after a stroke leads to the transformation of ependymal cells into radial glial cells."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Adult ependymal cells have the potential to divide and transform into radial glial cells after a stroke.\n2. TRUE: Radial glial cells are indeed neurogenic precursors that are found in the subventricular zone (SVZ) amongst other regions in the central nervous system.\n3. TRUE: Radial glial cells are known to support neuron migration; this is one of their roles during brain development and also potentially after injury such as a stroke.\n4. TRUE: The acute stimulation of proliferation of adult ependymal cells after a stroke can lead to their transformation into radial glial-like cells, contributing to the brain's response to injury.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, triple negative gliomas can be characterized by certain features on dynamic contrast material-enhanced (DCE) magnetic resonance (MR) images. These features can be captured and quantified using a computer-aided diagnosis (CAD) system, which can differentiate triple-negative breast cancer from other types of breast cancer and benign fibroadenoma lesions. The CAD system uses linear discriminant analysis and support vector machine classification to identify the most discriminatory features, which can provide added diagnostic benefit in identifying triple-negative cancer with DCE MR imaging in high-risk women.",
    "llama-2-13b-chat-hf_fact_raw": "1. Triple negative gliomas have specific features on dynamic contrast material-enhanced (DCE) magnetic resonance (MR) images.\n2. A computer-aided diagnosis (CAD) system can quantify the features of triple negative gliomas.\n3. The CAD system can differentiate triple-negative breast cancer from other types of breast cancer and benign fibroadenoma lesions.\n4. Linear discriminant analysis and support vector machine classification are used by the CAD system to identify discriminatory features.\n5. DCE MR imaging is utilized to identify triple-negative cancer in high-risk women with the help of the CAD system.",
    "llama-2-13b-chat-hf_fact": [
      "Triple negative gliomas have specific features on dynamic contrast material-enhanced (DCE) magnetic resonance (MR) images.",
      "A computer-aided diagnosis (CAD) system can quantify the features of triple negative gliomas.",
      "The CAD system can differentiate triple-negative breast cancer from other types of breast cancer and benign fibroadenoma lesions.",
      "Linear discriminant analysis and support vector machine classification are used by the CAD system to identify discriminatory features.",
      "DCE MR imaging is utilized to identify triple-negative cancer in high-risk women with the help of the CAD system."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: The specifics of dynamic contrast material-enhanced (DCE) magnetic resonance (MR) images for triple negative gliomas would need to be confirmed with medical literature or imaging studies.\n2. TRUE: A computer-aided diagnosis (CAD) system can be designed to quantify the features of various types of tumors on medical images, including gliomas.\n3. FALSE [correction]: The CAD system discussed in the context of triple negative gliomas would not be used to differentiate triple-negative breast cancer from other types of breast cancer and benign fibroadenoma lesions, as gliomas are a type of brain tumor, not breast cancer.\n4. UNKNOWN: Without specific information on the CAD system's methodology, it's unclear whether linear discriminant analysis and support vector machine classification are used. These are common machine learning methods used in CAD systems, but the statement's accuracy would need confirmation.\n5. FALSE [correction]: DCE MR imaging might be utilized to identify triple-negative breast cancer, not gliomas, in high-risk women with the help of a CAD system. The statement incorrectly conflates gliomas with breast cancer.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, TOPAZ1 is a unit for cleaning immunological plates. It consists of a cleaning device, discharge block, cleaning solution vessel, and wasted liquid collector. The technical parameters of the unit are also stated.",
    "llama-2-13b-chat-hf_fact_raw": "1. TOPAZ1 is a unit designed for cleaning immunological plates.\n2. The unit includes a cleaning device.\n3. TOPAZ1 features a discharge block.\n4. It comes with a cleaning solution vessel.\n5. The unit has a wasted liquid collector.",
    "llama-2-13b-chat-hf_fact": [
      "TOPAZ1 is a unit designed for cleaning immunological plates.",
      "The unit includes a cleaning device.",
      "TOPAZ1 features a discharge block.",
      "It comes with a cleaning solution vessel.",
      "The unit has a wasted liquid collector."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or information about \"TOPAZ1,\" which does not refer to a commonly known device or unit associated with a recognized process such as cleaning immunological plates, the true or false nature of these statements cannot be determined.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the gene that controls the expression of GATA-1 isoforms is not explicitly stated. However, the information suggests that the transcription factor GATA-1 and its cofactor, FOG-1, play a crucial role in regulating the expression of GATA-1 isoforms. Specifically, FOG-1 is shown to physically interact with GATA-1 and regulate its activity, with the mechanisms by which FOG-1 regulates GATA-1 function being unknown. The study found that a conditional form of GATA-1 (GATA-1-ER) strongly induced histone acetylation at the beta-major globin promoter in vivo, while a point mutation that impairs FOG-1 binding (GATA-1(V205M)-ER) failed to induce high levels of histone acetylation. These results suggest that FOG-1 plays a crucial role in regulating the expression of GATA-1 isoforms, particularly in the context of transcriptional activation.",
    "llama-2-13b-chat-hf_fact_raw": "1. The transcription factor GATA-1 and its cofactor, FOG-1, play a role in regulating the expression of GATA-1 isoforms.\n2. FOG-1 has been shown to physically interact with GATA-1.\n3. The mechanisms by which FOG-1 regulates GATA-1 function are unknown.\n4. A conditional form of GATA-1 (GATA-1-ER) can induce histone acetylation at the beta-major globin promoter in vivo.\n5. A point mutation that impairs FOG-1 binding in GATA-1 (GATA-1(V205M)-ER) failed to induce high levels of histone acetylation.",
    "llama-2-13b-chat-hf_fact": [
      "The transcription factor GATA-1 and its cofactor, FOG-1, play a role in regulating the expression of GATA-1 isoforms.",
      "FOG-1 has been shown to physically interact with GATA-1.",
      "The mechanisms by which FOG-1 regulates GATA-1 function are unknown.",
      "A conditional form of GATA-1 (GATA-1-ER) can induce histone acetylation at the beta-major globin promoter in vivo.",
      "A point mutation that impairs FOG-1 binding in GATA-1 (GATA-1(V205M)-ER) failed to induce high levels of histone acetylation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: The transcription factor GATA-1 and its cofactor, FOG-1 (Friend of GATA-1), are known to interact and play a critical role in the regulation of hematopoiesis, which may include the expression of GATA-1 isoforms.\n2. TRUE: FOG-1 is indeed known to physically interact with GATA-1; this interaction is critical for their function in the regulation of blood cell development.\n3. FALSE [correction]: The mechanisms by which FOG-1 regulates GATA-1 function are at least partially known, including modulating GATA-1's ability to bind DNA and recruit other regulatory molecules that affect gene expression during blood cell development. However, there may be aspects that are not yet fully understood.\n4. UNKNOWN: Without specific research context or references, it cannot be determined whether the statement about GATA-1-ER (likely an engineered variant of GATA-1 designed to be responsive to estrogen receptor ligands) inducing histone acetylation at the beta-major globin promoter in vivo is true or false.\n5. UNKNOWN: Similarly, the statement about GATA-1(V205M)-ER, which suggests a specific point mutation affecting FOG-1 binding and its impact on histone acetylation, would require specific research context or references to verify its accuracy.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, MIRA-seq is a Medical Information, Retrieval, and Archives System developed and implemented at the University Hospital Freiburg. It integrates the Minimum Basic Data Set into the hospital's patient administration system and provides access to basic medical data of all patients treated in all medical departments and separate buildings since 1986. MIRA is primarily used for readmission and scientific and managerial purposes, and its privacy-controlled access is possible via 610 online PCs and dialog terminals. The system is well-accepted by physicians, nurses, and administrators due to its ease of use and special extensions for different clinical departments.",
    "llama-2-13b-chat-hf_fact_raw": "1. MIRA-seq is a Medical Information, Retrieval, and Archives System implemented at University Hospital Freiburg.\n2. MIRA-seq integrates the Minimum Basic Data Set into the hospital's patient administration system.\n3. MIRA-seq provides access to basic medical data of patients treated since 1986 in all medical departments and separate buildings.\n4. The system offers privacy-controlled access through 610 online PCs and dialog terminals.\n5. MIRA-seq has special extensions for different clinical departments, contributing to its acceptance by physicians, nurses, and administrators.",
    "llama-2-13b-chat-hf_fact": [
      "MIRA-seq is a Medical Information, Retrieval, and Archives System implemented at University Hospital Freiburg.",
      "MIRA-seq integrates the Minimum Basic Data Set into the hospital's patient administration system.",
      "MIRA-seq provides access to basic medical data of patients treated since 1986 in all medical departments and separate buildings.",
      "The system offers privacy-controlled access through 610 online PCs and dialog terminals.",
      "MIRA-seq has special extensions for different clinical departments, contributing to its acceptance by physicians, nurses, and administrators."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: MIRA-seq refers to Methylation-based Inference of Regulatory Activity sequencing, a method used in genomics, not a Medical Information, Retrieval, and Archives System.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first statement is false because MIRA-seq does not refer to a medical information system but rather a genomic technique. Statements 2 through 5 cannot be verified without additional specific information regarding the context in which they are used. If MIRA-seq is indeed used in a statement referring to a genomic technique, then statements 2-5 would likely be unrelated and thus false, but without context, their truth value is unknown.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the indication of ARCALYST is that it is a novel type of highly Ca(2+)-selective channel that is specifically activated by low concentrations of agonist-induced arachidonic acid, and is involved in the regulation of intracellular calcium signals in cells such as parotid and pancreatic acinar cells.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 21q (long arm) and 21q (short arm).",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the R package that could be used for the identification of pediatric brain tumors is \"RNAA\".\nThe Cho/NAA ratio, which is a parameter obtained from in vivo proton magnetic resonance spectroscopy (MRS), is the most useful diagnostic marker for differentiating between normal brain, benign, and malignant tumors, as well as discriminating the three main groups of pediatric brain tumors (pilocytic astrocytoma, ependymoma, and medulloblastoma).\nTherefore, the R package \"RNAA\" could be used to analyze the MRS data and extract the Cho/NAA ratio, which could help in the differential diagnosis of pediatric brain tumors.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, NEMO (NF-kappaB essential modulator) is not a zinc finger protein. The information states that the zinc finger (ZF) motif in NEMO forms a specific complex with ubiquitin, but it does not classify NEMO as a zinc finger protein. Instead, the information suggests that the ZF motif in NEMO is a ubiquitin-binding domain of the ubiquitin-binding zinc finger type. Therefore, the answer to the user's question is no, NEMO is not a zinc finger protein.",
    "llama-2-13b-chat-hf_fact_raw": "1. NEMO stands for NF-kappaB essential modulator.\n2. The zinc finger (ZF) motif in NEMO forms a complex with ubiquitin.\n3. NEMO's ZF motif is a ubiquitin-binding domain of the ubiquitin-binding zinc finger type.\n4. NEMO is not classified as a zinc finger protein.",
    "llama-2-13b-chat-hf_fact": [
      "NEMO stands for NF-kappaB essential modulator.",
      "The zinc finger (ZF) motif in NEMO forms a complex with ubiquitin.",
      "NEMO's ZF motif is a ubiquitin-binding domain of the ubiquitin-binding zinc finger type.",
      "NEMO is not classified as a zinc finger protein."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in the document, it appears that TFIIS does affect nucleosome positioning. The document states that TFIIS contributes to nucleosome positioning in both gene promoters and bodies, and that the lack of TFIIS leads to changes in nucleosome occupancy and fuzziness. These changes are detected using a refined nucleosome-mapping method that corrects for sequence bias and preserves MNase-sensitive nucleosomes. The document also suggests that the effects of TFIIS on nucleosome positioning are not limited to the promoter region, but also occur in the gene body.",
    "llama-2-13b-chat-hf_fact_raw": "1. TFIIS contributes to nucleosome positioning in gene promoters and bodies.\n2. Lack of TFIIS leads to changes in nucleosome occupancy and fuzziness.\n3. A refined nucleosome-mapping method is used to detect changes due to the absence of TFIIS.\n4. This refined method corrects for sequence bias and preserves MNase-sensitive nucleosomes.\n5. The effects of TFIIS on nucleosome positioning occur both in the promoter region and in the gene body.",
    "llama-2-13b-chat-hf_fact": [
      "TFIIS contributes to nucleosome positioning in gene promoters and bodies.",
      "Lack of TFIIS leads to changes in nucleosome occupancy and fuzziness.",
      "A refined nucleosome-mapping method is used to detect changes due to the absence of TFIIS.",
      "This refined method corrects for sequence bias and preserves MNase-sensitive nucleosomes.",
      "The effects of TFIIS on nucleosome positioning occur both in the promoter region and in the gene body."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nWithout additional context on the specific research findings, experimental results, or consensus in scientific literature regarding TFIIS, it's not possible to definitively verify statements 1-4. However, statement 5 is a restatement of part of statement 1 and can be assumed to be true if statement 1 were true, but since the truth of statement 1 is unknown, we maintain the 5th as true based on the information given.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the origins of replication close to yeast centromeres fire late. The study found that a 200-bp stretch containing a cluster of three LCS elements can compel nearby origins to fire late, regardless of their distance from the origin or orientation. This suggests that the proximity of origins to the LCS elements can influence their firing time, causing them to fire later in S phase.",
    "llama-2-13b-chat-hf_fact_raw": "1. Origins of replication close to yeast centromeres tend to fire late.\n2. A 200-bp stretch containing a cluster of three LCS elements can make nearby origins fire late.\n3. The proximity of origins to LCS elements can influence their firing time in S phase.",
    "llama-2-13b-chat-hf_fact": [
      "Origins of replication close to yeast centromeres tend to fire late.",
      "A 200-bp stretch containing a cluster of three LCS elements can make nearby origins fire late.",
      "The proximity of origins to LCS elements can influence their firing time in S phase."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in the document, the properties of mammalian GA-sequences are:\n1. Length: GA-sequences are longer than 50 bases and can reach sizes of up to 1300 bases.\n2. Composition: GA-sequences consist exclusively of G's and A's, with no other bases present.\n3. Distribution: GA-sequences are ubiquitously located along the chromosomes of human, chimpanzee, dog, cat, rat, and mouse, with a species-dependent density.\n4. Uniqueness: All pure GA-sequences of the mammals tested were unique individuals, with no identical sequences found.\n5. Repeated motifs: GA-sequences contain several repeated short GA-containing motifs.\n6. Hexa-nucleotide spectrum: GA-sequences share a common hexa-nucleotide spectrum.\n7. Transcription: At most 2% of the human GA-sequences were transcribed into mRNAs, suggesting that the majority of GA-sequences are not coding for proteins.\n8. Point mutations: GA-sequences contained many fewer point mutations than one should expect from the genome at large.\n9. Base content: GA-sequences have a high content of G and A bases, with no other bases present.\n10. Function: The functions of pure GA-sequences are not known, but the article speculates that they may serve as genomic sign posts or spatial linkers that help generate the 3-dimensional organization of chromatin.",
    "llama-2-13b-chat-hf_fact_raw": "1. GA-sequences in mammals are longer than 50 bases and can reach sizes of up to 1300 bases.\n2. GA-sequences consist only of G's (guanine) and A's (adenine), with no other bases present.\n3. GA-sequences are found along the chromosomes of various mammalian species including human, chimpanzee, dog, cat, rat, and mouse.\n4. Each GA-sequence is unique, with no identical sequences found among the mammals tested.\n5. At most 2% of the human GA-sequences are transcribed into mRNAs.",
    "llama-2-13b-chat-hf_fact": [
      "GA-sequences in mammals are longer than 50 bases and can reach sizes of up to 1300 bases.",
      "GA-sequences consist only of G's (guanine) and A's (adenine), with no other bases present.",
      "GA-sequences are found along the chromosomes of various mammalian species including human, chimpanzee, dog, cat, rat, and mouse.",
      "Each GA-sequence is unique, with no identical sequences found among the mammals tested.",
      "At most 2% of the human GA-sequences are transcribed into mRNAs."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN: Without specific scientific data and references provided about GA-sequences (likely referring to repetitive sequences containing guanine (G) and adenine (A) in the genome), it is not possible to confirm whether GA-sequences in mammals are longer than 50 bases and can reach sizes of up to 1300 bases.\n\n2. FALSE [correction]: The term \"GA-sequence\" implies a sequence predominated by guanosine (G) and adenosine (A) bases, but without additional context, it is unlikely that these sequences consist solely of G's and A's without any occurrence of other bases, since natural DNA sequences typically include all four nucleobases (G, A, T, C).\n\n3. UNKNOWN: While it's plausible that similar sequences are found across various mammalian species due to shared evolutionary history, without specific references to scientific studies, it cannot be confirmed that GA-sequences are found along the chromosomes of the mentioned mammalian species.\n\n4. FALSE [correction]: Identical or highly similar sequences can be found among different mammals due to conserved regions of the genome. It is unlikely that each GA-sequence is entirely unique among all the mammals tested.\n\n5. UNKNOWN: The transcription rate of any particular DNA sequence into mRNA varies significantly and depends on multiple factors like gene regulation, cell type, and organism. Without specific scientific studies or data, the percentage of human GA-sequences transcribed into mRNAs cannot be determined.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are at least four Groucho-related genes (Grg) contained in the mouse genome.",
    "llama-2-13b-chat-hf_fact_raw": "1. There are at least four Groucho-related genes in the mouse genome.",
    "llama-2-13b-chat-hf_fact": [
      "There are at least four Groucho-related genes in the mouse genome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the RNA polymerase II subunit that carries RNA cleavage activity is the C-terminal domain (CTD) of the enzyme's largest subunit. Specifically, heptads in the vicinity of 30 to 37 in the CTD contribute modestly more than other sections to the cleavage activity, but no specific subsection of the CTD is necessary or sufficient for cleavage. The length of the CTD also plays a role in the cleavage activity, with significant activity requiring approximately 26 or more repeats.",
    "llama-2-13b-chat-hf_fact_raw": "1. The C-terminal domain (CTD) of the RNA polymerase II's largest subunit carries RNA cleavage activity.\n2. Heptads in the vicinity of 30 to 37 in the CTD contribute more to the cleavage activity than other sections.\n3. No specific subsection of the CTD is necessary or sufficient for cleavage by itself.\n4. The length of the CTD influences cleavage activity, with significant activity requiring approximately 26 or more repeats.",
    "llama-2-13b-chat-hf_fact": [
      "The C-terminal domain (CTD) of the RNA polymerase II's largest subunit carries RNA cleavage activity.",
      "Heptads in the vicinity of 30 to 37 in the CTD contribute more to the cleavage activity than other sections.",
      "No specific subsection of the CTD is necessary or sufficient for cleavage by itself.",
      "The length of the CTD influences cleavage activity, with significant activity requiring approximately 26 or more repeats."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The C-terminal domain (CTD) of RNA polymerase II's largest subunit does not carry RNA cleavage activity. RNA cleavage activity is associated with other factors in the transcription machinery, such as the cleavage and polyadenylation specificity factor (CPSF) within the pre-mRNA processing complex.\n2. UNKNOWN: Without specific context or reference, it is unclear whether heptad repeats in the vicinity of 30 to 37 in the CTD are more influential to cleavage activity than other sections.\n3. FALSE [correction]: This statement is contradictory as specific subsections of the CTD (like heptad repeats mentioned in the previous statement), if influential, would be necessary for whatever function they are attributed to, including interacting with other proteins involved in RNA processing. However, in general, the entire CTD is not involved in cleavage activity, as mentioned in the correction to the first statement.\n4. UNKNOWN: Specific effects of CTD length on cleavage activity would require references to experimental studies or detailed knowledge from the field of molecular biology. Generally, the CTD is known to be involved in the regulation of transcription and RNA processing, but its effect on cleavage activity specifically is not a common point of discussion in literature without a particular research context.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the genetic basis of Ohdo syndrome is not yet fully understood. The report states that subtelomeric FISH studies of all chromosome arms on two cases showed no abnormality, suggesting that the condition is not caused by a chromosomal abnormality. However, the report also notes that all cases with the severe phenotype have been sporadic, indicating that the condition may be caused by a genetic mutation or variations.\nOhdo syndrome is a multiple malformation syndrome that is characterized by a range of dysmorphic features and congenital abnormalities, including blepharophimosis, ptosis, dental hypoplasia, hearing impairment, and intellectual disability. The severity of the condition can vary widely, with some cases having mild features and others being more severely affected.\nMore research is needed to determine the specific genetic cause of Ohdo syndrome. However, the report suggests that the condition may be caused by a genetic mutation or variations that are inherited in an autosomal dominant or sporadic manner. Further genetic testing and analysis may be necessary to identify the specific genetic basis of the condition.",
    "llama-2-13b-chat-hf_fact_raw": "1. Subtelomeric FISH studies showed no chromosomal abnormalities in two cases of Ohdo syndrome.\n2. Cases with the severe phenotype of Ohdo syndrome have been sporadic.\n3. Ohdo syndrome may be caused by a genetic mutation or variations.\n4. Ohdo syndrome is characterized by blepharophimosis, ptosis, dental hypoplasia, hearing impairment, and intellectual disability.\n5. The specific genetic cause of Ohdo syndrome has not been fully determined.",
    "llama-2-13b-chat-hf_fact": [
      "Subtelomeric FISH studies showed no chromosomal abnormalities in two cases of Ohdo syndrome.",
      "Cases with the severe phenotype of Ohdo syndrome have been sporadic.",
      "Ohdo syndrome may be caused by a genetic mutation or variations.",
      "Ohdo syndrome is characterized by blepharophimosis, ptosis, dental hypoplasia, hearing impairment, and intellectual disability.",
      "The specific genetic cause of Ohdo syndrome has not been fully determined."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The genetic cause of Ohdo syndrome has been associated with mutations in genes such as KAT6B and MED12, although there may be additional genetic causes not yet fully determined.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is CTDquerier.",
    "llama-2-13b-chat-hf_fact_raw": "1. CTDquerier is an R/Bioconductor package.\n2. CTDquerier has been developed for the analysis of psychiatric disease genes.",
    "llama-2-13b-chat-hf_fact": [
      "CTDquerier is an R/Bioconductor package.",
      "CTDquerier has been developed for the analysis of psychiatric disease genes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: CTDquerier is a tool designed for retrieving data from the Comparative Toxicogenomics Database (CTD). It can be used for a variety of purposes, including the analysis of genes related to any disease or condition, not specifically or exclusively psychiatric diseases.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, the swirl sign in intracerebral hemorrhage is a relatively uncommon sign seen on noncontrast CT scans in patients with head trauma who develop extradural hematoma. The sign consists of two components: hyperacute and acute.\nThe hyperacute component represents ongoing active intracranial bleeding, while the acute component comprises surrounding hyperattenuated clotted blood. The presence of the swirl sign suggests expanding extradural hematoma with ongoing active bleeding, which requires aggressive surgical management for improved prognosis and survival.\nIn clinical scenarios, the identification of the swirl sign can be crucial in determining the appropriate course of treatment for patients with head trauma and intracerebral hemorrhage. Early identification and surgical management may improve the patient's chances of survival and reduce the risk of complications.",
    "llama-2-13b-chat-hf_fact_raw": "1. The swirl sign in intracerebral hemorrhage is seen on noncontrast CT scans.\n2. It is associated with patients who have head trauma and develop extradural hematoma.\n3. The swirl sign has two components: a hyperacute component representing active intracranial bleeding and an acute component representing surrounding hyperattenuated clotted blood.\n4. The presence of the swirl sign indicates ongoing active bleeding within an expanding extradural hematoma.\n5. Early identification and surgical management of the swirl sign may improve the prognosis and survival of the patient.",
    "llama-2-13b-chat-hf_fact": [
      "The swirl sign in intracerebral hemorrhage is seen on noncontrast CT scans.",
      "It is associated with patients who have head trauma and develop extradural hematoma.",
      "The swirl sign has two components: a hyperacute component representing active intracranial bleeding and an acute component representing surrounding hyperattenuated clotted blood.",
      "The presence of the swirl sign indicates ongoing active bleeding within an expanding extradural hematoma.",
      "Early identification and surgical management of the swirl sign may improve the prognosis and survival of the patient."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: The swirl sign in intracerebral hemorrhage is indeed seen on noncontrast CT scans and is indicative of active bleeding within the brain.\n\n2. FALSE [correction]: The swirl sign is typically associated with intracerebral hemorrhage (ICH), not extradural hematoma. An extradural hematoma is usually caused by trauma and is a collection of blood between the dura mater and the skull, not within the brain tissue itself.\n\n3. UNKNOWN: While the swirl sign represents a mix of different densities within a hemorrhage, the specific terminology of \"hyperacute\" and \"acute\" components in the context of the swirl sign is not standard, and without additional context, it's difficult to validate this statement.\n\n4. FALSE [correction]: The presence of the swirl sign indicates ongoing active bleeding within an expanding hematoma, but not specifically an extradural hematoma as previously mentioned. It can indicate active bleeding within the brain parenchyma, typically in the context of intracerebral hemorrhage.\n\n5. TRUE: Early identification and treatment of conditions indicated by the swirl sign, such as intracerebral hemorrhage, are critical. Surgical management in certain cases may help improve prognosis and survival, although the decision for surgery will depend on various factors including location, size of the hematoma, patient's clinical state, and underlying health conditions.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that Arabidopsis ROF1 expression is induced by heat stress and developmentally regulated. The study suggests that ROF1 binds heat shock proteins HSP90.1 and localizes in the cytoplasm under normal conditions, but exposure to heat stress induces nuclear localization of the ROF1-HSP90.1 complex, which is dependent on the presence of the transcription factor HsfA2. The study also found that the rof1 knockout plants exhibited collapse when exposed to high temperatures, while transgenic ROF1 over-expressors showed better survival. Additionally, the study found that the level of expression of small HSPs regulated by HsfA2 was reduced in rof1 knockout mutants, which correlates with the mutant phenotype.\nTherefore, based on the information provided, it can be concluded that heat stress induces the expression of Arabidopsis ROF1, and that ROF1 plays a role in prolonging thermotolerance by sustaining the levels of small HSPs that are essential for survival at high temperatures.",
    "llama-2-13b-chat-hf_fact_raw": "1. Arabidopsis ROF1 expression is induced by heat stress.\n2. ROF1 binds heat shock proteins HSP90.1.\n3. Heat stress induces nuclear localization of the ROF1-HSP90.1 complex.\n4. The nuclear localization of ROF1-HSP90.1 is dependent on the transcription factor HsfA2.\n5. ROF1 knockout plants have shown to collapse when exposed to high temperatures.",
    "llama-2-13b-chat-hf_fact": [
      "Arabidopsis ROF1 expression is induced by heat stress.",
      "ROF1 binds heat shock proteins HSP90.1.",
      "Heat stress induces nuclear localization of the ROF1-HSP90.1 complex.",
      "The nuclear localization of ROF1-HSP90.1 is dependent on the transcription factor HsfA2.",
      "ROF1 knockout plants have shown to collapse when exposed to high temperatures."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Arabidopsis ROF1 (AtFKBP62) expression is known to be induced by heat stress, which is part of the plant's response mechanism to high temperature conditions.\n2. TRUE: ROF1 (AtFKBP62) has been reported to interact with HSP90.1 in Arabidopsis, indicating that it does bind heat shock proteins such as HSP90.1.\n3. UNKNOWN: The subcellular localization of ROF1-HSP90.1 complex in response to heat stress can vary, and without specific evidence from the passage, it's not possible to confirm whether heat stress induces nuclear localization of the ROF1-HSP90.1 complex.\n4. UNKNOWN: The passage does not provide enough information to determine whether the nuclear localization of the ROF1-HSP90.1 complex is dependent on the transcription factor HsfA2. The relationship between ROF1-HSP90.1 and HsfA2 requires specific evidence.\n5. UNKNOWN: While ROF1 knockout plants may display increased sensitivity to heat stress, there is insufficient information to confirm the exact phenotypic outcome such as \"collapse\" when exposed to high temperatures. More detail from the passage or supporting literature would be required to validate this statement.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the most common cause of hereditary renal amyloidosis is the fibrinogen alpha-chain gene mutation, specifically the arginine to leucine substitution (Arg554Leu). This mutation was found in all three affected individuals in the family and was confirmed by amino acid sequence analysis of amyloid fibril protein isolated from postmortem kidney tissue.",
    "llama-2-13b-chat-hf_fact_raw": "1. The fibrinogen alpha-chain gene mutation is the most common cause of hereditary renal amyloidosis.\n2. The specific mutation commonly associated with hereditary renal amyloidosis is the arginine to leucine substitution at position 554 (Arg554Leu).\n3. The Arg554Leu mutation was observed in all three affected individuals in a particular family studied.\n4. Amino acid sequence analysis of amyloid fibril protein from postmortem kidney tissue confirmed the Arg554Leu mutation.",
    "llama-2-13b-chat-hf_fact": [
      "The fibrinogen alpha-chain gene mutation is the most common cause of hereditary renal amyloidosis.",
      "The specific mutation commonly associated with hereditary renal amyloidosis is the arginine to leucine substitution at position 554 (Arg554Leu).",
      "The Arg554Leu mutation was observed in all three affected individuals in a particular family studied.",
      "Amino acid sequence analysis of amyloid fibril protein from postmortem kidney tissue confirmed the Arg554Leu mutation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The most common cause of hereditary renal amyloidosis is the mutation in the gene encoding for transthyretin (TTR). However, fibrinogen alpha-chain gene mutations can also be a cause.\n2. FALSE [correction]: The specific mutation commonly associated with hereditary renal amyloidosis in the fibrinogen alpha-chain gene is the arginine to cysteine substitution at position 554 (Arg554Cys), not leucine.\n3. UNKNOWN: Without specific information about the study or family in question, we cannot confirm or deny the presence of the Arg554Leu mutation in all three affected individuals.\n4. UNKNOWN: Without additional context or results from the referenced analysis, we cannot verify the confirmation of the Arg554Leu mutation.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question \"Has the proteome of mice hippocampus been analysed?\" is:\nYes, the proteome of mice hippocampus has been analysed.\nThe information provided in the text states that the mouse hippocampus has been a major target of analysis in the search for molecular correlates to neuronal information storage, and that a proteomic approach has been chosen to establish a comprehensive reference database of proteins expressed in the mouse hippocampus. The text also mentions that 469 individual proteins were identified through 2-DE coupled to MS (MALDI-TOF/TOF) analysis, providing a comprehensive profile of the proteins expressed in the mouse hippocampus.",
    "llama-2-13b-chat-hf_fact_raw": "1. The proteome of mice hippocampus has been analysed.\n2. A proteomic approach was used to create a comprehensive reference database of proteins in the mouse hippocampus.\n3. Through the analysis, 469 individual proteins were identified.\n4. The method of analysis used was 2-DE coupled to MS (MALDI-TOF/TOF).\n5. The analysis aimed to find molecular correlates to neuronal information storage in the mouse hippocampus.",
    "llama-2-13b-chat-hf_fact": [
      "The proteome of mice hippocampus has been analysed.",
      "A proteomic approach was used to create a comprehensive reference database of proteins in the mouse hippocampus.",
      "Through the analysis, 469 individual proteins were identified.",
      "The method of analysis used was 2-DE coupled to MS (MALDI-TOF/TOF).",
      "The analysis aimed to find molecular correlates to neuronal information storage in the mouse hippocampus."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Without specific details from the passage, it's not possible to confirm the exact number of proteins identified. The actual number could be different from 469.\n4. TRUE (assuming it's consistent with information from the passage)\n5. TRUE (assuming it's consistent with the goals described in the passage)",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, mouse chromosomes are not acrocentric. The information states that chromosome 19 and the sex chromosomes are the only acrocentric chromosomes, indicating that the other chromosomes are metacentric or sub-metacentric.",
    "llama-2-13b-chat-hf_fact_raw": "1. Mouse chromosome 19 is acrocentric.\n2. Mouse sex chromosomes are acrocentric.\n3. Chromosomes other than chromosome 19 and sex chromosomes in mice are metacentric or sub-metacentric.",
    "llama-2-13b-chat-hf_fact": [
      "Mouse chromosome 19 is acrocentric.",
      "Mouse sex chromosomes are acrocentric.",
      "Chromosomes other than chromosome 19 and sex chromosomes in mice are metacentric or sub-metacentric."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Mouse sex chromosomes are not acrocentric; the X chromosome is sub-metacentric and the Y chromosome is acrocentric.\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the siRNA-based drug that is in clinical trials for the treatment of pancreatic cancer is pSsik-ras(GAT).",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the HPG pore refers to the pores present in the hydrophilic polysaccharide (HP) based granules used in the study. The study aimed to investigate the release-controlling action of these granules in relation to the initial pore structure of the formulations. The HPG pore structure was found to have a significant impact on the release of the water-soluble model compound, benzamide, from the swollen matrices. The study showed that the release of the compound was not affected by the total porosity nor the median pore diameter of the initial dry matrix, indicating that the HPG pores play a crucial role in controlling the release of the active ingredient.",
    "llama-2-13b-chat-hf_fact_raw": "1. The HPG pore refers to the pores present in hydrophilic polysaccharide based granules.\n2. The study investigated the release-controlling action of hydrophilic polysaccharide based granules.\n3. The initial pore structure of formulations was a focus of the study concerning release-controlling action.\n4. HPG pore structure significantly impacts the release of benzamide from swollen matrices.\n5. The study indicated that release of the compound was not affected by the total porosity or the median pore diameter of the initial dry matrix.",
    "llama-2-13b-chat-hf_fact": [
      "The HPG pore refers to the pores present in hydrophilic polysaccharide based granules.",
      "The study investigated the release-controlling action of hydrophilic polysaccharide based granules.",
      "The initial pore structure of formulations was a focus of the study concerning release-controlling action.",
      "HPG pore structure significantly impacts the release of benzamide from swollen matrices.",
      "The study indicated that release of the compound was not affected by the total porosity or the median pore diameter of the initial dry matrix."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The term \"HPG pore\" might be a reference to a specific kind of pore in some contexts, but it's not a well-established term in chemistry or material science literature. The pores in hydrophilic polysaccharide-based granules are not typically referred to with this specific abbreviation. It is advisable to refer to the actual passage or scientific literature for the correct terminology.\n2. UNKNOWN: Without further detail, it's unclear whether the study mentioned indeed investigated the release-controlling action of hydrophilic polysaccharide-based granules; this would need to be verified with the original research document or passage.\n3. UNKNOWN: Similarly, whether the initial pore structure of formulations was a particular focus concerning release-controlling action is also not ascertainable without additional context.\n4. UNKNOWN: The impact of HPG pore structure on the release of benzamide from swollen matrices would require specific knowledge of the study's findings, which are not provided here.\n5. UNKNOWN: The statement about the relationship between the release of the compound and the total porosity or the median pore diameter of the initial dry matrix requires specific information from the study to determine its truthfulness.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the 959 Nematode Genomes initiative is a community-curated semantic wiki that aims to coordinate the sequencing efforts of individual labs to collectively sequence 959 genomes spanning the phylum Nematoda. The wiki provides a platform for researchers to track sequencing projects, share preliminary data, and collaborate on nematode genomics research. The initiative has already fostered new international collaborations and attracted newcomers to the field of nematode genomics.",
    "llama-2-13b-chat-hf_fact_raw": "1. The 959 Nematode Genomes initiative is a community-curated semantic wiki.\n2. The aim of the initiative is to coordinate the sequencing of 959 genomes spanning the phylum Nematoda.\n3. The initiative provides a platform to track sequencing projects and share preliminary data.\n4. It facilitates collaboration on nematode genomics research.\n5. The initiative has resulted in new international collaborations and attracted newcomers to the field of nematode genomics.",
    "llama-2-13b-chat-hf_fact": [
      "The 959 Nematode Genomes initiative is a community-curated semantic wiki.",
      "The aim of the initiative is to coordinate the sequencing of 959 genomes spanning the phylum Nematoda.",
      "The initiative provides a platform to track sequencing projects and share preliminary data.",
      "It facilitates collaboration on nematode genomics research.",
      "The initiative has resulted in new international collaborations and attracted newcomers to the field of nematode genomics."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The 959 Nematode Genomes initiative is not primarily known as a community-curated semantic wiki; it is a project aiming to sequence the genomes of 959 nematode species.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the R package for analyzing Non-invasive prenatal testing (NIPT) data is called \"NIPTmer\".",
    "llama-2-13b-chat-hf_fact_raw": "1. The R package \"NIPTmer\" has been developed for analyzing Non-invasive prenatal testing (NIPT) data.",
    "llama-2-13b-chat-hf_fact": [
      "The R package \"NIPTmer\" has been developed for analyzing Non-invasive prenatal testing (NIPT) data."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided in Document-0, Achenbach's syndrome is a rare condition characterized by spontaneous or mechanically induced haematomas (bleeding under the skin) on the volar aspects of fingers (the palmar surface of the fingers). This condition is associated with burning pain and swelling of the digits (fingers).\nThe case described in Document-0 involves a 46-year-old nursing sister who presented with this condition. The exact cause of Achenbach's syndrome is not well understood, but it is thought to be related to trauma or injury to the fingers, which can lead to bleeding under the skin. The condition is rare and has only been reported in a few cases in the medical literature.\nSymptoms of Achenbach's syndrome may include pain, swelling, and bruising on the fingers, as well as limited mobility and function of the affected digits. Treatment for the condition typically involves rest, ice, compression, and elevation (RICE) to reduce pain and swelling, as well as antibiotics to prevent infection. In severe cases, surgical intervention may be necessary to drain the haematoma and promote healing.\nIt's important to note that Achenbach's syndrome is a relatively rare condition, and it is not well understood. Further research is needed to better understand the causes and treatment options for this condition.",
    "llama-2-13b-chat-hf_fact_raw": "1. Achenbach's syndrome is characterized by spontaneous or mechanically induced hematomas on the palmar surfaces of fingers.\n2. Achenbach's syndrome is associated with symptoms such as burning pain, swelling, and bruising of the fingers.\n3. The exact cause of Achenbach's syndrome is not well understood.\n4. Treatment for Achenbach's syndrome typically involves rest, ice, compression, and elevation (RICE).\n5. In severe cases of Achenbach's syndrome, surgical intervention may be required to drain the hematoma.",
    "llama-2-13b-chat-hf_fact": [
      "Achenbach's syndrome is characterized by spontaneous or mechanically induced hematomas on the palmar surfaces of fingers.",
      "Achenbach's syndrome is associated with symptoms such as burning pain, swelling, and bruising of the fingers.",
      "The exact cause of Achenbach's syndrome is not well understood.",
      "Treatment for Achenbach's syndrome typically involves rest, ice, compression, and elevation (RICE).",
      "In severe cases of Achenbach's syndrome, surgical intervention may be required to drain the hematoma."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Surgical intervention is not typically a part of the treatment for Achenbach's syndrome, as the condition usually resolves on its own without the need for invasive procedures.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the algorithm used for detection of long repeat expansions is the Repeat Expansion Detection (RED) method.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Repeat Expansion Detection (RED) method is used for detection of long repeat expansions.",
    "llama-2-13b-chat-hf_fact": [
      "The Repeat Expansion Detection (RED) method is used for detection of long repeat expansions."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, neuroligin-3 promotes medulloblastoma (MB) and glioblastoma (GBM).",
    "llama-2-13b-chat-hf_fact_raw": "1. Neuroligin-3 promotes medulloblastoma (MB).\n2. Neuroligin-3 promotes glioblastoma (GBM).",
    "llama-2-13b-chat-hf_fact": [
      "Neuroligin-3 promotes medulloblastoma (MB).",
      "Neuroligin-3 promotes glioblastoma (GBM)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Neuroligin-3 has been implicated in promoting the growth of medulloblastoma (MB), according to research studies. It is believed to do so by enhancing the proliferation of tumor cells and impacting the tumor microenvironment.\n\n2. TRUE: Similarly, neuroligin-3 has also been found to promote the growth and viability of glioblastoma (GBM) cells. Research indicates that neuroligin-3 can affect cell signaling that contributes to tumor progression in glioblastoma.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the approximate size of gas vesicles in Microcylus aquaticus cells is around 100 nm in diameter, as this is the maximum diameter observed in the study. However, it's important to note that the size of the vesicles increased over time, with smaller vesicles appearing at later time points.",
    "llama-2-13b-chat-hf_fact_raw": "1. Gas vesicles in Microcylus aquaticus cells are approximately 100 nm in diameter.\n2. The size of gas vesicles can increase over time.\n3. Smaller gas vesicles appear at later time points in the study observed.",
    "llama-2-13b-chat-hf_fact": [
      "Gas vesicles in Microcylus aquaticus cells are approximately 100 nm in diameter.",
      "The size of gas vesicles can increase over time.",
      "Smaller gas vesicles appear at later time points in the study observed."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The gas vesicles in Microcystis (not Microcylus) aquaticus cells are approximately 200-600 nm in diameter when fully formed.\n2. TRUE\n3. FALSE [correction]: Typically, smaller gas vesicles appear at earlier stages of formation and are observed at earlier time points in a study. As they mature, their size typically increases.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here is a list of BET proteins:\n1. BRD2 (bromodomain-containing protein 2)\n2. BRD3 (bromodomain-containing protein 3)\n3. BRD4 (bromodomain-containing protein 4)\n4. BRDT (testis-specific BRDT protein)\nThese proteins are members of the BET family and play a key role in regulating gene transcription. They are considered attractive therapeutic targets for cancer and other human diseases.",
    "llama-2-13b-chat-hf_fact_raw": "1. BRD2 is a member of the BET protein family.\n2. BRD3 is a member of the BET protein family.\n3. BRD4 is a member of the BET protein family.\n4. BRDT is a member of the BET protein family and is testis-specific.\n5. BET proteins play a significant role in regulating gene transcription.",
    "llama-2-13b-chat-hf_fact": [
      "BRD2 is a member of the BET protein family.",
      "BRD3 is a member of the BET protein family.",
      "BRD4 is a member of the BET protein family.",
      "BRDT is a member of the BET protein family and is testis-specific.",
      "BET proteins play a significant role in regulating gene transcription."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the algorithm developed for prediction of protein subcellular localization using deep learning is the \"comprehensive system\" presented in the document. This system integrates protein sequence-derived data and text-based information to predict the subcellular localization of proteins, and has been tested on three large data sets with successful results, outperforming previous methods for a wide range of eukaryotic subcellular localizations.",
    "llama-2-13b-chat-hf_fact_raw": "1. An algorithm for prediction of protein subcellular localization using deep learning has been developed.\n2. This algorithm is known as the \"comprehensive system.\"\n3. The algorithm integrates protein sequence-derived data and text-based information for predictions.\n4. It has been tested on three large data sets.\n5. It outperformed previous methods for predicting a wide range of eukaryotic subcellular localizations.",
    "llama-2-13b-chat-hf_fact": [
      "An algorithm for prediction of protein subcellular localization using deep learning has been developed.",
      "This algorithm is known as the \"comprehensive system.\"",
      "The algorithm integrates protein sequence-derived data and text-based information for predictions.",
      "It has been tested on three large data sets.",
      "It outperformed previous methods for predicting a wide range of eukaryotic subcellular localizations."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe provided statements are specific claims related to a particular scientific development in the field of bioinformatics or computational biology. Without having access to the specific passage these statements are drawn from, or any publicly available information confirming these details, I cannot determine the truthfulness of the statements. The realm of protein subcellular localization prediction using deep learning is a specialized one, and such claims would typically be verified by reviewing the relevant scientific literature or specific study results.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, MULTOVL is an application suite that detects and statistically analyzes multiple overlaps of genomic regions in a fast and efficient manner. It supports the detection of multiple region intersections, unions, and \"solitary\" genomic regions, and estimates the significance of actually observed overlaps by comparing them with empirical null distributions generated by random shuffling of the input regions.",
    "llama-2-13b-chat-hf_fact_raw": "1. MULTOVL is an application suite designed for detecting and statistically analyzing multiple overlaps of genomic regions.\n2. It can detect multiple region intersections, unions, and solitary genomic regions.\n3. MULTOVL compares actual observed overlaps with empirical null distributions generated by random shuffling of the input regions to estimate their significance.",
    "llama-2-13b-chat-hf_fact": [
      "MULTOVL is an application suite designed for detecting and statistically analyzing multiple overlaps of genomic regions.",
      "It can detect multiple region intersections, unions, and solitary genomic regions.",
      "MULTOVL compares actual observed overlaps with empirical null distributions generated by random shuffling of the input regions to estimate their significance."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that GDF15 can be a biomarker for metformin treatment. The study found that metformin treatment was associated with a 40% rise in GDF15 levels in participants with diabetes, independent of other major cardiovascular risk factors. This suggests that GDF15 may be a useful biomarker for monitoring the effectiveness of metformin treatment in patients with diabetes. Additionally, the study suggests that the relatively high GDF15 bioavailability may partly explain the protective cardiovascular effects of metformin.",
    "llama-2-13b-chat-hf_fact_raw": "1. GDF15 levels increased by 40% in response to metformin treatment in participants with diabetes.\n2. The increase in GDF15 levels was found to be independent of other major cardiovascular risk factors.\n3. GDF15 may be a useful biomarker for monitoring metformin treatment effectiveness in patients with diabetes.\n4. High GDF15 bioavailability may partly explain metformin's protective cardiovascular effects.",
    "llama-2-13b-chat-hf_fact": [
      "GDF15 levels increased by 40% in response to metformin treatment in participants with diabetes.",
      "The increase in GDF15 levels was found to be independent of other major cardiovascular risk factors.",
      "GDF15 may be a useful biomarker for monitoring metformin treatment effectiveness in patients with diabetes.",
      "High GDF15 bioavailability may partly explain metformin's protective cardiovascular effects."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout the specific context, study, or scientific findings to reference, it is impossible to verify the accuracy of these biomedical statements. These details would typically be found in a medical or scientific journal article, and without access to that evidence or data, the validity of these statements cannot be determined.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that recursive splicing is more common in long introns (those longer than 40 kb) in Drosophila melanogaster. The information states that recursive sites occur in most very long introns and tend to occur near the midpoints of introns. This suggests that recursive splicing may be more prevalent in longer introns, as there is a higher likelihood of finding multiple segments that can be removed in a recursive manner. However, it is important to note that the detection of recursive splicing can be difficult due to the instability of splicing intermediates, so further research is needed to confirm this observation.",
    "llama-2-13b-chat-hf_fact_raw": "1. Recursive splicing is more common in long introns of Drosophila melanogaster than in short introns.\n2. Long introns are categorized as those longer than 40 kilobases (kb).\n3. Most very long introns in Drosophila melanogaster contain recursive sites.\n4. Recursive sites tend to occur near the midpoints of introns in Drosophila melanogaster.\n5. The detection of recursive splicing can be challenging due to the instability of splicing intermediates.",
    "llama-2-13b-chat-hf_fact": [
      "Recursive splicing is more common in long introns of Drosophila melanogaster than in short introns.",
      "Long introns are categorized as those longer than 40 kilobases (kb).",
      "Most very long introns in Drosophila melanogaster contain recursive sites.",
      "Recursive sites tend to occur near the midpoints of introns in Drosophila melanogaster.",
      "The detection of recursive splicing can be challenging due to the instability of splicing intermediates."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: Recursive splicing is indeed more common in long introns, and Drosophila melanogaster (fruit fly) is one of the organisms where such splicing has been observed.\n\n2. FALSE [correction]: The definition of long introns can vary, but typically, long introns in the context of eukaryotic genes are considered to be those longer than a few kilobases, but not necessarily as high as 40 kilobases. The exact definition of \"long\" can vary depending on the study, but 40 kb would usually be considered \"very long\" rather than just \"long.\"\n\n3. TRUE: It has been noted in genetic studies that most very long introns in Drosophila melanogaster contain recursive splicing sites, supporting the idea that recursive splicing helps in the processing of long introns.\n\n4. TRUE: Recursive sites often occur at regular intervals within long introns, and near the midpoints is a typical location for these sites, which aid in the step-wise splicing of these long intronic regions.\n\n5. TRUE: The detection of recursive splicing has been noted as challenging in scientific literature because the lariat splicing intermediates involved in recursive splicing are generally unstable and transient, making them difficult to capture and study.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here is the answer to the user's question:\nThe TALE-iD method is used for high-throughput synthesis of TALE-nucleases, activators, and repressors that recognize DNA sequences between 14 and 31 base pairs.",
    "llama-2-13b-chat-hf_fact_raw": "1. The TALE-iD method is used for high-throughput synthesis of TALE-nucleases.\n2. The TALE-iD method is used for synthesizing TALE activators and repressors.\n3. The TALE-iD method targets DNA sequences between 14 and 31 base pairs in length.",
    "llama-2-13b-chat-hf_fact": [
      "The TALE-iD method is used for high-throughput synthesis of TALE-nucleases.",
      "The TALE-iD method is used for synthesizing TALE activators and repressors.",
      "The TALE-iD method targets DNA sequences between 14 and 31 base pairs in length."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the Lisp framework developed for image processing is FunImageJ. It is built upon the ImageJ software ecosystem and is freely available as a plugin to Fiji. The framework provides a natural functional-style for programming and accounts for the performance requirements necessary in big data processing commonly encountered in biological image analysis. For more information, you can contact the developer at kharrington@uidaho.edu.",
    "llama-2-13b-chat-hf_fact_raw": "1. FunImageJ is a Lisp framework developed for image processing.\n2. FunImageJ is built upon the ImageJ software ecosystem.\n3. FunImageJ is available as a plugin to Fiji.\n4. FunImageJ is designed for performance requirements in big data processing.\n5. FunImageJ is used commonly in biological image analysis.",
    "llama-2-13b-chat-hf_fact": [
      "FunImageJ is a Lisp framework developed for image processing.",
      "FunImageJ is built upon the ImageJ software ecosystem.",
      "FunImageJ is available as a plugin to Fiji.",
      "FunImageJ is designed for performance requirements in big data processing.",
      "FunImageJ is used commonly in biological image analysis."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it is estimated that approximately 85% of the genes in S. cerevisiae are the result of an ancient whole genome duplication. This is based on the observation that most of the duplicated genes (85%) were lost before the speciation of S. castellii, which diverged from S. cerevisiae before the duplication event. Only a small amount of paralogous gene loss (4-6%) occurred after speciation.",
    "llama-2-13b-chat-hf_fact_raw": "1. Approximately 85% of the genes in S. cerevisiae are the result of an ancient whole genome duplication.\n2. Most of the duplicated genes in S. cerevisiae were lost before the speciation of S. castellii.\n3. S. castellii diverged from S. cerevisiae before the ancient whole genome duplication event.\n4. There has been a small amount (4-6%) of paralogous gene loss after the speciation in S. cerevisiae.",
    "llama-2-13b-chat-hf_fact": [
      "Approximately 85% of the genes in S. cerevisiae are the result of an ancient whole genome duplication.",
      "Most of the duplicated genes in S. cerevisiae were lost before the speciation of S. castellii.",
      "S. castellii diverged from S. cerevisiae before the ancient whole genome duplication event.",
      "There has been a small amount (4-6%) of paralogous gene loss after the speciation in S. cerevisiae."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: S. castellii diverged from S. cerevisiae after the ancient whole genome duplication event.\n4. FALSE [correction]: There has been a significant amount of paralogous gene loss after the speciation in S. cerevisiae, but the specific percentage can fluctuate based on the study and the methods used to estimate it. Saying 4-6% is likely an underestimate, as estimates typically suggest a higher percentage of gene loss.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the complex bound by estrogen-related receptor  (Esrrb) is estradiol-pyridine tetra acetate europium(III).",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, ZCCHC17 is a human nuclear protein with sequence homology to yeast Air1p/Air2p proteins, which are RNA-binding subunits of the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex involved in nuclear RNA quality control and degradation in yeast. The ZCCHC17 protein contains four retroviral-type zinc knuckle motifs, and its role is expected to be in the RNA quality control in human, as it has been studied using NMR spectral assignment of the zinc knuckle region.",
    "llama-2-13b-chat-hf_fact_raw": "1. ZCCHC17 is a human nuclear protein.\n2. ZCCHC17 has sequence homology to yeast Air1p/Air2p proteins.\n3. Air1p/Air2p proteins are subunits of the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex in yeast.\n4. The TRAMP complex is involved in nuclear RNA quality control and degradation in yeast.\n5. The ZCCHC17 protein contains four retroviral-type zinc knuckle motifs.",
    "llama-2-13b-chat-hf_fact": [
      "ZCCHC17 is a human nuclear protein.",
      "ZCCHC17 has sequence homology to yeast Air1p/Air2p proteins.",
      "Air1p/Air2p proteins are subunits of the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex in yeast.",
      "The TRAMP complex is involved in nuclear RNA quality control and degradation in yeast.",
      "The ZCCHC17 protein contains four retroviral-type zinc knuckle motifs."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The ZCCHC17 protein, also known as ZCCHC17 or nuclear poly(A) binding protein 1 (PABPN1), contains one RNA recognition motif and one zinc knuckle; it does not contain four retroviral-type zinc knuckle motifs.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the proteins that form the nuclear pore basket in human cells are:\n* SENP1\n* SENP2\n* Nucleoporins (30 different proteins)\nThese proteins work together to create specialized channels that convey cargo between the cytoplasm and the nuclear interior. The study mentioned in the information found that codepletion of SENP1 and SENP2 leads to mislocalization and reduction of nucleoporins, indicating a new role for these proteins in nucleoporin homeostasis and proper configuration of the nuclear pore complex.",
    "llama-2-13b-chat-hf_fact_raw": "1. SENP1 is one of the proteins that form the nuclear pore basket in human cells.\n2. SENP2 is also a protein that forms the nuclear pore basket in human cells.\n3. There are 30 different nucleoporins that form part of the nuclear pore basket.\n4. The nuclear pore basket is involved in transporting cargo between the cytoplasm and the nuclear interior.\n5. Codepletion of SENP1 and SENP2 leads to mislocalization and reduction of nucleoporins.",
    "llama-2-13b-chat-hf_fact": [
      "SENP1 is one of the proteins that form the nuclear pore basket in human cells.",
      "SENP2 is also a protein that forms the nuclear pore basket in human cells.",
      "There are 30 different nucleoporins that form part of the nuclear pore basket.",
      "The nuclear pore basket is involved in transporting cargo between the cytoplasm and the nuclear interior.",
      "Codepletion of SENP1 and SENP2 leads to mislocalization and reduction of nucleoporins."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: SENP1 is a SUMO-specific protease and does not form part of the nuclear pore basket.\n2. FALSE [correction]: SENP2, like SENP1, is a SUMO-specific protease and does not form the nuclear pore basket.\n3. FALSE [correction]: It is believed that there are around 30 different types of nucleoporins that are part of the nuclear pore complex, but not specifically the nuclear pore basket, which is just a sub-structure.\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, gepotidacin is a type IIA topoisomerase inhibitor.",
    "llama-2-13b-chat-hf_fact_raw": "1. Gepotidacin is an inhibitor of type IIA topoisomerase.",
    "llama-2-13b-chat-hf_fact": [
      "Gepotidacin is an inhibitor of type IIA topoisomerase."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n\nGepotidacin is indeed an inhibitor of bacterial type IIA topoisomerases, which include DNA gyrase and topoisomerase IV. These enzymes are important for DNA replication and are targeted by antibiotics to prevent bacterial growth. Gepotidacin is being investigated for its potential use as an antibiotic.",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, here is a description of Canvas SPW:\nCanvas SPW is a new tool developed for the identification of inherited and de novo copy number variants from pedigree sequencing data. It supports a variety of family structures and provides a range of scoring and filtering options to automate and streamline the identification of de novo variants. The tool is designed to address the challenge of joint variant calling in pedigrees, where the complexity of consensus breakpoint alignment across samples within an arbitrary pedigree structure can be a major hurdle.\nWith Canvas SPW, users can analyze pedigree sequencing data and identify inherited and de novo copy number variants with high accuracy and efficiency. The tool is available for download from GitHub and is suitable for use in a variety of research and clinical settings.\nSome of the key features of Canvas SPW include:\n* Support for a range of family structures, including simplex, trio, and multiplex families\n* A variety of scoring and filtering options to automate and streamline the identification of de novo variants\n* Ability to handle large datasets and perform joint variant calling across multiple samples\n* Integration with popular sequencing platforms and software tools\nOverall, Canvas SPW is a powerful and flexible tool that can help researchers and clinicians identify inherited and de novo copy number variants in pediatric and late-onset genetic diseases more accurately and efficiently.",
    "llama-2-13b-chat-hf_fact_raw": "1. Canvas SPW is a tool developed for the identification of inherited and de novo copy number variants from pedigree sequencing data.\n2. The tool supports a range of family structures, including simplex, trio, and multiplex families.\n3. Canvas SPW provides scoring and filtering options to aid in the identification of de novo variants.\n4. It is capable of performing joint variant calling across multiple samples in a pedigree.\n5. Canvas SPW is available for download from GitHub.",
    "llama-2-13b-chat-hf_fact": [
      "Canvas SPW is a tool developed for the identification of inherited and de novo copy number variants from pedigree sequencing data.",
      "The tool supports a range of family structures, including simplex, trio, and multiplex families.",
      "Canvas SPW provides scoring and filtering options to aid in the identification of de novo variants.",
      "It is capable of performing joint variant calling across multiple samples in a pedigree.",
      "Canvas SPW is available for download from GitHub."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\n[Assuming that Canvas SPW exists and the statements provided are based on its actual capabilities and availability. Without specific knowledge of a tool called \"Canvas SPW,\" the responses provided are based on typical features of such pedigree analysis tools.]",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are some STING agonists that may be relevant to the patient's condition:\n1. Echiichthys draco venom: As the patient was stung by a great weever fish, the venom from the fish is likely to be a STING agonist.\n2. Bradykinin: Bradykinin is a peptide that is released during inflammation and can cause pain, swelling, and redness. The patient's symptoms of severe swelling, pain, and erythema at the sting site suggest that bradykinin may be involved in the sting reaction.\n3. Prostaglandins: Prostaglandins are inflammatory mediators that can cause pain, fever, and inflammation. The patient's symptoms of pain, swelling, and numbness suggest that prostaglandins may be involved in the sting reaction.\n4. Histamine: Histamine is a chemical released during allergic reactions that can cause symptoms such as itching, hives, and swelling. The patient's symptoms of itching and swelling suggest that histamine may be involved in the sting reaction.\n5. Leukotrienes: Leukotrienes are inflammatory mediators that can cause pain, swelling, and inflammation. The patient's symptoms of swelling and pain suggest that leukotrienes may be involved in the sting reaction.\nIt is important to note that the patient's symptoms were only slightly reduced by morphine therapy, which suggests that the sting reaction may be more severe than a typical allergic reaction. Additionally, the development of Raynaud phenomenon after four months suggests that the sting reaction may have caused lasting damage to the patient's tissues.",
    "llama-2-13b-chat-hf_fact_raw": "1. The venom from the great weever fish (Echiichthys draco) is considered a STING agonist.\n2. Bradykinin is identified as a peptide that can be released during inflammation.\n3. Prostaglandins are known as inflammatory mediators that can cause pain, fever, and inflammation.\n4. Histamine is recognized as a chemical that can be released during allergic reactions, leading to symptoms like itching, hives, and swelling.\n5. Leukotrienes are inflammatory mediators associated with causing pain, swelling, and inflammation.",
    "llama-2-13b-chat-hf_fact": [
      "The venom from the great weever fish (Echiichthys draco) is considered a STING agonist.",
      "Bradykinin is identified as a peptide that can be released during inflammation.",
      "Prostaglandins are known as inflammatory mediators that can cause pain, fever, and inflammation.",
      "Histamine is recognized as a chemical that can be released during allergic reactions, leading to symptoms like itching, hives, and swelling.",
      "Leukotrienes are inflammatory mediators associated with causing pain, swelling, and inflammation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The venom from the great weever fish is considered a pain agonist, not specifically a STING agonist.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, here is a description of SLIC-CAGE:\nSLIC-CAGE is a scanning liquid-filled ionization chamber (SLIC) electronic portal imaging device that has been investigated for its dosimetric characteristics. The system is capable of measuring the portal (transmission) dose with an accuracy of within 3% of the ionization chamber results for homogeneous material. The imaging system is dependent on incident radiation intensity and can be described to within 1% accuracy on central axis using a square root function. For two-dimensional dosimetry applications, the system is calibrated with a 10 cm Perspex block used as beam flattening material on the detector cassette to correct for variations in individual ion chamber sensitivity and the effect of nonuniform beam profiles produced by the flattening filter. The system has been found to be accurate in measuring open and wedged dose profiles, with agreement within 3.5% accuracy.",
    "llama-2-13b-chat-hf_fact_raw": "1. SLIC-CAGE is a scanning liquid-filled ionization chamber electronic portal imaging device.\n2. SLIC-CAGE can measure portal dose with an accuracy of within 3% of the ionization chamber results for homogeneous material.\n3. The accuracy of the SLIC-CAGE imaging system can be described to within 1% on central axis using a square root function.\n4. For calibration, the system uses a 10 cm Perspex block on the detector cassette to correct for variations in individual ion chamber sensitivity and nonuniform beam profiles.\n5. The system has been found accurate in measuring open and wedged dose profiles, with agreement within 3.5% accuracy.",
    "llama-2-13b-chat-hf_fact": [
      "SLIC-CAGE is a scanning liquid-filled ionization chamber electronic portal imaging device.",
      "SLIC-CAGE can measure portal dose with an accuracy of within 3% of the ionization chamber results for homogeneous material.",
      "The accuracy of the SLIC-CAGE imaging system can be described to within 1% on central axis using a square root function.",
      "For calibration, the system uses a 10 cm Perspex block on the detector cassette to correct for variations in individual ion chamber sensitivity and nonuniform beam profiles.",
      "The system has been found accurate in measuring open and wedged dose profiles, with agreement within 3.5% accuracy."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: SLIC-CAGE can measure portal dose with an accuracy of within 1% of the ionization chamber results for homogeneous material.\n3. FALSE [correction]: The accuracy of the SLIC-CAGE imaging system cannot be simply defined to within 1% on central axis using a square root function, accuracy would depend on various factors and the specific context of the measurement.\n4. UNKNOWN\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the roles of LEM-3 are:\n1. Transporting P143 to the nucleus: LEF-3 is required for the nuclear localization of P143, and the N-terminal 56 amino acid residues of LEF-3 are sufficient for nuclear localization.\n2. Supporting DNA replication: LEF-3 is an essential protein for DNA replication in transient assays, and fusing the LEF-3 nuclear localization signal domain to P143 does not alter the function of P143 in supporting DNA replication.\n3. Performing other essential replication functions once inside the nucleus: LEF-3 performs other essential replication functions once inside the nucleus, in addition to transporting P143.",
    "llama-2-13b-chat-hf_fact_raw": "1. LEF-3 is required for the nuclear localization of P143.\n2. The N-terminal 56 amino acid residues of LEF-3 are sufficient for nuclear localization.\n3. LEF-3 is an essential protein for DNA replication in transient assays.\n4. Fusing the LEF-3 nuclear localization signal domain to P143 does not alter the function of P143 in supporting DNA replication.\n5. LEF-3 performs other essential replication functions in addition to transporting P143 once inside the nucleus.",
    "llama-2-13b-chat-hf_fact": [
      "LEF-3 is required for the nuclear localization of P143.",
      "The N-terminal 56 amino acid residues of LEF-3 are sufficient for nuclear localization.",
      "LEF-3 is an essential protein for DNA replication in transient assays.",
      "Fusing the LEF-3 nuclear localization signal domain to P143 does not alter the function of P143 in supporting DNA replication.",
      "LEF-3 performs other essential replication functions in addition to transporting P143 once inside the nucleus."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: These statements seem to pertain to specialized scientific research, possibly within the fields of molecular biology or biochemistry. Without access to the specific passage or study they are derived from, their veracity cannot be determined from general knowledge alone. For accurate assessment, knowledge of the specific functions of the proteins LEF-3 and P143, as well as the experimental evidence presented in the passage, would be required.]",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the releases of tmVar are:\n1. PPF/PNVP matrices loaded with acetazolamide (AZ) and 5% PEG. The study found that these matrices released AZ in 56 days, which is approximately 25% of the release period found for the unmodified matrices.\n2. PPF/PNVP matrices loaded with timolol maleate (TM) and 5% PEG. The study found that these matrices released TM in a comparable period to the AZ-loaded matrices.\n3. PPF/PNVP matrices with increased NVP content. The study found that these matrices released the drugs more quickly than the unmodified matrices, with a significant acceleration in drug release.\n4. PPF/PNVP matrices loaded with 1% PEG. The study found that these matrices released the drugs one-third faster than the unmodified matrices.",
    "llama-2-13b-chat-hf_fact_raw": "1. PPF/PNVP matrices loaded with acetazolamide (AZ) and 5% PEG released AZ in 56 days according to a study.\n2. PPF/PNVP matrices with timolol maleate (TM) and 5% PEG released TM in a period comparable to the AZ-loaded matrices, as found in a study.\n3. A study showed that PPF/PNVP matrices with increased NVP content released drugs more quickly than unmodified matrices.\n4. According to a study, PPF/PNVP matrices loaded with 1% PEG released drugs one-third faster than the unmodified matrices.",
    "llama-2-13b-chat-hf_fact": [
      "PPF/PNVP matrices loaded with acetazolamide (AZ) and 5% PEG released AZ in 56 days according to a study.",
      "PPF/PNVP matrices with timolol maleate (TM) and 5% PEG released TM in a period comparable to the AZ-loaded matrices, as found in a study.",
      "A study showed that PPF/PNVP matrices with increased NVP content released drugs more quickly than unmodified matrices.",
      "According to a study, PPF/PNVP matrices loaded with 1% PEG released drugs one-third faster than the unmodified matrices."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific information or access to the study/studies mentioned in the statements, it is not possible to verify the accuracy of the drug release rates, comparability, or effects of modifications such as increased NVP content or 1% PEG on drug release from PPF/PNVP matrices.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the database of somatic mutations in normal cells is the NIST reference material NA12878 genome.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-13b-chat-hf_response": "Yes, there are graph kernel libraries available implemented in JAVA. One such library is the Graph Kernels (GK) library, which is an open-source library for graph comparison and kernel methods. The library is implemented in JAVA and provides a range of graph kernels, including label histogram based kernels, random walk based kernels, and the state-of-the-art Weisfeiler-Lehman graph kernel.\nThe GK library is designed to be efficient and scalable, making it suitable for large-scale graph processing. It also provides a range of tools for working with graph kernels, including kernel computation, kernel approximation, and kernel evaluation.\nThe GK library is available under an open-source license and can be downloaded from the following link:\n<https://github.com/graph-kernels/graph-kernels>\nAdditionally, there are other Java libraries for graph processing and analysis that may also provide graph kernel functionality, such as the Java Graph Library (JGL) and the Weka data mining software. However, these libraries may not have the same focus on graph kernels as the GK library.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Graph Kernels (GK) library is an open-source library for graph comparison and kernel methods.\n2. The GK library is implemented in JAVA.\n3. The GK library offers graph kernels including label histogram based kernels, random walk based kernels, and the Weisfeiler-Lehman graph kernel.\n4. The GK library is designed for large-scale graph processing.\n5. The library is available for download under an open-source license from GitHub.",
    "llama-2-13b-chat-hf_fact": [
      "The Graph Kernels (GK) library is an open-source library for graph comparison and kernel methods.",
      "The GK library is implemented in JAVA.",
      "The GK library offers graph kernels including label histogram based kernels, random walk based kernels, and the Weisfeiler-Lehman graph kernel.",
      "The GK library is designed for large-scale graph processing.",
      "The library is available for download under an open-source license from GitHub."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE\n\nWithout specific details on the \"Graph Kernels (GK) library\" being referred to, it's difficult to verify the accuracy of statements 1, 2, and 4, considering there could be multiple libraries with a similar name or focus. However, statement 3 generally describes types of graph kernels that are commonly used in graph comparison and could reasonably be expected to be offered in a graph kernel library. Statement 5 is generally true for most open-source libraries as GitHub is a common platform for distributing such software; however, the statement doesn't specify which GK library, so one cannot be certain without the specific context.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, the four advances integrated into the SHERLOCKv2 platform are:\n1. Four-channel single-reaction multiplexing with orthogonal CRISPR enzymes\n2. Quantitative measurement of input as low as 2 attomolar\n3. 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme\n4. Lateral-flow readout\nThese advances allow for multiplexed, portable, rapid, and quantitative detection of nucleic acids, making the SHERLOCKv2 platform a powerful tool for clinical diagnostics and biotechnological applications.",
    "llama-2-13b-chat-hf_fact_raw": "1. The SHERLOCKv2 platform incorporates four-channel single-reaction multiplexing with orthogonal CRISPR enzymes.\n2. It enables quantitative measurement of input as low as 2 attomolar.\n3. The platform has a 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme.\n4. SHERLOCKv2 includes a lateral-flow readout feature for detection.",
    "llama-2-13b-chat-hf_fact": [
      "The SHERLOCKv2 platform incorporates four-channel single-reaction multiplexing with orthogonal CRISPR enzymes.",
      "It enables quantitative measurement of input as low as 2 attomolar.",
      "The platform has a 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme.",
      "SHERLOCKv2 includes a lateral-flow readout feature for detection."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nEach of the statements provided appears consistent with information about the SHERLOCKv2 (Specific High Sensitivity Enzymatic Reporter unLOCKing) CRISPR-based diagnostic platform, as it was described in scientific literature prior to my knowledge cutoff date. SHERLOCKv2 is known for its enhanced sensitivity and multiplexing capabilities, which fits with statements 1 and 3. Its ability to detect molecules at very low concentrations, such as attomolar levels, aligns with statement 2. The inclusion of a lateral-flow readout is a feature that enables the visualization of results, matching statement 4.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, the bartender algorithm is a novel approach to the cocktail party problem that uses a cortronic artificial neural network architecture as the front end of a speech processing system. Here are the key features of the algorithm:\n1. Detailed knowledge of signals: The algorithm assumes and exploits detailed knowledge of the signals it wishes to attend to in the cocktail party environment.\n2. Preprocessing: The algorithm provides preprocessing in advance of a pattern recognition system, rather than separating one or more of the mixed sources explicitly.\n3. Biologically feasible: The neural network model employed by the algorithm is more biologically feasible than other approaches to the cocktail party problem.\nThe bartender algorithm can be applied to other areas of information processing, not just the cocktail party problem.",
    "llama-2-13b-chat-hf_fact_raw": "1. The bartender algorithm uses a cortronic artificial neural network architecture.\n2. It deals with the cocktail party problem in speech processing.\n3. The algorithm assumes detailed knowledge of the signals in a cocktail party environment.\n4. The algorithm performs preprocessing for a pattern recognition system.\n5. The neural network model used in the algorithm is considered more biologically feasible compared to other approaches to the cocktail party problem.",
    "llama-2-13b-chat-hf_fact": [
      "The bartender algorithm uses a cortronic artificial neural network architecture.",
      "It deals with the cocktail party problem in speech processing.",
      "The algorithm assumes detailed knowledge of the signals in a cocktail party environment.",
      "The algorithm performs preprocessing for a pattern recognition system.",
      "The neural network model used in the algorithm is considered more biologically feasible compared to other approaches to the cocktail party problem."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: There is no widely recognized algorithm known as the \"bartender algorithm\" in the context of artificial neural networks or speech processing.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nSince the \"bartender algorithm\" is not a standard term in the field of speech processing or neural networks, it's not possible to evaluate the accuracy of statements 2 through 5 without additional context or clarification about what the \"bartender algorithm\" is supposed to be.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, one web-based pedigree editor that is available is \"pedigreejs\". It is an interactive graphical pedigree editor written in JavaScript, which uses standard pedigree nomenclature and is freely available under GPL licence. It is easily configurable, extensible, and lightweight, making it suitable for incorporation into web applications. The software is available at <https://ccge-boadicea.github.io/pedigreejs/>, and contact information for the developer is provided as tjc29@cam.ac.uk.",
    "llama-2-13b-chat-hf_fact_raw": "1. \"pedigreejs\" is a web-based pedigree editor.\n2. \"pedigreejs\" is written in JavaScript.\n3. The software uses standard pedigree nomenclature.\n4. \"pedigreejs\" is freely available under the GPL licence.\n5. The software can be found at <https://ccge-boadicea.github.io/pedigreejs/>.",
    "llama-2-13b-chat-hf_fact": [
      "\"pedigreejs\" is a web-based pedigree editor.",
      "\"pedigreejs\" is written in JavaScript.",
      "The software uses standard pedigree nomenclature.",
      "\"pedigreejs\" is freely available under the GPL licence.",
      "The software can be found at <https://ccge-boadicea.github.io/pedigreejs/>."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: \"pedigreejs\" is freely available under the MIT license, not the GPL license.\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are several curated databases that exist for spider-venom toxins, including:\n1. The Spider Venom Database (SVD): This database contains information on the composition and properties of spider venoms from a variety of species. It includes data on the types and amounts of toxins present in the venom, as well as information on the molecular weights and isoelectric points of the toxins.\n2. The Venom Peptide Database (VPD): This database contains information on venom peptides and proteins from a variety of arachnid species, including spiders. It includes data on the sequences, structures, and functions of the peptides and proteins, as well as information on their distribution and evolution.\n3. The Arachnid Venom Database (AVD): This database contains information on the venoms of arachnids, including spiders, scorpions, and ticks. It includes data on the composition and properties of the venoms, as well as information on the molecular biology and evolution of the venom glands.\n4. The Toxin and Venom Compendium (TOXINS): This database contains information on a wide range of toxins and venoms, including those from spiders. It includes data on the sequences, structures, and functions of the toxins, as well as information on their distribution and evolution.\nThese databases can be accessed online and provide a wealth of information on the diversity and complexity of spider-venom toxins. The study you mentioned, which analyzed the transcriptome of the pseudoscorpion Synsphyronus apimelus, provides new insights into the diversity of components within pseudoscorpion venom and highlights the need for further research on the venoms of these understudied arachnids.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Spider Venom Database (SVD) contains information on the composition and properties of spider venoms from various species, including data on toxins present.\n2. The Venom Peptide Database (VPD) features information on venom peptides and proteins from various arachnids, including data on their sequences and functions.\n3. The Arachnid Venom Database (AVD) focuses on venoms from arachnids such as spiders, scorpions, and ticks, and includes data on venom composition and venom gland evolution.\n4. The Toxin and Venom Compendium (TOXINS) offers information on a range of toxins and venoms, including those from spiders, with data on their sequences and structures.\n5. The pseudoscorpion Synsphyronus apimelus has been the subject of research analyzing its venom's transcriptome, which provided new insights into venom diversity.",
    "llama-2-13b-chat-hf_fact": [
      "The Spider Venom Database (SVD) contains information on the composition and properties of spider venoms from various species, including data on toxins present.",
      "The Venom Peptide Database (VPD) features information on venom peptides and proteins from various arachnids, including data on their sequences and functions.",
      "The Arachnid Venom Database (AVD) focuses on venoms from arachnids such as spiders, scorpions, and ticks, and includes data on venom composition and venom gland evolution.",
      "The Toxin and Venom Compendium (TOXINS) offers information on a range of toxins and venoms, including those from spiders, with data on their sequences and structures.",
      "The pseudoscorpion Synsphyronus apimelus has been the subject of research analyzing its venom's transcriptome, which provided new insights into venom diversity."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE - The Spider Venom Database does exist and contains information on the composition and properties of spider venoms, which includes data on the toxins present.\n\n2. UNKNOWN - While databases concerning venom peptides and proteins exist, the specificity of the name \"Venom Peptide Database\" cannot be confirmed without additional context or reference. The Venom Knowledge Base (VenomKB) is a known entity that contains such information, but it is not clear if VPD is an abbreviation or a different database.\n\n3. UNKNOWN - The name \"Arachnid Venom Database\" suggests a database compiling information on arachnid venoms, which could be plausible, but without specific references to this database, its existence cannot be confirmed. It's possible that there are databases that contain such information, but whether they are specifically designated as AVD is unknown.\n\n4. UNKNOWN - The existence of a compendium called \"Toxin and Venom Compendium (TOXINS)\" is not verifiable without additional context or references. While databases such as Toxin and Toxin Target Database (T3DB) or the aforementioned VenomKB do contain information on a range of toxins and venoms, the specific nomenclature provided here cannot be confirmed to be a true entity.\n\n5. TRUE - Research on the venom transcriptomes of pseudoscorpions, including Synsphyronus apimelus, has been conducted, which has contributed to the understanding of venom diversity. Pseudoscorpion venoms have been studied, and transcriptome analysis is a common method for examining venom components to gain insights into their complexity and evolutionary context.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nNo, Axitinib does not prolong survival for pancreatic cancer patients.\nAccording to the information provided in the text, a phase 3 trial was conducted to assess the effect of treatment with gemcitabine plus axitinib on overall survival in patients with metastatic or locally advanced pancreatic adenocarcinoma. The trial found that the addition of axitinib to gemcitabine did not improve overall survival in these patients. In fact, the study found that the hazard ratio for overall survival was 1.014 (95% CI 0.786-1.309), indicating that there was no significant difference in survival between the group receiving gemcitabine plus axitinib and the group receiving gemcitabine plus placebo. Therefore, based on this study, it can be concluded that axitinib does not prolong survival for pancreatic cancer patients.",
    "llama-2-13b-chat-hf_fact_raw": "1. A phase 3 trial aimed to assess the effect of treatment with gemcitabine plus axitinib on pancreatic cancer patients' overall survival.\n2. The trial involved patients with metastatic or locally advanced pancreatic adenocarcinoma.\n3. The addition of axitinib to gemcitabine did not improve overall survival for these patients.\n4. The study reported a hazard ratio for overall survival of 1.014 (95% CI 0.786-1.309).\n5. The trial concluded that axitinib does not prolong survival for pancreatic cancer patients.",
    "llama-2-13b-chat-hf_fact": [
      "A phase 3 trial aimed to assess the effect of treatment with gemcitabine plus axitinib on pancreatic cancer patients' overall survival.",
      "The trial involved patients with metastatic or locally advanced pancreatic adenocarcinoma.",
      "The addition of axitinib to gemcitabine did not improve overall survival for these patients.",
      "The study reported a hazard ratio for overall survival of 1.014 (95% CI 0.786-1.309).",
      "The trial concluded that axitinib does not prolong survival for pancreatic cancer patients."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe truthfulness of these statements can only be verified by examining the actual results and conclusions of the specific phase 3 trial mentioned. Without access to the original study or published results, it is not possible to accurately validate these statements.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, MLP regulates F-actin dynamics through its self-association and actin filament cross-linking.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are two pseudokinases in the human kinome:\n1. T-kininogen, which is cleaved by cathepsin D and 72 kDa protease to release two types of kinin, Ile-Ser-bradykinin (T-kinin) and Met-Ile-Ser-bradykinin (Met-T-kinin).\n2. The novel kinin, Met-T-kinin, which is also released from T-kininogen through consecutive cleavage by cathepsin D and 72 kDa protease.\nTherefore, there are two pseudokinases in the human kinome: T-kininogen and Met-T-kinin.",
    "llama-2-13b-chat-hf_fact_raw": "1. T-kininogen is a pseudokinase in the human kinome.\n2. T-kininogen can be cleaved by cathepsin D and 72 kDa protease.\n3. T-kininogen release includes two types of kinin: Ile-Ser-bradykinin (T-kinin) and Met-Ile-Ser-bradykinin (Met-T-kinin).\n4. Met-T-kinin is considered a pseudokinase in the human kinome.\n5. Met-T-kinin is released from T-kininogen through consecutive cleavage by cathepsin D and 72 kDa protease.",
    "llama-2-13b-chat-hf_fact": [
      "T-kininogen is a pseudokinase in the human kinome.",
      "T-kininogen can be cleaved by cathepsin D and 72 kDa protease.",
      "T-kininogen release includes two types of kinin: Ile-Ser-bradykinin (T-kinin) and Met-Ile-Ser-bradykinin (Met-T-kinin).",
      "Met-T-kinin is considered a pseudokinase in the human kinome.",
      "Met-T-kinin is released from T-kininogen through consecutive cleavage by cathepsin D and 72 kDa protease."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: T-kininogen is not a pseudokinase; it is a type of proteinase inhibitor and a precursor to kinins.\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: Met-T-kinin is not a pseudokinase; it is a peptide, not an enzyme or protein kinase.\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-13b-chat-hf_response": "Sure, based on the information provided, here are three apoE mimetics:\n1. The apoE mimetic peptide described in Document-0, which possesses the putative receptor binding domain 141-150 (LRKLRKRLLR) of apoE covalently linked to the class A amphipathic helical peptide 18A. This peptide has been shown to dramatically reduce plasma cholesterol in dyslipidemic mouse and rabbit models.\n2. Peptide AP33, which consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-I (residues 181-192). This peptide has been shown to mimic the activity of apoE and reduce cholesterol levels in mice.\n3. Peptide AP40, which consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-II (residues 181-192). This peptide has also been shown to mimic the activity of apoE and reduce cholesterol levels in mice.\nNote that these are just a few examples of apoE mimetics, and there may be other mimetics that have been developed or identified in the scientific literature.",
    "llama-2-13b-chat-hf_fact_raw": "1. The apoE mimetic peptide described as having the receptor binding domain 141-150 (LRKLRKRLLR) of apoE reduces plasma cholesterol in dyslipidemic mouse and rabbit models.\n2. Peptide AP33 mimics the activity of apoE and consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-I (residues 181-192).\n3. Peptide AP33 has been shown to reduce cholesterol levels in mice.\n4. Peptide AP40 mimics the activity of apoE and consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-II (residues 181-192).\n5. Peptide AP40 has been demonstrated to reduce cholesterol levels in mice.",
    "llama-2-13b-chat-hf_fact": [
      "The apoE mimetic peptide described as having the receptor binding domain 141-150 (LRKLRKRLLR) of apoE reduces plasma cholesterol in dyslipidemic mouse and rabbit models.",
      "Peptide AP33 mimics the activity of apoE and consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-I (residues 181-192).",
      "Peptide AP33 has been shown to reduce cholesterol levels in mice.",
      "Peptide AP40 mimics the activity of apoE and consists of the N-terminal domain of human apoE (residues 138-149) linked to the C-terminal domain of human apoA-II (residues 181-192).",
      "Peptide AP40 has been demonstrated to reduce cholesterol levels in mice."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Peptide AP40 is typically described as consisting of the receptor binding region of human apoE (residues 141-155), not as being linked to the C-terminal domain of human apoA-II (residues 181-192).\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are sex differences in the activity of SAMHD1. Female rats show greater and more rapid sensitization of locomotor activity and stereotyped behavior compared to male rats, and this is accompanied by a sex difference in one neurochemical correlate of sensitization, with an elevation in resting striatal dihydroxyphenlacetic acid (DOPAC) to DA ratios in female, but not male rats. Additionally, males were more variable and heterogeneous in their response to repeated AMPH treatment, which may make it more difficult to identify neurochemical correlates of sensitization in males. These findings suggest that there is a sex difference in the responsiveness of brain DA systems to repetitive activation, which contributes to individual variation in the susceptibility to sensitization.",
    "llama-2-13b-chat-hf_fact_raw": "1. Female rats show greater and more rapid sensitization of locomotor activity and stereotyped behavior compared to male rats.\n2. There is an elevation in resting striatal dihydroxyphenylacetic acid (DOPAC) to dopamine (DA) ratios in female rats, but not in male rats.\n3. Male rats demonstrate more variable and heterogeneous responses to repeated amphetamine (AMPH) treatment.\n4. The responsiveness of brain dopamine (DA) systems to repetitive activation exhibits sex differences.\n5. These sex differences may contribute to individual variation in the susceptibility to sensitization.",
    "llama-2-13b-chat-hf_fact": [
      "Female rats show greater and more rapid sensitization of locomotor activity and stereotyped behavior compared to male rats.",
      "There is an elevation in resting striatal dihydroxyphenylacetic acid (DOPAC) to dopamine (DA) ratios in female rats, but not in male rats.",
      "Male rats demonstrate more variable and heterogeneous responses to repeated amphetamine (AMPH) treatment.",
      "The responsiveness of brain dopamine (DA) systems to repetitive activation exhibits sex differences.",
      "These sex differences may contribute to individual variation in the susceptibility to sensitization."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThese statements are based on research findings in the field of psychopharmacology that suggest sex differences in the responsiveness of brain dopamine systems to certain drugs, including the differential effects on male and female rats in response to amphetamine treatment. However, without access to the specific research that these statements are drawn from, it is assumed that these statements are consistent with general findings in the field. If the statements were not accurately representing the findings of the relevant studies, the corrections would require access to those studies for precise details.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that RUNX2 does not directly inhibit astrocyte differentiation. The study discussed focuses on the regulation of ameloblast differentiation in LS8 cells, which are cells involved in tooth development, and the role of microRNA-1963 in this process. The study found that microRNA-1963 suppresses ameloblast differentiation by targeting the 3'UTR of Smoc2, a protein that promotes ameloblast differentiation. Therefore, it is likely that RUNX2 does not play a direct role in astrocyte differentiation, as the study is focused on the regulation of ameloblast differentiation in the context of tooth development.",
    "llama-2-13b-chat-hf_fact_raw": "1. RUNX2 does not directly inhibit astrocyte differentiation according to the information provided.\n2. The discussed study focuses on the regulation of ameloblast differentiation in LS8 cells.\n3. LS8 cells are involved in tooth development.\n4. The study found that microRNA-1963 suppresses ameloblast differentiation.\n5. MicroRNA-1963 targets the 3'UTR of Smoc2, which promotes ameloblast differentiation.",
    "llama-2-13b-chat-hf_fact": [
      "RUNX2 does not directly inhibit astrocyte differentiation according to the information provided.",
      "The discussed study focuses on the regulation of ameloblast differentiation in LS8 cells.",
      "LS8 cells are involved in tooth development.",
      "The study found that microRNA-1963 suppresses ameloblast differentiation.",
      "MicroRNA-1963 targets the 3'UTR of Smoc2, which promotes ameloblast differentiation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nGiven the context provided, I can confirm that statement 3 is true; LS8 cells are indeed a cell line that is used to study tooth development, particularly amelogenesis or enamel formation. However, the information provided lacks details on RUNX2's role in astrocyte differentiation, the focus of the studied regulation of ameloblast differentiation, the specific findings in relation to microRNA-1963, and the targeting of Smoc2's 3'UTR, thus the response to these statements is UNKNOWN. If more specific information related to these points was provided within the passage, a true or false determination could be made.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the Cobb-Stainsby excision arthroplasty would be performed in the gluteal region, specifically in the right gluteal area, as this is where the patient has a gluteal angioma and spinal arteriovenous malformation.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a procedure that can be performed in the gluteal region.\n2. In the provided context, the Cobb-Stainsby excision arthroplasty is to be performed specifically in the right gluteal area.",
    "llama-2-13b-chat-hf_fact": [
      "The Cobb-Stainsby excision arthroplasty is a procedure that can be performed in the gluteal region.",
      "In the provided context, the Cobb-Stainsby excision arthroplasty is to be performed specifically in the right gluteal area."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is a procedure performed on the hip joint, not the gluteal region specifically.\n2. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that overexpression of GRHL2 does not directly lead to Epithelial-to-Mesenchymal Transition (EMT). However, overexpression of LOXL2, which is a transcription factor, can induce EMT through the activation of the IRE1-XBP1 signaling pathway and the upregulation of EMT-TFs such as SNAI1, SNAI2, ZEB2, and TCF3. Therefore, the answer to the question is \"no\" GRHL2 over-expression does not lead to EMT, but overexpression of LOXL2 can induce EMT through a specific signaling pathway.",
    "llama-2-13b-chat-hf_fact_raw": "1. Overexpression of GRHL2 does not directly lead to Epithelial-to-Mesenchymal Transition (EMT).\n2. Overexpression of LOXL2 can induce EMT.\n3. EMT can be induced through the activation of the IRE1-XBP1 signaling pathway.\n4. EMT is associated with the upregulation of EMT-TFs such as SNAI1, SNAI2, ZEB2, and TCF3.\n5. LOXL2 is a transcription factor that can induce EMT when overexpressed.",
    "llama-2-13b-chat-hf_fact": [
      "Overexpression of GRHL2 does not directly lead to Epithelial-to-Mesenchymal Transition (EMT).",
      "Overexpression of LOXL2 can induce EMT.",
      "EMT can be induced through the activation of the IRE1-XBP1 signaling pathway.",
      "EMT is associated with the upregulation of EMT-TFs such as SNAI1, SNAI2, ZEB2, and TCF3.",
      "LOXL2 is a transcription factor that can induce EMT when overexpressed."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: GRHL2 typically acts to inhibit EMT and maintain the epithelial phenotype, so its overexpression does not directly lead to EMT.\n2. TRUE: LOXL2 has been shown to induce EMT in various studies, contributing to the progression of fibrosis and cancer.\n3. TRUE: Activation of the IRE1-XBP1 signaling pathway is one of the mechanisms that can induce EMT.\n4. TRUE: EMT is indeed associated with the upregulation of EMT-inducing transcription factors (EMT-TFs) such as SNAI1, SNAI2, ZEB2, and TCF3.\n5. FALSE [correction]: LOXL2 is not a transcription factor; it is an enzyme that modifies extracellular matrix proteins. It can contribute to EMT by remodeling the extracellular matrix and altering cell-matrix interactions.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct mention of T-UCRs being implicated in lung cancer. However, the study discussed in the provided information focuses on the role of a macrophage-derived T-UCR, uc.306, in the prognosis of hepatitis B (HBV)-related hepatocellular carcinoma (HCC). The study found that low expression of uc.306 was significantly associated with a shorter overall survival in HCC patients.\nTherefore, based on the information provided, it can be inferred that T-UCRs, including uc.306, may have a role in the development and prognosis of certain types of cancer, such as HCC, but there is no direct evidence of their involvement in lung cancer.",
    "llama-2-13b-chat-hf_fact_raw": "1. The study mentioned focused on the role of a macrophage-derived T-UCR, uc.306, in hepatitis B (HBV)-related hepatocellular carcinoma (HCC).\n2. The study found that low expression of uc.306 was significantly associated with shorter overall survival in HCC patients.\n3. There is no direct evidence of T-UCRs involvement in lung cancer according to the provided information.",
    "llama-2-13b-chat-hf_fact": [
      "The study mentioned focused on the role of a macrophage-derived T-UCR, uc.306, in hepatitis B (HBV)-related hepatocellular carcinoma (HCC).",
      "The study found that low expression of uc.306 was significantly associated with shorter overall survival in HCC patients.",
      "There is no direct evidence of T-UCRs involvement in lung cancer according to the provided information."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here is the answer to the user's question:\nGPR151 is an orphan G protein-coupled receptor whose function is currently unknown. The expression of GPR151 is restricted to the habenula, dorsal horn of the spinal cord, and dorsal root ganglion, which suggests a role in nociception. However, based on the results of a study using Gpr151 loss-of-function mutant mice and wild-type controls, it appears that GPR151 does not play a role in the modulation of pain-related behaviors. Additionally, galanin, a neuropeptide that is structurally related to GPR151, does not appear to be an endogenous ligand for the receptor, as it did not induce calcium signaling responses in ND7/23 cells transfected with GPR151. Overall, more research is needed to fully understand the function of GPR151 and its potential role in nociception.",
    "llama-2-13b-chat-hf_fact_raw": "1. GPR151 is an orphan G protein-coupled receptor with an unknown function.\n2. The expression of GPR151 is limited to the habenula, dorsal horn of the spinal cord, and dorsal root ganglion.\n3. A study suggested that GPR151 may not play a role in the modulation of pain-related behaviors.\n4. Galanin does not appear to be an endogenous ligand for GPR151, as it did not induce calcium signaling responses in specific transfected cells.\n5. There is still a need for further research to understand the function of GPR151.",
    "llama-2-13b-chat-hf_fact": [
      "GPR151 is an orphan G protein-coupled receptor with an unknown function.",
      "The expression of GPR151 is limited to the habenula, dorsal horn of the spinal cord, and dorsal root ganglion.",
      "A study suggested that GPR151 may not play a role in the modulation of pain-related behaviors.",
      "Galanin does not appear to be an endogenous ligand for GPR151, as it did not induce calcium signaling responses in specific transfected cells.",
      "There is still a need for further research to understand the function of GPR151."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: A study suggested that GPR151 may play a role in the modulation of pain-related behaviors.\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine are:\n1. A/Hong Kong/68 (Beare and Bynoe strain)\n2. Other three live attenuated inhibitor-resistant influenza vaccines (specific strains not specified)\nThese vaccines have been shown to be antigenic and to cause no significant reactions when characterized by an index of attenuation equal to or slightly better than 1.0 compared to the 'reference' attenuated A/Hong Kong/68 strain. Additionally, the vaccines have been found to induce heterologous antibodies and oral administration of underattenuated preparations did not cause severe reactions, suggesting that the vaccines are safe and effective.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus A/Hong Kong/68 (Beare and Bynoe strain).\n2. There are three additional live attenuated inhibitor-resistant influenza vaccines in the Fluzone intradermal quadrivalent vaccine (specific strains not specified).\n3. The vaccines in the Fluzone intradermal quadrivalent vaccine are supposed to have an index of attenuation equal to or slightly better than 1.0 compared to the A/Hong Kong/68 strain.\n4. The vaccines have been found to induce heterologous antibodies.\n5. Oral administration of underattenuated preparations of the vaccines did not cause severe reactions.",
    "llama-2-13b-chat-hf_fact": [
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus A/Hong Kong/68 (Beare and Bynoe strain).",
      "There are three additional live attenuated inhibitor-resistant influenza vaccines in the Fluzone intradermal quadrivalent vaccine (specific strains not specified).",
      "The vaccines in the Fluzone intradermal quadrivalent vaccine are supposed to have an index of attenuation equal to or slightly better than 1.0 compared to the A/Hong Kong/68 strain.",
      "The vaccines have been found to induce heterologous antibodies.",
      "Oral administration of underattenuated preparations of the vaccines did not cause severe reactions."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Fluzone Intradermal Quadrivalent is an inactivated influenza vaccine, not a live attenuated vaccine. It contains four influenza virus strains that are killed (inactivated), so they cannot cause the flu.\n2. FALSE [correction]: Since Fluzone is an inactivated vaccine, it does not contain live attenuated strains. The term \"inhibitor-resistant\" would not typically be used to describe inactivated influenza vaccines.\n3. FALSE [correction]: The concept of an \"index of attenuation\" applies to live attenuated vaccines; since the Fluzone Intradermal Quadrivalent vaccine contains inactivated viruses, this measure is not relevant.\n4. TRUE: Influenza vaccines, including inactivated ones like Fluzone Intradermal Quadrivalent, can induce the production of antibodies that are heterologous, which means they can target different but related influenza strains.\n5. UNKNOWN: Without specific clinical trial data or studies regarding oral administration of underattenuated preparations of these vaccines, it is not possible to determine the accuracy of this statement.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the part of the TNFR2 gene that is genetically associated with Systemic Lupus Erythematosus (SLE) is the TNF-alpha gene. The study mentioned in the information found a significantly higher frequency of a 5.5 kb NcoI fragment from SLE patients compared to normal controls, suggesting that the polymorphic TNF genes may be involved in the pathogenesis of SLE.",
    "llama-2-13b-chat-hf_fact_raw": "1. The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).\n2. The TNF-alpha gene is a part of the TNFR2 gene associated with SLE.\n3. A study found a significantly higher frequency of a 5.5 kb NcoI fragment from SLE patients in comparison to normal controls.\n4. The polymorphic TNF genes may be involved in the pathogenesis of SLE according to the study.",
    "llama-2-13b-chat-hf_fact": [
      "The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).",
      "The TNF-alpha gene is a part of the TNFR2 gene associated with SLE.",
      "A study found a significantly higher frequency of a 5.5 kb NcoI fragment from SLE patients in comparison to normal controls.",
      "The polymorphic TNF genes may be involved in the pathogenesis of SLE according to the study."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The TNF-alpha gene is not a part of the TNFR2 gene. TNF-alpha (Tumor Necrosis Factor-alpha) and TNFR2 (Tumor Necrosis Factor Receptor 2) are separate entities, although they may interact as part of a signaling cascade.\n3. UNKNOWN\n4. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is currently no vaccine available for peanut allergy. However, researchers have been exploring the use of immunoadjuvants, such as poly(anhydride) nanoparticles, to enhance the immune response to peanut proteins and potentially treat peanut allergy. The study you provided suggests that oral immunization with spray-dried poly(anhydride) nanoparticles loaded with peanut proteins may be effective in inducing a balanced T(H)1 and T(H)2 antibody response and reducing the production of T(H)2 cytokines. However, more research is needed to confirm these findings and to determine the safety and efficacy of this approach in humans.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is currently no vaccine available for peanut allergy.\n2. Researchers are exploring the use of immunoadjuvants to treat peanut allergy.\n3. Poly(anhydride) nanoparticles are being studied as a potential immunoadjuvant for peanut allergy.\n4. Oral immunization with spray-dried poly(anhydride) nanoparticles loaded with peanut proteins might induce a balanced T(H)1 and T(H)2 antibody response.\n5. The approach using poly(anhydride) nanoparticles requires more research to confirm its effectiveness and determine safety and efficacy in humans.",
    "llama-2-13b-chat-hf_fact": [
      "There is currently no vaccine available for peanut allergy.",
      "Researchers are exploring the use of immunoadjuvants to treat peanut allergy.",
      "Poly(anhydride) nanoparticles are being studied as a potential immunoadjuvant for peanut allergy.",
      "Oral immunization with spray-dried poly(anhydride) nanoparticles loaded with peanut proteins might induce a balanced T(H)1 and T(H)2 antibody response.",
      "The approach using poly(anhydride) nanoparticles requires more research to confirm its effectiveness and determine safety and efficacy in humans."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: As of my last update in early 2023, there was no widely available vaccine for peanut allergy, although there were various treatments and experimental vaccines under research and development.\n2. TRUE: Researchers are indeed exploring the use of immunoadjuvants among other strategies to treat allergies such as peanut allergy.\n3. TRUE: Poly(anhydride) nanoparticles are one of the many different types of immunoadjuvants that researchers are studying for potential use in allergies, including peanut allergy.\n4. TRUE: The statement aligns with the type of response researchers hope to achieve using nanoparticle-based immunoadjuvants. A balanced T(H)1 and T(H)2 response suggests a controlled immune response that doesn't skew too far towards allergenic (T(H)2) reactivity.\n5. TRUE: A statement like this reflects the typical process of scientific research; new treatments, especially those involving nanotechnology and immunotherapy, require extensive research to confirm their effectiveness and safety before they are considered for use in humans.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the mouse Fxy gene's chromosomal position is on the minute short arm of the mouse Y chromosome.",
    "llama-2-13b-chat-hf_fact_raw": "1. The mouse Fxy gene is located on the Y chromosome.\n2. The Fxy gene is situated on the short arm of the mouse Y chromosome.",
    "llama-2-13b-chat-hf_fact": [
      "The mouse Fxy gene is located on the Y chromosome.",
      "The Fxy gene is situated on the short arm of the mouse Y chromosome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The mouse Fxy gene, also known as Fxyp, is located on the X chromosome, not the Y chromosome.\n2. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method is the use of a synthetic DNA intercalator, methidiumpropyl-EDTA (MPE), to cleave DNA in the presence of ferrous ion and oxygen, which exhibits no sequence specificity. This property makes MPE a better reagent for protection analysis, also known as \"footprinting\" analysis, to identify the nucleotides involved in a protein-DNA interaction. The method is applied to specific DNA-protein complexes from a crude nuclear extract, and the results are compared to those obtained previously using DNase I.",
    "llama-2-13b-chat-hf_fact_raw": "1. Methidiumpropyl-EDTA sequencing (MPE-seq) method uses a synthetic DNA intercalator called methidiumpropyl-EDTA (MPE).\n2. MPE cleaves DNA in the presence of ferrous ion and oxygen.\n3. The MPE-seq method does not exhibit sequence specificity.\n4. MPE-seq is used for \"footprinting\" analysis to identify nucleotides involved in protein-DNA interactions.\n5. The method is applied to DNA-protein complexes from a crude nuclear extract and can be compared with results from DNase I analysis.",
    "llama-2-13b-chat-hf_fact": [
      "Methidiumpropyl-EDTA sequencing (MPE-seq) method uses a synthetic DNA intercalator called methidiumpropyl-EDTA (MPE).",
      "MPE cleaves DNA in the presence of ferrous ion and oxygen.",
      "The MPE-seq method does not exhibit sequence specificity.",
      "MPE-seq is used for \"footprinting\" analysis to identify nucleotides involved in protein-DNA interactions.",
      "The method is applied to DNA-protein complexes from a crude nuclear extract and can be compared with results from DNase I analysis."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, it appears that the programming language used for implementing GWAR is not explicitly mentioned. However, the document mentions \"modern programming language concepts\" and \"object-relational mapper\" which suggests that the language used may be an object-oriented language such as Java, Python, or C#. Additionally, the use of a domain-specific language (DSL) called Arden Syntax suggests that the language may be a statically-typed language with strong type checking and a focus on expressiveness and readability.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, xaliproden does not improve the prognosis of amyotrophic lateral sclerosis (ALS). The two randomized, double-blind, placebo-controlled studies conducted to assess the drug's efficacy and safety found that the primary endpoints did not reach statistical significance. However, there was a trend in favor of the add-on 1 mg dose of xaliproden vs. placebo for time to vital capacity <50% and time to vital capacity <50% or death, although the results were not statistically significant. Additionally, the drug was found to have a small effect on clinically noteworthy aspects of disease progression in ALS, such as vital capacity. Overall, xaliproden does not appear to improve the prognosis of ALS.",
    "llama-2-13b-chat-hf_fact_raw": "1. Xaliproden was assessed for efficacy and safety in the prognosis of amyotrophic lateral sclerosis (ALS) through two randomized, double-blind, placebo-controlled studies.\n2. The primary endpoints of the studies concerning xaliproden's effects on ALS did not reach statistical significance.\n3. There was a trend favoring the 1 mg dose of xaliproden compared to placebo for the time to vital capacity <50% and time to vital capacity <50% or death, although this was not statistically significant.\n4. Xaliproden had a small effect on clinically significant aspects of disease progression in ALS, specifically on vital capacity.\n5. Overall, xaliproden does not improve the prognosis of amyotrophic lateral sclerosis.",
    "llama-2-13b-chat-hf_fact": [
      "Xaliproden was assessed for efficacy and safety in the prognosis of amyotrophic lateral sclerosis (ALS) through two randomized, double-blind, placebo-controlled studies.",
      "The primary endpoints of the studies concerning xaliproden's effects on ALS did not reach statistical significance.",
      "There was a trend favoring the 1 mg dose of xaliproden compared to placebo for the time to vital capacity <50% and time to vital capacity <50% or death, although this was not statistically significant.",
      "Xaliproden had a small effect on clinically significant aspects of disease progression in ALS, specifically on vital capacity.",
      "Overall, xaliproden does not improve the prognosis of amyotrophic lateral sclerosis."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: It is unclear if xaliproden had a clinically significant effect on disease progression in ALS as the earlier statement indicates the primary endpoints were not met. Therefore, we cannot confirm a small effect without further data.\n5. Given the available statements, it seems likely that xaliproden does not improve prognosis in ALS since the primary endpoints were not met. However, without more context on how \"overall\" is defined and additional data from the studies, it's hard to make a definitively true or false claim, so the response to this statement is UNKNOWN.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the transgenes are inserted in chromosome 2 in the case of the LiPS-A3S line.",
    "llama-2-13b-chat-hf_fact_raw": "1. In the LiPS-A3S line, transgenes are inserted in chromosome 2.",
    "llama-2-13b-chat-hf_fact": [
      "In the LiPS-A3S line, transgenes are inserted in chromosome 2."
    ],
    "llama-2-13b-chat-hf_judge_raw": "UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the tool that exists for predicting drug synergy with deep learning is called DeepSynergy. According to the information, DeepSynergy uses chemical and genomic information as input, a normalization strategy to account for input data heterogeneity, and conical layers to model drug synergies. The results show that DeepSynergy significantly outperformed other machine learning methods in predicting novel drug combinations and had a high predictive performance for classifying these combinations. The tool is available for use via the website www.bioinf.jku.at/software/DeepSynergy, and more information can be found in the supplementary data available online.",
    "llama-2-13b-chat-hf_fact_raw": "1. DeepSynergy is a tool used for predicting drug synergy with deep learning.\n2. DeepSynergy utilizes chemical and genomic information as input.\n3. The tool incorporates a normalization strategy to handle input data heterogeneity.\n4. DeepSynergy is claimed to have significantly outperformed other machine learning methods in predicting novel drug combinations.\n5. Information about DeepSynergy is available online at www.bioinf.jku.at/software/DeepSynergy.",
    "llama-2-13b-chat-hf_fact": [
      "DeepSynergy is a tool used for predicting drug synergy with deep learning.",
      "DeepSynergy utilizes chemical and genomic information as input.",
      "The tool incorporates a normalization strategy to handle input data heterogeneity.",
      "DeepSynergy is claimed to have significantly outperformed other machine learning methods in predicting novel drug combinations.",
      "Information about DeepSynergy is available online at www.bioinf.jku.at/software/DeepSynergy."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Information about DeepSynergy can be found online at various scientific publication websites and repositories, but the given URL is not correct or specific to a page with information about DeepSynergy. The actual webpage for DeepSynergy would depend on current hosting and availability, so a correct URL cannot be provided without up-to-date verification.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the cloud-based platform that has been developed for comparing GWAS is the GWAtoolbox. The GWAtoolbox is an R package that standardizes and accelerates the handling of data from genome-wide association studies (GWAS), particularly in the context of large-scale GWAS meta-analyses. It has a key feature of performing quality control (QC) of any number of files in a matter of minutes, and it allows for between-study comparison to identify systematic bias. The GWAtoolbox is available at http://www.eurac.edu/GWAtoolbox and can be contacted at cfuchsb@umich.edu or daniel.taliun@eurac.edu.",
    "llama-2-13b-chat-hf_fact_raw": "1. The GWAtoolbox is a cloud-based platform developed for comparing GWAS.\n2. The GWAtoolbox is an R package designed to standardize and accelerate the handling of GWAS data.\n3. The GWAtoolbox is used particularly for large-scale GWAS meta-analyses.\n4. A key feature of the GWAtoolbox is performing quality control of any number of files in a matter of minutes.\n5. The GWAtoolbox can perform between-study comparisons to identify systematic bias.",
    "llama-2-13b-chat-hf_fact": [
      "The GWAtoolbox is a cloud-based platform developed for comparing GWAS.",
      "The GWAtoolbox is an R package designed to standardize and accelerate the handling of GWAS data.",
      "The GWAtoolbox is used particularly for large-scale GWAS meta-analyses.",
      "A key feature of the GWAtoolbox is performing quality control of any number of files in a matter of minutes.",
      "The GWAtoolbox can perform between-study comparisons to identify systematic bias."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The GWAtoolbox is an R package developed for comparing GWAS, not specifically a cloud-based platform.\n2. TRUE\n3. TRUE\n4. TRUE (assuming it's a feature claimed by the developers, but this could vary based on actual performance which is not verifiable here).\n5. TRUE (assuming it's a feature of the GWAtoolbox, but specifics would need to be verified with documentation or empirical testing).",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, ZIMET 3164 has shown some effectiveness in inhibiting the growth of sarcomas, specifically sarcoma 180 P, sarcoma 180 G, and Walker 256 carcinosarcoma. However, the drug was not effective in prolonging the survival time of mice bearing Ehrlich ascites carcinoma or the leukaemias L 1210 and LAJ I. Additionally, the drug seemed to interfere with the afferent limb of the immune response, as administration exclusively prior to immunization only induced moderate immunosuppression, while injection afterwards failed to affect the primary response at all.\nTherefore, based on the information provided, it is possible that CMB305, which is a derivative of ZIMET 3164, may also have some effectiveness against sarcomas, but further research and testing would be needed to confirm this. However, it is worth noting that the effectiveness of CMB305 against sarcomas may be limited by its inability to prolong the survival time of mice bearing certain types of cancer, as well as its potential interference with the immune response.",
    "llama-2-13b-chat-hf_fact_raw": "1. ZIMET 3164 has shown effectiveness in inhibiting the growth of sarcoma 180 P, sarcoma 180 G, and Walker 256 carcinosarcoma.\n2. ZIMET 3164 was not effective in prolonging the survival time of mice with Ehrlich ascites carcinoma or the leukemias L 1210 and LAJ I.\n3. Administration of ZIMET 3164 prior to immunization induced moderate immunosuppression.\n4. Injection of ZIMET 3164 after immunization did not affect the primary immune response.\n5. CMB305 is a derivative of ZIMET 3164.",
    "llama-2-13b-chat-hf_fact": [
      "ZIMET 3164 has shown effectiveness in inhibiting the growth of sarcoma 180 P, sarcoma 180 G, and Walker 256 carcinosarcoma.",
      "ZIMET 3164 was not effective in prolonging the survival time of mice with Ehrlich ascites carcinoma or the leukemias L 1210 and LAJ I.",
      "Administration of ZIMET 3164 prior to immunization induced moderate immunosuppression.",
      "Injection of ZIMET 3164 after immunization did not affect the primary immune response.",
      "CMB305 is a derivative of ZIMET 3164."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe provided statements are related to the effects of a compound named ZIMET 3164, its impact on specific types of cancer, and its immunological effects. Additionally, there is a statement about CMB305 being a derivative of ZIMET 3164. These statements are very specific and would require access to scientific research, clinical trial results, or detailed biochemical data to verify. Without such specific information available, it is not possible to determine the veracity of these statements. Therefore, all statements must be listed as UNKNOWN.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the manifestations of the Saint's Triad are:\n1. Cholelithiasis (gallstones)\n2. Diverticulosis\n3. Hiatus hernia\nThese three conditions are the components of the Saint's Triad, and they were found to be present in 7 out of 684 patients (1.02%) in the study. Additionally, there were 86 cases of bifocal associations, which are combinations of two of these conditions.",
    "llama-2-13b-chat-hf_fact_raw": "1. Cholelithiasis, or gallstones, is a component of the Saint's Triad.\n2. Diverticulosis is a component of the Saint's Triad.\n3. Hiatus hernia is a component of the Saint's Triad.\n4. The Saint's Triad was found to be present in 7 out of 684 patients (1.02%) in a study mentioned.\n5. Bifocal associations, which are combinations of two conditions of the Saint's Triad, numbered 86 cases in the study.",
    "llama-2-13b-chat-hf_fact": [
      "Cholelithiasis, or gallstones, is a component of the Saint's Triad.",
      "Diverticulosis is a component of the Saint's Triad.",
      "Hiatus hernia is a component of the Saint's Triad.",
      "The Saint's Triad was found to be present in 7 out of 684 patients (1.02%) in a study mentioned.",
      "Bifocal associations, which are combinations of two conditions of the Saint's Triad, numbered 86 cases in the study."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation: Saint's Triad consists of cholelithiasis (gallstones), diverticulosis, and hiatus hernia. Without specific details of the study mentioned in statements 4 and 5, we cannot confirm the accuracy of those statistics, so the response is \"UNKNOWN\" for both.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct answer to the question of whether overexpression of LY6K is associated with better prognosis for non-small cell lung cancer (NSCLC) patients. However, the information does provide some insights that may be relevant to the question.\nFirstly, the document mentions that PLK1 is overexpressed in many tumors, including SCLC, and that its overexpression is associated with tumor aggressiveness and a poor prognosis. This suggests that high levels of PLK1 expression may be a negative prognostic marker for SCLC patients.\nSecondly, the document reports that BI 6727, a selective PLK1 inhibitor, significantly induced the inhibition of proliferation and apoptosis in SCLC cell lines, and attenuated growth and apoptosis in NCI-H446 xenografts. This suggests that targeting PLK1 with a specific inhibitor may be a potential therapeutic strategy for SCLC patients.\nFinally, the document mentions that the level of histone H2AX phosphorylation at serine-139 (2AX) was markedly increased both in vitro and in vivo after BI 6727 treatment. This suggests that BI 6727 may be inducing DNA damage and activating the ATR/ATM-Chk1/Chk2 checkpoint pathway, which could potentially lead to cell cycle arrest and/or apoptosis in SCLC cells.\nIn conclusion, while the document does not directly address the question of LY6K overexpression and prognosis, it provides some insights into the potential therapeutic targeting of PLK1 in SCLC, and suggests that BI 6727 may be a promising therapeutic agent for this disease. However, further research is needed to determine the clinical significance of LY6K overexpression in SCLC and to validate the therapeutic potential of BI 6727 in clinical settings.",
    "llama-2-13b-chat-hf_fact_raw": "1. PLK1 is overexpressed in many tumors, including small cell lung cancer (SCLC), and its overexpression is associated with tumor aggressiveness and a poor prognosis.\n2. BI 6727, a selective PLK1 inhibitor, significantly induced inhibition of proliferation and apoptosis in SCLC cell lines.\n3. Treatment with BI 6727 attenuated growth and induced apoptosis in NCI-H446 xenografts.\n4. The level of histone H2AX phosphorylation at serine-139 was markedly increased after BI 6727 treatment both in vitro and in vivo.\n5. BI 6727 treatment may activate the ATR/ATM-Chk1/Chk2 checkpoint pathway.\n\nNote: The statements refer to small cell lung cancer (SCLC) rather than non-small cell lung cancer (NSCLC) as mentioned in the query, which should be kept in mind during verification.",
    "llama-2-13b-chat-hf_fact": [
      "PLK1 is overexpressed in many tumors, including small cell lung cancer (SCLC), and its overexpression is associated with tumor aggressiveness and a poor prognosis.",
      "BI 6727, a selective PLK1 inhibitor, significantly induced inhibition of proliferation and apoptosis in SCLC cell lines.",
      "Treatment with BI 6727 attenuated growth and induced apoptosis in NCI-H446 xenografts.",
      "The level of histone H2AX phosphorylation at serine-139 was markedly increased after BI 6727 treatment both in vitro and in vivo.",
      "BI 6727 treatment may activate the ATR/ATM-Chk1/Chk2 checkpoint pathway.",
      "te: The statements refer to small cell lung cancer (SCLC) rather than non-small cell lung cancer (NSCLC) as mentioned in the query, which should be kept in mind during verification."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n6. UNKNOWN (This statement appears to be a note to the responder and not an actual content statement to verify against the context provided).",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, here are the Cdk targets that are dephosphorylated during cytokinesis:\n1. Aip1\n2. Ede1\n3. Inn1\nThese targets are identified through phosphoproteome analysis of mitotic exit and were found to be dephosphorylated at the time of cytokinesis.",
    "llama-2-13b-chat-hf_fact_raw": "1. Aip1 is dephosphorylated during cytokinesis.\n2. Ede1 is dephosphorylated during cytokinesis.\n3. Inn1 is dephosphorylated during cytokinesis.\n4. The identification of the Cdk targets was done through phosphoproteome analysis of mitotic exit.\n5. These targets were found to be dephosphorylated specifically at the time of cytokinesis.",
    "llama-2-13b-chat-hf_fact": [
      "Aip1 is dephosphorylated during cytokinesis.",
      "Ede1 is dephosphorylated during cytokinesis.",
      "Inn1 is dephosphorylated during cytokinesis.",
      "The identification of the Cdk targets was done through phosphoproteome analysis of mitotic exit.",
      "These targets were found to be dephosphorylated specifically at the time of cytokinesis."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe specific knowledge about Aip1 and Ede1 regarding their phosphorylation status during cytokinesis is not provided, so I cannot verify these statements without additional context or information. Inn1, on the other hand, is a well-known protein that is dephosphorylated during cytokinesis. The identification of Cdk targets through phosphoproteome analysis of mitotic exit is a common method used in cell biology, and typically, targets identified would be those that are dephosphorylated at specific times during the cell cycle, such as cytokinesis.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Xanamem is a metabolite of Alprazolam (Xanax), a benzodiazepine tranquilizer.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the role of the Hof1-Cyk3 interaction in yeast is to regulate cytokinesis, the process of cell division. Specifically, the interaction between Hof1 and Cyk3 is involved in the formation of a septum during cytokinesis, which is a critical step in the separation of the daughter cells.\nHof1, a protein with an SH3 domain, forms a ring at the bud neck of dividing yeast cells and is involved in the deposition of the septum. The interaction between Hof1 and Cyk3, a protein with a PSTPIP1 domain, is important for the proper formation of the septum and cytokinesis.\nThe Vrp1 protein, which interacts with Hof1, also plays a role in regulating cytokinesis. The Vrp1 protein has a HOT domain that binds to the Hof1 SH3 domain and counteracts its inhibitory effect on cytokinesis. This interaction between Vrp1 and Hof1 is critical for proper cytokinesis in yeast.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Hof1-Cyk3 interaction in yeast regulates cytokinesis, the process of cell division.\n2. The interaction is involved in the formation of a septum during cytokinesis, which is essential for the separation of daughter cells.\n3. Hof1 is a protein that forms a ring at the bud neck of dividing yeast cells and is involved in septum deposition.\n4. Cyk3 is a protein with a PSTPIP1 domain that plays an important role in the proper formation of the septum and cytokinesis.\n5. Vrp1 is a protein with a HOT domain that interacts with Hof1 and is critical for proper cytokinesis in yeast.",
    "llama-2-13b-chat-hf_fact": [
      "The Hof1-Cyk3 interaction in yeast regulates cytokinesis, the process of cell division.",
      "The interaction is involved in the formation of a septum during cytokinesis, which is essential for the separation of daughter cells.",
      "Hof1 is a protein that forms a ring at the bud neck of dividing yeast cells and is involved in septum deposition.",
      "Cyk3 is a protein with a PSTPIP1 domain that plays an important role in the proper formation of the septum and cytokinesis.",
      "Vrp1 is a protein with a HOT domain that interacts with Hof1 and is critical for proper cytokinesis in yeast."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE: The Hof1-Cyk3 interaction in yeast is known to regulate cytokinesis, which is the process of cell division.\n2. TRUE: During cytokinesis in yeast, the interaction between Hof1 and Cyk3 is indeed involved in the formation of a septum, which separates the daughter cells.\n3. TRUE: Hof1 is indeed a protein that localizes to the bud neck in dividing yeast cells and is involved in the deposition of the septum.\n4. UNKNOWN: Cyk3 is a protein involved in cytokinesis, and while it plays a role in septum formation and cell division, I do not have information verifying the specificity of the PSTPIP1 domain within Cyk3 in yeast.\n5. FALSE [correction]: Vrp1 is a protein that does not contain a HOT domain, but instead contains a verprolin domain. It is involved in actin cytoskeleton organization, and while it interacts with Hof1, it is not described as containing a HOT domain and its critical role in cytokinesis does not specifically rely on this non-existent domain.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the following T-UCRs have been implicated in gastric cancer:\n1. Ubiquitin C-terminal hydrolase L1 (UCH-L1)\nAccording to the study described in the text, UCH-L1 expression was increased in gastric cardiac adenocarcinoma (GCA) specimens compared to normal tissues, and high expression of UCH-L1 was associated with poor prognosis. The study also found that silencing of UCH-L1 reduced the ability of gastric cancer cells to proliferate, form colonies, migrate, and invade. These findings suggest that UCH-L1 is a promising prognostic biomarker for GCAs and may play an important role in the carcinogenesis of gastric cancer.",
    "llama-2-13b-chat-hf_fact_raw": "1. Ubiquitin C-terminal hydrolase L1 (UCH-L1) expression was increased in gastric cardiac adenocarcinoma (GCA) specimens compared to normal tissues.\n2. High expression of UCH-L1 was associated with poor prognosis in gastric cancer.\n3. Silencing of UCH-L1 reduced the ability of gastric cancer cells to proliferate.\n4. Silencing of UCH-L1 reduced the ability of gastric cancer cells to form colonies.\n5. Silencing of UCH-L1 reduced the ability of gastric cancer cells to migrate and invade.",
    "llama-2-13b-chat-hf_fact": [
      "Ubiquitin C-terminal hydrolase L1 (UCH-L1) expression was increased in gastric cardiac adenocarcinoma (GCA) specimens compared to normal tissues.",
      "High expression of UCH-L1 was associated with poor prognosis in gastric cancer.",
      "Silencing of UCH-L1 reduced the ability of gastric cancer cells to proliferate.",
      "Silencing of UCH-L1 reduced the ability of gastric cancer cells to form colonies.",
      "Silencing of UCH-L1 reduced the ability of gastric cancer cells to migrate and invade."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided relate to specialized medical/biological research findings. Without access to the specific study or studies these statements are drawn from, I cannot verify their accuracy. These statements would require referencing up-to-date and specific scientific literature to determine their truthfulness.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the Lupus Severity Index (LSI) is a measure of the severity of liver disease, calculated based on the distribution of counts between the liver and bone marrow, and adjusted for spleen size. The LSI is correlated with the liver-bone marrow index (LBI) and the severity score is calculated by combining the LBI and LSI. The severity score is a useful tool for evaluating the severity of liver disease, and is correlated with hepatic fibrosis and the Child-Pugh classification.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Lupus Severity Index (LSI) is a measure of the severity of liver disease.\n2. The LSI is calculated based on the distribution of counts between the liver and bone marrow.\n3. The LSI is adjusted for spleen size.\n4. The Lupus Severity Index (LSI) is correlated with the liver-bone marrow index (LBI).\n5. The LSI severity score is correlated with hepatic fibrosis and the Child-Pugh classification.",
    "llama-2-13b-chat-hf_fact": [
      "The Lupus Severity Index (LSI) is a measure of the severity of liver disease.",
      "The LSI is calculated based on the distribution of counts between the liver and bone marrow.",
      "The LSI is adjusted for spleen size.",
      "The Lupus Severity Index (LSI) is correlated with the liver-bone marrow index (LBI).",
      "The LSI severity score is correlated with hepatic fibrosis and the Child-Pugh classification."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The Lupus Severity Index (LSI) is not a measure of the severity of liver disease; it is intended to measure the severity of lupus, an autoimmune disease.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: The LSI severity score, if it is referring to lupus severity, would not be directly correlated with hepatic fibrosis and the Child-Pugh classification, which are measures used to assess liver disease severity.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the following disorders are caused by de novo mutations in ZSWIM6:\n1. Acromelic frontonasal dysostosis (AFND)\n2. Severe-profound intellectual disability\n3. Central and peripheral nervous system symptoms\nThese disorders are caused by recurrent de novo missense variants within the C-terminal Sin3-like domain of ZSWIM6, which lead to a gain-of-function effect and result in the absence of frontonasal or limb malformations. The c.2737C>T variant in the penultimate exon of ZSWIM6 does not trigger nonsense-mediated decay of the ZSWIM6 mRNA in affected individual-derived cells, which supports the existence of a truncated ZSWIM6 protein lacking the Sin3-like domain, which could have a dominant-negative effect.",
    "llama-2-13b-chat-hf_fact_raw": "1. Acromelic frontonasal dysostosis (AFND) is caused by de novo mutations in ZSWIM6.\n2. Severe-profound intellectual disability can be caused by de novo mutations in ZSWIM6.\n3. Symptoms affecting the central and peripheral nervous system can be caused by de novo mutations in ZSWIM6.\n4. Recurrent de novo missense variants within the C-terminal Sin3-like domain of ZSWIM6 lead to a gain-of-function effect.\n5. The c.2737C>T variant in ZSWIM6 does not trigger nonsense-mediated decay of the ZSWIM6 mRNA in cells derived from affected individuals.",
    "llama-2-13b-chat-hf_fact": [
      "Acromelic frontonasal dysostosis (AFND) is caused by de novo mutations in ZSWIM6.",
      "Severe-profound intellectual disability can be caused by de novo mutations in ZSWIM6.",
      "Symptoms affecting the central and peripheral nervous system can be caused by de novo mutations in ZSWIM6.",
      "Recurrent de novo missense variants within the C-terminal Sin3-like domain of ZSWIM6 lead to a gain-of-function effect.",
      "The c.2737C>T variant in ZSWIM6 does not trigger nonsense-mediated decay of the ZSWIM6 mRNA in cells derived from affected individuals."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Acromelic frontonasal dysostosis (AFND) is usually caused by de novo mutations in the ALX1 (also known as ALX3) gene, not ZSWIM6.\n2. TRUE: Severe-profound intellectual disability can be associated with de novo mutations in the ZSWIM6 gene.\n3. TRUE: Symptoms affecting the central and peripheral nervous system can be associated with mutations in the ZSWIM6 gene.\n4. UNKNOWN: Without specific literature or research data, the statement about the properties of missense variants within the C-terminal Sin3-like domain of ZSWIM6 is too specialized to determine its truthfulness. Hence, the effect of these variants, whether gain-of-function or otherwise, cannot be definitively known without additional context.\n5. UNKNOWN: The statement about the c.2737C>T variant in ZSWIM6 and its effects on mRNA decay requires specific genetic or molecular biology knowledge that was not provided. Without additional scientific evidence or context, the truth of this statement can't be determined.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the disease that can be classified using the Koos Classification is Early Onset Scoliosis (EOS). The study discussed in the text used the Classification of Early Onset Scoliosis (C-EOS) scheme to classify cases of EOS, and found high levels of interobserver and intraobserver agreement with the scheme. Therefore, the Koos Classification can be considered a reliable tool for classifying EOS patients for clinical communication and research.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Koos Classification is used for classifying Early Onset Scoliosis (EOS).\n2. The Classification of Early Onset Scoliosis (C-EOS) scheme is used to classify cases of EOS.\n3. The study mentioned found high levels of interobserver agreement with the C-EOS scheme.\n4. The study mentioned found high levels of intraobserver agreement with the C-EOS scheme.\n5. The Koos Classification is used for clinical communication and research pertaining to EOS.",
    "llama-2-13b-chat-hf_fact": [
      "The Koos Classification is used for classifying Early Onset Scoliosis (EOS).",
      "The Classification of Early Onset Scoliosis (C-EOS) scheme is used to classify cases of EOS.",
      "The study mentioned found high levels of interobserver agreement with the C-EOS scheme.",
      "The study mentioned found high levels of intraobserver agreement with the C-EOS scheme.",
      "The Koos Classification is used for clinical communication and research pertaining to EOS."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation:\nThe veracity of statements about specific medical classification systems and the results of studies requires specialized knowledge or access to the specific study or medical literature references. Since the exact study is not provided and general knowledge databases do not usually contain detailed medical classification system evaluations, the truthfulness of statements 1, 3, 4, and 5 cannot be determined without additional context. Statement 2 is a true statement in the context of medical classification systems, as C-EOS is indeed a known scheme used to classify cases of Early Onset Scoliosis.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the in vivo effects of AZD8601 are:\n1. Vasodilation: AZD8601 causes pronounced, sustained, and dose-dependent vasodilation, as observed using multi-parametric photoacoustic microscopy.\n2. Blood flow upregulation: Intradermal injection of AZD8601 leads to increased blood flow, as observed using multi-parametric photoacoustic microscopy.\n3. Neovessel formation: AZD8601 promotes neovessel formation, as observed using multi-parametric photoacoustic microscopy.\n4. Improved vascularization: Sequential dosing of AZD8601 improves vascularization of the wound bed, as observed using a boron nanoparticle-based tissue oxygen sensor.\n5. Accelerated re-epithelialization: Sequential dosing of AZD8601 leads to accelerated re-epithelialization during the early phase of diabetic wound healing.\nOverall, the in vivo effects of AZD8601 suggest that it has the potential to be a useful therapeutic agent for improving blood flow, promoting neovessel formation, and accelerating wound healing in diabetic wounds.",
    "llama-2-13b-chat-hf_fact_raw": "1. AZD8601 causes pronounced, sustained, and dose-dependent vasodilation.\n2. Intradermal injection of AZD8601 leads to increased blood flow.\n3. AZD8601 promotes neovessel formation.\n4. Sequential dosing of AZD8601 improves vascularization of the wound bed.\n5. Sequential dosing of AZD8601 leads to accelerated re-epithelialization during the early phase of diabetic wound healing.",
    "llama-2-13b-chat-hf_fact": [
      "AZD8601 causes pronounced, sustained, and dose-dependent vasodilation.",
      "Intradermal injection of AZD8601 leads to increased blood flow.",
      "AZD8601 promotes neovessel formation.",
      "Sequential dosing of AZD8601 improves vascularization of the wound bed.",
      "Sequential dosing of AZD8601 leads to accelerated re-epithelialization during the early phase of diabetic wound healing."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or content from a reliable source, it is impossible to verify these scientific statements regarding AZD8601. These assertions require reference to scientific research, clinical study results, or expert consensus to be validated.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, SAHFS (senescence-associated heterochromatic foci) are formed through spatial repositioning of the genome, which is correlated with but does not require the repressive marks of histone H3 trimethylated on lysine 9 (H3K9me3) and H3K27me3. The layered high-order chromatin structures (HOCS) within SAHFS are likely achieved through the spatial rearrangement of pre-existing heterochromatin, rather than the spreading of heterochromatin.",
    "llama-2-13b-chat-hf_fact_raw": "1. SAHFS (senescence-associated heterochromatic foci) are formed through spatial repositioning of the genome.\n2. The formation of SAHFS is correlated with, but does not require, histone H3 trimethylated on lysine 9 (H3K9me3).\n3. The formation of SAHFS is correlated with, but does not require, histone H3 trimethylated on lysine 27 (H3K27me3).\n4. The high-order chromatin structures (HOCS) in SAHFS are formed by spatial rearrangement of pre-existing heterochromatin.\n5. SAHFS are not created by spreading of heterochromatin.",
    "llama-2-13b-chat-hf_fact": [
      "SAHFS (senescence-associated heterochromatic foci) are formed through spatial repositioning of the genome.",
      "The formation of SAHFS is correlated with, but does not require, histone H3 trimethylated on lysine 9 (H3K9me3).",
      "The formation of SAHFS is correlated with, but does not require, histone H3 trimethylated on lysine 27 (H3K27me3).",
      "The high-order chromatin structures (HOCS) in SAHFS are formed by spatial rearrangement of pre-existing heterochromatin.",
      "SAHFS are not created by spreading of heterochromatin."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The formation of SAHFS is indeed correlated with histone H3 trimethylated on lysine 27 (H3K27me3).\n4. TRUE\n5. FALSE [correction]: SAHFS can be formed by the spreading of heterochromatin.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the function of the PDZ domain in SATB1 is to interact with other cellular proteins and regulate global gene expression. The PDZ domain mediates interactions with chromatin proteins and represses the activity of SATB1-regulated genes. Overexpression of the PDZ domain results in de-repression of these genes, leading to changes in cellular signaling cascades and functions.",
    "llama-2-13b-chat-hf_fact_raw": "1. The PDZ domain in SATB1 interacts with other cellular proteins.\n2. The PDZ domain is involved in regulating global gene expression.\n3. The PDZ domain mediates interactions with chromatin proteins.\n4. Repression of SATB1-regulated genes involves the PDZ domain.\n5. Overexpression of the PDZ domain in SATB1 results in de-repression of genes regulated by SATB1.",
    "llama-2-13b-chat-hf_fact": [
      "The PDZ domain in SATB1 interacts with other cellular proteins.",
      "The PDZ domain is involved in regulating global gene expression.",
      "The PDZ domain mediates interactions with chromatin proteins.",
      "Repression of SATB1-regulated genes involves the PDZ domain.",
      "Overexpression of the PDZ domain in SATB1 results in de-repression of genes regulated by SATB1."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific contextual information or scientific references related to SATB1 and its PDZ domain, I cannot accurately determine the truth of these statements. PDZ domains are known to be involved in protein-protein interactions, but without specific evidence or information on the role of the PDZ domain in SATB1, it is not possible to ascertain the veracity of these claims.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the basis of the BLISS technique is the use of Blissymbols as a facilitating technique for communication, learning, and writing skills for adult aphasic patients with severe verbal apraxia. The technique is found to be effective for candidates with good auditory comprehension, good visual-perceptual skills, and a high level of motivation. Additionally, the group therapy approach is found to be beneficial in providing needed motivation and encouraging verbal language and writing skills.",
    "llama-2-13b-chat-hf_fact_raw": "1. The BLISS technique uses Blissymbols as a facilitating technique for communication, learning, and writing skills.\n2. The BLISS technique targets adult aphasic patients with severe verbal apraxia.\n3. Candidates with good auditory comprehension, good visual-perceptual skills, and high motivation benefit from the BLISS technique.\n4. The group therapy approach within the BLISS technique helps provide motivation and encourages verbal language and writing skills.",
    "llama-2-13b-chat-hf_fact": [
      "The BLISS technique uses Blissymbols as a facilitating technique for communication, learning, and writing skills.",
      "The BLISS technique targets adult aphasic patients with severe verbal apraxia.",
      "Candidates with good auditory comprehension, good visual-perceptual skills, and high motivation benefit from the BLISS technique.",
      "The group therapy approach within the BLISS technique helps provide motivation and encourages verbal language and writing skills."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The BLISS technique is not limited to adult aphasic patients with severe verbal apraxia; it was designed for non-verbal children, although it might be beneficial for a broader population, the statement as it stands is too narrow.\n3. TRUE\n4. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-13b-chat-hf_response": "Sure, based on the information provided, here are three NK3 antagonists:\n1. C3-alkylsulfoxide substituted quinolines: These compounds have been synthesized and have shown excellent NK3 functional activity, good selectivity, and drug-like properties.\n2. Compound 1: This compound has been identified as a potent NK3 antagonist with good in vitro/in vivo DMPK characteristics and activity in a gerbil locomotor activity model.\n3. Compound 2: This compound has also been identified as a potent NK3 antagonist with good selectivity and drug-like properties, and has shown activity in a gerbil locomotor activity model.\nPlease note that these are specific compounds mentioned in the provided document, and there may be other NK3 antagonists that have been identified or developed since the document was written.",
    "llama-2-13b-chat-hf_fact_raw": "1. C3-alkylsulfoxide substituted quinolines are synthesized compounds that have demonstrated NK3 functional activity.\n2. Compound 1 has been identified as a potent NK3 antagonist with good in vitro/in vivo DMPK characteristics.\n3. Compound 2 is identified as a potent NK3 antagonist with activity in a gerbil locomotor activity model.",
    "llama-2-13b-chat-hf_fact": [
      "C3-alkylsulfoxide substituted quinolines are synthesized compounds that have demonstrated NK3 functional activity.",
      "Compound 1 has been identified as a potent NK3 antagonist with good in vitro/in vivo DMPK characteristics.",
      "Compound 2 is identified as a potent NK3 antagonist with activity in a gerbil locomotor activity model."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nThe statements provided are specific claims about scientific compounds and their biological activity. Without access to the precise scientific literature or study that these statements might be referring to, I cannot verify the accuracy of these claims. Hence, I must classify the veracity of these statements as \"UNKNOWN.\"",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is compound 47.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the protective efficacy of Vaxchora (Shanchol) against moderate to severe cholera is estimated to be 86.6% (95% confidence interval: 56.7-95.8). This means that receiving two complete doses of the vaccine can significantly protect against cholera in the short term, with a high degree of effectiveness.",
    "llama-2-13b-chat-hf_fact_raw": "1. The protective efficacy of Vaxchora (Shanchol) against moderate to severe cholera is estimated to be 86.6%.\n2. The 95% confidence interval for the protective efficacy of Vaxchora against moderate to severe cholera is 56.7% to 95.8%.",
    "llama-2-13b-chat-hf_fact": [
      "The protective efficacy of Vaxchora (Shanchol) against moderate to severe cholera is estimated to be 86.6%.",
      "The 95% confidence interval for the protective efficacy of Vaxchora against moderate to severe cholera is 56.7% to 95.8%."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nThe accuracy of the statements hinges on specific epidemiological data that is not provided, and without access to the latest research or data concerning Vaxchora (Shanchol) protective efficacy and its confidence intervals, I cannot confirm the veracity of these percentages.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, the first cholera vaccine approved in the US was Vaxchora, which was approved by the US FDA on June 10, 2016.",
    "llama-2-13b-chat-hf_fact_raw": "1. The first cholera vaccine approved in the US was Vaxchora.\n2. Vaxchora was approved by the US FDA on June 10, 2016.",
    "llama-2-13b-chat-hf_fact": [
      "The first cholera vaccine approved in the US was Vaxchora.",
      "Vaxchora was approved by the US FDA on June 10, 2016."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is not specified in the given document. The document focuses on the presentation of a case of renal granulomatous disease in a patient with CVID, and the pathogenesis of granulomatous disease in CVID is discussed, but there is no mention of a specific monogenic cause. Therefore, I cannot provide an answer to the user's question based on the given information.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the IFIT1 gene does not play a direct role in Systemic Lupus Erythematosus (SLE). The study focused on the IFNG gene and its polymorphism, and found that the +874 intron polymorphism of IFNG was associated with arthritis in SLE patients in the Thai population. The study suggests that the +874 intron polymorphism of IFNG can be used as a marker for SLE susceptibility with arthritis in the Thai population.",
    "llama-2-13b-chat-hf_fact_raw": "1. The IFIT1 gene does not play a direct role in Systemic Lupus Erythematosus (SLE).\n2. The study mentioned focused on the IFNG gene and its polymorphism.\n3. The +874 intron polymorphism of IFNG is associated with arthritis in SLE patients in the Thai population.\n4. The +874 intron polymorphism of IFNG can be used as a marker for SLE susceptibility with arthritis in the Thai population.",
    "llama-2-13b-chat-hf_fact": [
      "The IFIT1 gene does not play a direct role in Systemic Lupus Erythematosus (SLE).",
      "The study mentioned focused on the IFNG gene and its polymorphism.",
      "The +874 intron polymorphism of IFNG is associated with arthritis in SLE patients in the Thai population.",
      "The +874 intron polymorphism of IFNG can be used as a marker for SLE susceptibility with arthritis in the Thai population."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nThe statements provided lack the necessary context to determine the truth regarding genetic associations with Systemic Lupus Erythematosus (SLE), roles of specific genes or polymorphisms, or their significance in the Thai population. A detailed understanding of the study mentioned, as well as expert knowledge in genetics and rheumatology, would be required to assess the accuracy of these statements.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the Liverpool Elbow Score (LES) is a validated elbow-specific score that consists of a patient-answered questionnaire (PAQ) and a clinical assessment. The PAQ portion of the LES can be used independently as a postal questionnaire to assess outcome after total elbow arthroplasty. The study found a good correlation between the LES PAQ component and the Mayo Elbow Performance Score (MEPS), suggesting that outcome assessment is possible by postal questionnaire.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Liverpool Elbow Score (LES) is an elbow-specific score.\n2. The LES includes a patient-answered questionnaire (PAQ).\n3. The patient-answered questionnaire portion of the LES can be used independently as a postal questionnaire.\n4. The LES is used to assess outcome after total elbow arthroplasty.\n5. There is a good correlation between the LES PAQ component and the Mayo Elbow Performance Score (MEPS).",
    "llama-2-13b-chat-hf_fact": [
      "The Liverpool Elbow Score (LES) is an elbow-specific score.",
      "The LES includes a patient-answered questionnaire (PAQ).",
      "The patient-answered questionnaire portion of the LES can be used independently as a postal questionnaire.",
      "The LES is used to assess outcome after total elbow arthroplasty.",
      "There is a good correlation between the LES PAQ component and the Mayo Elbow Performance Score (MEPS)."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nWithout specific data or a reference stating the correlation between the LES PAQ component and the MEPS, the level of correlation cannot be determined.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-13b-chat-hf_response": "The 100,000 Genomes Project, launched in 2010, was a groundbreaking initiative aimed at creating a comprehensive catalog of human genetic variation and developing new methods for accurately identifying and characterizing genetic variation using cutting-edge sequencing technologies. As part of this project, an unprecedented amount of data was generated, and to facilitate widespread access to this data, the project's members developed and deployed several tools.\nOne of the key efforts on sarcoma from the 100,000 Genomes Project was the analysis of genomic data from patients with this type of cancer. Sarcoma is a rare and complex form of cancer that affects connective tissue, and understanding its genetic underpinnings is crucial for improving diagnosis and treatment.\nThe project's researchers used advanced sequencing technologies to generate high-quality genomic data from a large number of sarcoma patients. This data was then analyzed using sophisticated computational tools to identify genetic mutations and other variations that may be driving the development and progression of the disease.\nSome of the key findings from the project's sarcoma research include the identification of novel genetic mutations that are associated with an increased risk of developing sarcoma, as well as the discovery of new genetic subtypes of the disease. These findings have the potential to improve our understanding of the molecular mechanisms underlying sarcoma and may lead to the development of new diagnostic tests and targeted therapies.\nIn addition to the research itself, the 100,000 Genomes Project has also made a significant contribution to the development of new tools and methods for analyzing and interpreting large-scale genomic data. These resources have the potential to benefit not just sarcoma research, but also the broader field of genomic medicine.\nOverall, the efforts on sarcoma from the 100,000 Genomes Project represent a significant step forward in our understanding of this complex and rare form of cancer, and have the potential to lead to new diagnostic and therapeutic strategies for patients with sarcoma.",
    "llama-2-13b-chat-hf_fact_raw": "1. The 100,000 Genomes Project was launched in 2010 with the aim to catalog human genetic variation and develop new methods for identifying genetic variation.\n2. The project included an analysis of genomic data from sarcoma patients to better understand the genetics of this cancer form.\n3. Sarcoma affects connective tissue and is considered a rare and complex form of cancer.\n4. Researchers from the 100,000 Genomes Project used advanced sequencing technologies for generating genomic data from sarcoma patients.\n5. Key findings from the project's sarcoma research included the identification of novel genetic mutations associated with an increased risk of developing sarcoma and the discovery of new genetic subtypes of the disease.",
    "llama-2-13b-chat-hf_fact": [
      "The 100,000 Genomes Project was launched in 2010 with the aim to catalog human genetic variation and develop new methods for identifying genetic variation.",
      "The project included an analysis of genomic data from sarcoma patients to better understand the genetics of this cancer form.",
      "Sarcoma affects connective tissue and is considered a rare and complex form of cancer.",
      "Researchers from the 100,000 Genomes Project used advanced sequencing technologies for generating genomic data from sarcoma patients.",
      "Key findings from the project's sarcoma research included the identification of novel genetic mutations associated with an increased risk of developing sarcoma and the discovery of new genetic subtypes of the disease."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: The 100,000 Genomes Project was launched in 2012 with the aim to sequence 100,000 whole genomes from NHS patients.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nYes, protein ALEX1 contains armadillo repeats.\nAccording to the information provided in the text, ALEX1 contains two armadillo repeat domains. This is consistent with the definition of armadillo repeat proteins, which are characterized by the presence of 6 to 13 armadillo repeat domains. Therefore, ALEX1 can be classified as an armadillo repeat protein.",
    "llama-2-13b-chat-hf_fact_raw": "1. Protein ALEX1 contains armadillo repeats.\n2. ALEX1 contains two armadillo repeat domains.\n3. Armadillo repeat proteins are characterized by the presence of 6 to 13 armadillo repeat domains.",
    "llama-2-13b-chat-hf_fact": [
      "Protein ALEX1 contains armadillo repeats.",
      "ALEX1 contains two armadillo repeat domains.",
      "Armadillo repeat proteins are characterized by the presence of 6 to 13 armadillo repeat domains."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: ALEX1 does not contain two armadillo repeat domains; protein ALEX1 is characterized by the presence of one armadillo repeat domain.\n3. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-13b-chat-hf_response": "Based on the information provided in Document-0, the following are enzymes that remove histone modifications:\n1. Histone deacetylases (HDACs): These enzymes catalyze the removal of acetyl groups from the epsilon-amino groups of conserved lysine residues in the amino terminal tail of histones.\n2. Other HDACs: In addition to the 18 potential deacetylase enzymes mentioned in the document, there may be other HDACs that are responsible for removing acetyl groups from histones in humans.\nNote that the document focuses specifically on histone deacetylases and their role in removing acetyl groups from histones, but it is possible that other enzymes may also be involved in removing other histone modifications.",
    "llama-2-13b-chat-hf_fact_raw": "1. Histone deacetylases (HDACs) remove acetyl groups from the epsilon-amino groups of lysine residues in histone proteins.\n2. There are at least 18 potential deacetylase enzymes that can deacetylate histones in humans.",
    "llama-2-13b-chat-hf_fact": [
      "Histone deacetylases (HDACs) remove acetyl groups from the epsilon-amino groups of lysine residues in histone proteins.",
      "There are at least 18 potential deacetylase enzymes that can deacetylate histones in humans."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-13b-chat-hf_response": "Based on the information provided in the document, there is no significant increase in the risk of brain tumors associated with head CT scans in children. The overall risk of malignancy and benign brain tumors was not significantly different between the exposed and unexposed cohorts. However, there was a significant increase in the risk of benign brain tumors in the exposed cohort compared to the unexposed cohort. The frequency of CT examinations was found to be a strong predictor of the subsequent risk of malignancy and benign brain tumors. Therefore, while head CT scans do not appear to increase the risk of brain tumors, frequent exposure to CT scans may be associated with an increased risk of benign brain tumors in children.",
    "llama-2-13b-chat-hf_fact_raw": "1. There is no significant increase in the risk of brain tumors associated with head CT scans in children.\n2. The overall risk of malignancy and benign brain tumors was not significantly different between exposed and unexposed cohorts.\n3. There was a significant increase in the risk of benign brain tumors in the exposed cohort compared to the unexposed cohort.\n4. The frequency of CT examinations is a strong predictor of the subsequent risk of malignancy and benign brain tumors.\n5. Frequent exposure to CT scans may be associated with an increased risk of benign brain tumors in children.",
    "llama-2-13b-chat-hf_fact": [
      "There is no significant increase in the risk of brain tumors associated with head CT scans in children.",
      "The overall risk of malignancy and benign brain tumors was not significantly different between exposed and unexposed cohorts.",
      "There was a significant increase in the risk of benign brain tumors in the exposed cohort compared to the unexposed cohort.",
      "The frequency of CT examinations is a strong predictor of the subsequent risk of malignancy and benign brain tumors.",
      "Frequent exposure to CT scans may be associated with an increased risk of benign brain tumors in children."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: There is an increased risk of brain tumors associated with head CT scans in children, according to some studies showing a higher incidence of brain tumors in children who have undergone multiple CT scans.\n2. FALSE [correction]: Some studies have found that the overall risk of both malignancy and benign brain tumors can be significantly different between exposed and unexposed cohorts, with exposed children having a higher risk.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-13b-chat-hf_response": "Sure! Based on the information provided, Otx2 is associated with primed pluripotency.",
    "llama-2-13b-chat-hf_fact_raw": "1. Otx2 is associated with primed pluripotency.",
    "llama-2-13b-chat-hf_fact": [
      "Otx2 is associated with primed pluripotency."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct answer to the user's question about the number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region. The provided information discusses the use of a support vector machine-based model to identify DHS in general, but does not provide specific information about the beta globin locus region.\nHowever, I can provide some background information on DHS and their importance in understanding gene regulation. DHS are regions of the genome that are more accessible to DNaseI digestion due to their open chromatin structure. These regions are often associated with regulatory elements such as promoters, enhancers, and other cis-acting elements that control gene expression.\nThe number of DHS in a given region can vary depending on the specific locus and the cell type being studied. For example, a study published in the journal Nature Genetics in 2017 found that the human beta globin locus contains approximately 300 DHS in peripheral blood mononuclear cells. However, this number may be different in other cell types or under different conditions.\nTherefore, to answer the user's question, I would need more specific information about the region of interest and the cell type being studied. Additionally, I would recommend using a computational method such as the support vector machine-based model mentioned in the provided information to identify DHS in the specific region of interest.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-13b-chat-hf_response": "Sure, here are some European influenza vaccines that are available or have been used in the past:\n1. Fluarix (GlaxoSmithKline): This is a quadrivalent vaccine that protects against A(H1N1)pdm09, A(H3N2), and two B strains (B/Victoria and B/Yamagata).\n2. Fluvir (Sanofi Pasteur): This is also a quadrivalent vaccine that protects against the same strains as Fluarix.\n3. FluMist (MedImmune): This is a live attenuated vaccine that protects against A(H1N1)pdm09, A(H3N2), and two B strains (B/Victoria and B/Yamagata).\n4. Influenza Vaccine (Novartis): This is a trivalent vaccine that protects against A(H1N1)pdm09, A(H3N2), and one B strain (B/Yamagata).\n5. Influenza A(H1N1) 2009 Monovalent Vaccine (GlaxoSmithKline): This is a monovalent vaccine that protects against the A(H1N1)pdm09 strain.\n6. Influenza A(H3N2) 2009 Monovalent Vaccine (GlaxoSmithKline): This is another monovalent vaccine that protects against the A(H3N2) strain.\n7. Influenza B (Victoria) Monovalent Vaccine (GlaxoSmithKline): This is a monovalent vaccine that protects against the B/Victoria strain.\n8. Influenza B (Yamagata) Monovalent Vaccine (GlaxoSmithKline): This is another monovalent vaccine that protects against the B/Yamagata strain.\nPlease note that the availability of these vaccines may vary depending on the country and the season. It's also important to keep in mind that the effectiveness of these vacc",
    "llama-2-13b-chat-hf_fact_raw": "1. Fluarix is a quadrivalent influenza vaccine produced by GlaxoSmithKline.\n2. Fluvir is a quadrivalent influenza vaccine produced by Sanofi Pasteur.\n3. FluMist is a live attenuated influenza vaccine produced by MedImmune.\n4. Novartis produces a trivalent influenza vaccine.\n5. GlaxoSmithKline produces a monovalent vaccine for Influenza A(H1N1) 2009.",
    "llama-2-13b-chat-hf_fact": [
      "Fluarix is a quadrivalent influenza vaccine produced by GlaxoSmithKline.",
      "Fluvir is a quadrivalent influenza vaccine produced by Sanofi Pasteur.",
      "FluMist is a live attenuated influenza vaccine produced by MedImmune.",
      "Novartis produces a trivalent influenza vaccine.",
      "GlaxoSmithKline produces a monovalent vaccine for Influenza A(H1N1) 2009."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Fluzone is a quadrivalent influenza vaccine produced by Sanofi Pasteur, not Fluvir.\n3. TRUE\n4. UNKNOWN (Due to the continuous changes in vaccine manufacturers' product lines and the lack of a specified time frame, it is unknown without more context if Novartis currently or at any time produced a trivalent influenza vaccine; Novartis' vaccines were acquired by CSL's subsidiary, Seqirus in 2015).\n5. UNKNOWN (While GlaxoSmithKline (GSK) has produced various influenza vaccines, it is unclear without a specific time frame whether they currently produce or have produced a monovalent vaccine for Influenza A(H1N1) 2009; such vaccines were more common during the 2009 H1N1 pandemic).",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nNo, the Paramyxovirus genome is not segmented, it is negative-sense RNA.\nAccording to the information provided in the text, Paramyxoviruses have a nonsegmented negative-stranded RNA genome. This means that the genome is not divided into smaller segments, but rather exists as a single, continuous strand of RNA.",
    "llama-2-13b-chat-hf_fact_raw": "1. The Paramyxovirus genome is negative-sense RNA.\n2. Paramyxoviruses have a nonsegmented RNA genome.",
    "llama-2-13b-chat-hf_fact": [
      "The Paramyxovirus genome is negative-sense RNA.",
      "Paramyxoviruses have a nonsegmented RNA genome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, Roflumilast Cream is effective in treating cerebral inflammation following subarachnoid hemorrhage (SAH).",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, several tools have been developed for identifying and visualizing ncRNA promoters. These tools include:\n1. RiboGap: A database for finding known ncRNAs and discovering simple sequence motifs with regulatory roles. RiboGap can be used to easily extract intergenic sequences of eubacteria and archaea to find conserved RNA structures upstream of given genes.\n2. Tools for predicting conserved RNA secondary structure: Several tools have been developed for predicting the secondary structure of RNA, such as RNAfold, RNAstructure, and Pfold. These tools can be used to identify potential ncRNA promoters by predicting the stability of the RNA structure and identifying conserved elements.\n3. Tools for de novo discovery of ncRNAs: Tools such as Cufflinks, HISAT2, and STAR can be used for de novo discovery of ncRNAs by aligning RNA-seq reads to a reference genome and identifying novel transcripts. These tools can be used to identify potential ncRNA promoters by analyzing the expression levels and stability of the transcripts.\n4. Tools for visualizing ncRNA promoters: Tools such as Integrative Genomics Viewer (IGV) and UCSC Genome Browser can be used to visualize the location of ncRNA promoters in the genome and to identify potential regulatory elements.\nThese tools can be used in combination to identify and visualize ncRNA promoters, and to extend analysis further to choose the best candidate ncRNAs for experimental validation.",
    "llama-2-13b-chat-hf_fact_raw": "1. RiboGap is a database designed for finding known ncRNAs and discovering simple sequence motifs with regulatory roles.\n2. RNAfold, RNAstructure, and Pfold are tools developed for predicting the secondary structure of RNA.\n3. Cufflinks, HISAT2, and STAR are tools that can be used for de novo discovery of ncRNAs by aligning RNA-seq reads to a reference genome.\n4. Integrative Genomics Viewer (IGV) and UCSC Genome Browser are tools used for visualizing the location of ncRNA promoters in the genome.",
    "llama-2-13b-chat-hf_fact": [
      "RiboGap is a database designed for finding known ncRNAs and discovering simple sequence motifs with regulatory roles.",
      "RNAfold, RNAstructure, and Pfold are tools developed for predicting the secondary structure of RNA.",
      "Cufflinks, HISAT2, and STAR are tools that can be used for de novo discovery of ncRNAs by aligning RNA-seq reads to a reference genome.",
      "Integrative Genomics Viewer (IGV) and UCSC Genome Browser are tools used for visualizing the location of ncRNA promoters in the genome."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: RiboGap is not a database; it is a computational method for designing gapmer antisense oligonucleotides targeting ribosomal RNA.\n2. TRUE\n3. FALSE [correction]: Cufflinks is used for assembling transcripts, HISAT2 and STAR are indeed tools for aligning RNA-seq reads to a reference genome, but they are generally used for mapping and not specifically for de novo discovery of ncRNAs, which would require additional analyses.\n4. TRUE: While IGV and UCSC Genome Browser are indeed used for visualization, they are not limited to displaying the location of ncRNA promoters; they can visualize various genomic features, but this statement doesn't include incorrect information.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the following are example genes that have been identified as down-regulated in glioblastoma using the SWIM tool:\n1. COL3A1\n2. COL5A2\n3. LAMA2\n4. MEIS2\n5. MEOX2\n6. NR2E1\n7. PITX2\n8. TFAP2B\n9. ZFPM2\nThese genes are involved in various biological processes such as cell adhesion, extracellular matrix organization, and transcriptional regulation. The down-regulation of these genes in glioblastoma may play a role in the progression of the disease.\nIt's worth noting that the SWIM tool uses a combination of differential expression analysis and protein-protein interaction network analysis to identify potentially driver genes in glioblastoma. The tool also considers the topological properties of the PPI network and the enrichment of biological pathways to prioritize the most promising candidate genes for further investigation.",
    "llama-2-13b-chat-hf_fact_raw": "1. COL3A1 has been identified as down-regulated in glioblastoma using the SWIM tool.\n2. COL5A2 has been identified as down-regulated in glioblastoma using the SWIM tool.\n3. LAMA2 has been identified as down-regulated in glioblastoma using the SWIM tool.\n4. MEIS2 has been identified as down-regulated in glioblastoma using the SWIM tool.\n5. MEOX2 has been identified as down-regulated in glioblastoma using the SWIM tool.",
    "llama-2-13b-chat-hf_fact": [
      "COL3A1 has been identified as down-regulated in glioblastoma using the SWIM tool.",
      "COL5A2 has been identified as down-regulated in glioblastoma using the SWIM tool.",
      "LAMA2 has been identified as down-regulated in glioblastoma using the SWIM tool.",
      "MEIS2 has been identified as down-regulated in glioblastoma using the SWIM tool.",
      "MEOX2 has been identified as down-regulated in glioblastoma using the SWIM tool."
    ],
    "llama-2-13b-chat-hf_judge_raw": "UNKNOWN\n\nThe accuracy of the statements provided regarding specific gene regulation (down-regulation of COL3A1, COL5A2, LAMA2, MEIS2, MEOX2 in glioblastoma) using the SWIM tool is not verifiable without access to the specific research or data extracted using the SWIM tool. SWIM (Semantic Word Integration Measure) is not a widely recognized acronym or tool in the context of gene regulation, and without additional context or specific research findings, the truthfulness of these statements cannot be assessed. \n\nIn scientific contexts, databases, bioinformatics tools, and study results can help determine the gene expression profiles in various conditions, but these findings are often subject to validation and replication in the scientific community. Therefore, without proper references, these statements remain unknown.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there are several R packages that have been developed for studying TADs (Transcriptional Activity Domains) using the ISA (Investigation, Study, Assay) format. These packages include:\n1. Risa: This package provides a central component to support the ISA format by enabling effortless integration with R, the popular, open-source data crunching environment. It offers functionality for parsing ISA-Tab datasets into R objects, augmenting annotation with extra metadata, interfacing with domain-specific R packages, suggesting potentially useful R packages, and saving back to ISA-Tab files augmented with analysis-specific metadata from R.\n2. ISA-tools: This package provides a set of tools for working with ISA-Tab files, including functions for parsing, creating, and validating ISA-Tab files.\n3. ISA-utils: This package provides a set of utility functions for working with ISA-Tab files, including functions for extracting and manipulating metadata, and for converting ISA-Tab files to and from other formats.\n4. BiocManager: This package provides a set of functions for working with Bioconductor packages and datasets, including functions for installing, loading, and managing packages and datasets.\n5. limma: This package provides a set of functions for performing linear regression analysis of gene expression data, including functions for normalizing and transforming data, and for estimating and testing gene expression levels.\n6. edgeR: This package provides a set of functions for performing differential expression analysis of gene expression data, including functions for normalizing and transforming data, and for estimating and testing differential expression levels.\n7. DESeq2: This package provides a set of functions for performing differential expression analysis of gene expression data, including functions for normalizing and transforming data, and for estimating and testing differential expression levels.\nThese packages can be installed and loaded into R using the install.packages() and library() functions, respectively. For example, to install and load the Risa package, you can use the following commands:\ninstall.packages(\"Risa\")\nlibrary(Risa)\nOnce the packages are installed and loaded, you can use their functions to analyze and process your TAD data. For example, you can use the Risa::parseISA() function to parse an ISA-Tab file and load its",
    "llama-2-13b-chat-hf_fact_raw": "1. Risa is an R package that provides functionality for parsing ISA-Tab datasets into R objects.\n2. ISA-tools is an R package with functions for parsing, creating, and validating ISA-Tab files.\n3. ISA-utils is an R package that offers utility functions for working with ISA-Tab files.\n4. BiocManager is an R package that helps users install, load, and manage Bioconductor packages and datasets.\n5. limma, edgeR, and DESeq2 are R packages used for differential expression analysis of gene expression data.",
    "llama-2-13b-chat-hf_fact": [
      "Risa is an R package that provides functionality for parsing ISA-Tab datasets into R objects.",
      "ISA-tools is an R package with functions for parsing, creating, and validating ISA-Tab files.",
      "ISA-utils is an R package that offers utility functions for working with ISA-Tab files.",
      "BiocManager is an R package that helps users install, load, and manage Bioconductor packages and datasets.",
      "limma, edgeR, and DESeq2 are R packages used for differential expression analysis of gene expression data."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: ISA-tools is not an R package, but a suite of tools including software and libraries for working with ISA-Tab files. Risa is an R package that provides functionality for these files.\n3. UNKNOWN: The statement may be referring to utility functions within the ISA-tools suite, but without more specific information on an R package named \"ISA-utils,\" the accuracy of this statement can't be determined.\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the bioconductor tool that has been developed for accessing bacterial regulatory networks is the synthetic \"population control\" circuit. This circuit regulates cell density through a feedback mechanism based on quorum sensing, and was used in the study described in Document-0 to observe the dynamics of Escherichia coli. The circuit enables sustained oscillations in cell density and associated morphological changes over hundreds of hours, demonstrating its ability to control bacterial behavior.",
    "llama-2-13b-chat-hf_fact_raw": "1. A bioconductor tool developed for accessing bacterial regulatory networks is called the synthetic \"population control\" circuit.\n2. The synthetic \"population control\" circuit regulates cell density through a feedback mechanism.\n3. Quorum sensing is used in the feedback mechanism of the synthetic \"population control\" circuit.\n4. The synthetic \"population control\" circuit was used in a study to observe the dynamics of Escherichia coli.\n5. The circuit is capable of sustaining oscillations in cell density and morphological changes over hundreds of hours.",
    "llama-2-13b-chat-hf_fact": [
      "A bioconductor tool developed for accessing bacterial regulatory networks is called the synthetic \"population control\" circuit.",
      "The synthetic \"population control\" circuit regulates cell density through a feedback mechanism.",
      "Quorum sensing is used in the feedback mechanism of the synthetic \"population control\" circuit.",
      "The synthetic \"population control\" circuit was used in a study to observe the dynamics of Escherichia coli.",
      "The circuit is capable of sustaining oscillations in cell density and morphological changes over hundreds of hours."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Bioconductor is actually a suite of software tools for the analysis and comprehension of genomic data, not specifically for accessing bacterial regulatory networks or the synthetic \"population control\" circuit.\n2. UNKNOWN: Without more details on the specific synthetic \"population control\" circuit being referred to, it's not possible to verify the specifics of its regulatory mechanism, although synthetic biological circuits can be designed to regulate cell density through various mechanisms including feedback control.\n3. UNKNOWN: Similarly, without specific details on the synthetic \"population control\" circuit mentioned, it cannot be determined if quorum sensing, a process that bacteria use to 'measure' their density and coordinate behavior, is used within its feedback mechanism.\n4. UNKNOWN: The statement lacks detail and could be true for some synthetic circuits used in research on Escherichia coli, but without a specific reference to an actual study or circuit, the truth of this statement cannot be determined.\n5. UNKNOWN: The capability of the synthetic \"population control\" circuit to sustain oscillations in cell density and morphological changes over hundreds of hours would depend on the design of the circuit. This is plausible for some synthetic circuits, but without specific details regarding the circuit in question, this statement's accuracy cannot be confirmed.",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the end products of the shikimate pathway are:\n1. Aromatic amino acids\n2. Secondary metabolites\n3. Shikimate\nThe shikimate pathway is a metabolic pathway that produces these end products in many organisms, including yeast. The pathway is important for the synthesis of aromatic amino acids, which are essential for many cellular processes. The end products of the shikimate pathway are also used in the production of secondary metabolites, which have a wide range of applications in nutraceuticals and pharmaceuticals.",
    "llama-2-13b-chat-hf_fact_raw": "1. Aromatic amino acids are end products of the shikimate pathway.\n2. Secondary metabolites are produced as end products of the shikimate pathway.\n3. Shikimate is an end product of the shikimate pathway.\n4. The shikimate pathway is found in many organisms, including yeast.\n5. The shikimate pathway is important for the synthesis of essential aromatic amino acids for cellular processes.",
    "llama-2-13b-chat-hf_fact": [
      "Aromatic amino acids are end products of the shikimate pathway.",
      "Secondary metabolites are produced as end products of the shikimate pathway.",
      "Shikimate is an end product of the shikimate pathway.",
      "The shikimate pathway is found in many organisms, including yeast.",
      "The shikimate pathway is important for the synthesis of essential aromatic amino acids for cellular processes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Aromatic amino acids are not end products of the shikimate pathway; rather, they are synthesized from intermediates of the pathway.\n2. TRUE\n3. FALSE [correction]: Shikimate is an intermediate, not an end product, of the shikimate pathway.\n4. TRUE\n5. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the answer to the user's question is:\nYes, cabergoline is used for the treatment of Nelson's syndrome.\nThe case report provided shows that cabergoline treatment was effective in normalizing plasma ACTH levels and causing the disappearance of the pituitary adenoma in a patient with Nelson's syndrome. The treatment was effective at a dose of 1 mg/week and was increased to 2 mg/week after 6 months. The normalization of plasma ACTH levels and the disappearance of the pituitary adenoma were maintained during continued treatment with cabergoline. Additionally, the case report suggests that cabergoline may be a valid therapeutic alternative for the treatment of Nelson's syndrome.",
    "llama-2-13b-chat-hf_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. A case report showed cabergoline treatment normalized plasma ACTH levels in a patient with Nelson's syndrome.\n3. The same case report indicated that cabergoline treatment caused the disappearance of the pituitary adenoma in a patient with Nelson's syndrome.\n4. The treatment with cabergoline was initially effective at a dose of 1 mg/week.\n5. The dose of cabergoline was increased to 2 mg/week after 6 months in the reported case.",
    "llama-2-13b-chat-hf_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "A case report showed cabergoline treatment normalized plasma ACTH levels in a patient with Nelson's syndrome.",
      "The same case report indicated that cabergoline treatment caused the disappearance of the pituitary adenoma in a patient with Nelson's syndrome.",
      "The treatment with cabergoline was initially effective at a dose of 1 mg/week.",
      "The dose of cabergoline was increased to 2 mg/week after 6 months in the reported case."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. FALSE [correction]: Cabergoline is usually used for the treatment of prolactinomas and other conditions associated with hyperprolactinemia, not typically for Nelson's syndrome, which involves treatment of ACTH-producing tumors after the removal of adrenal glands.\n2. TRUE (assuming the case report exists as stated and its findings are correctly summarized)\n3. UNKNOWN (while cabergoline can shrink some types of pituitary tumors, without specific information from the case report, it is not possible to confirm this statement)\n4. UNKNOWN (without access to the case report or additional information, the initial effective dose of cabergoline in this specific case cannot be confirmed)\n5. UNKNOWN (similar to the above, without specific information from the case report, it is not possible to confirm the dose adjustment)",
    "llama-2-13b-chat-hf_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the main manifestation of Liebenberg syndrome is the transformation of the upper limbs to reflect lower limb characteristics.",
    "llama-2-13b-chat-hf_fact_raw": "1. The main manifestation of Liebenberg syndrome is the transformation of the upper limbs to reflect lower limb characteristics.",
    "llama-2-13b-chat-hf_fact": [
      "The main manifestation of Liebenberg syndrome is the transformation of the upper limbs to reflect lower limb characteristics."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-13b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-13b-chat-hf_response": "Based on the information provided, here are some orally bioavailable MPS1 kinase inhibitors:\n1. MPI-0479605: This is a purine-based lead compound that was optimized for improved bioavailability, selectivity, and activity against MPS1. The compound showed improved G2/M escape assay activity and was well-tolerated in mice.\n2. MPI-0482694: This compound is a structural derivative of MPI-0479605 and was designed to improve oral bioavailability. It showed improved activity against MPS1 and was well-tolerated in mice.\n3. MPI-0488471: This compound is a further optimization of MPI-0479605 and was designed to improve oral bioavailability and selectivity. It showed improved activity against MPS1 and was well-tolerated in mice.\nThese compounds have been optimized for oral bioavailability, selectivity, and activity against MPS1, and have shown promising results in preclinical studies. However, it is important to note that further studies are needed to confirm their efficacy and safety in humans.",
    "llama-2-13b-chat-hf_fact_raw": "1. MPI-0479605 is a purine-based lead compound optimized for bioavailability, selectivity, and activity against MPS1.\n2. MPI-0479605 was demonstrated to have improved G2/M escape assay activity and was well-tolerated in mice.\n3. MPI-0482694 is a structural derivative of MPI-0479605, designed to improve oral bioavailability and exhibited improved activity against MPS1 in mice.\n4. MPI-0488471 is an optimization of MPI-0479605, aiming for enhanced oral bioavailability and selectivity, and showed improved activity against MPS1 in mice. \n5. The compounds mentioned have been subject to preclinical studies, but their efficacy and safety in humans require further confirmation.",
    "llama-2-13b-chat-hf_fact": [
      "MPI-0479605 is a purine-based lead compound optimized for bioavailability, selectivity, and activity against MPS1.",
      "MPI-0479605 was demonstrated to have improved G2/M escape assay activity and was well-tolerated in mice.",
      "MPI-0482694 is a structural derivative of MPI-0479605, designed to improve oral bioavailability and exhibited improved activity against MPS1 in mice.",
      "MPI-0488471 is an optimization of MPI-0479605, aiming for enhanced oral bioavailability and selectivity, and showed improved activity against MPS1 in mice.",
      "The compounds mentioned have been subject to preclinical studies, but their efficacy and safety in humans require further confirmation."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE \nPlease note that while I can confirm the general nature of drug development (as stated in statement 5), without specific information on compounds MPI-0482694 and MPI-0488471, I cannot verify the accuracy of statements 3 and 4.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no mention of golimumab being tested for diabetes. The study only focuses on evaluating the efficacy and safety of subcutaneous (SC) golimumab in patients with rheumatoid arthritis (RA) who previously received intravenous (IV) golimumab with or without methotrexate (MTX). The study does not mention anything about diabetes or testing golimumab for diabetes. Therefore, the answer to the question \"Was golimumab tested for diabetes?\" is no.",
    "llama-2-13b-chat-hf_fact_raw": "1. Golimumab was tested for its efficacy and safety in patients with rheumatoid arthritis (RA).\n2. The study evaluated subcutaneous (SC) golimumab.\n3. Patients in the study previously received intravenous (IV) golimumab.\n4. Some patients in the study received golimumab with methotrexate (MTX).\n5. The study did not mention testing golimumab for diabetes.",
    "llama-2-13b-chat-hf_fact": [
      "Golimumab was tested for its efficacy and safety in patients with rheumatoid arthritis (RA).",
      "The study evaluated subcutaneous (SC) golimumab.",
      "Patients in the study previously received intravenous (IV) golimumab.",
      "Some patients in the study received golimumab with methotrexate (MTX).",
      "The study did not mention testing golimumab for diabetes."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE (This is true based on the assumption that the context focuses specifically on rheumatoid arthritis treatment with golimumab and methotrexate; however, without the full context its impossible to be certain that diabetes wasnt mentioned at all. Typically, a study focused on RA would not test a treatment for diabetes unless there was a specific rationale for doing so.)",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, progeria is caused by an autosomal recessive gene, specifically mutations in the LMNA gene that encodes nuclear scaffold proteins lamin A and C. The LMNA-associated cardiocutaneous progeria syndrome (LCPS) is a new progeria syndrome that has been identified, and it is characterized by prominent cutaneous and cardiovascular manifestations, as well as cancer susceptibility. The mutation that causes LCPS is a heterozygous c.899A>G (p.D300G) mutation in the LMNA gene, which alters the coiled-coil domain of lamin A/C and leads to abnormal nuclear morphology.",
    "llama-2-13b-chat-hf_fact_raw": "1. Progeria is caused by mutations in the LMNA gene.\n2. The LMNA gene encodes nuclear scaffold proteins lamin A and C.\n3. LMNA-associated cardiocutaneous progeria syndrome (LCPS) is a type of progeria syndrome.\n4. LCPS is characterized by cutaneous and cardiovascular manifestations, as well as cancer susceptibility.\n5. The mutation that causes LCPS is a heterozygous c.899A>G (p.D300G) mutation in the LMNA gene.",
    "llama-2-13b-chat-hf_fact": [
      "Progeria is caused by mutations in the LMNA gene.",
      "The LMNA gene encodes nuclear scaffold proteins lamin A and C.",
      "LMNA-associated cardiocutaneous progeria syndrome (LCPS) is a type of progeria syndrome.",
      "LCPS is characterized by cutaneous and cardiovascular manifestations, as well as cancer susceptibility.",
      "The mutation that causes LCPS is a heterozygous c.899A>G (p.D300G) mutation in the LMNA gene."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE - While LCPS (LMNA-associated cardiocutaneous progeria syndrome) is indeed characterized by cutaneous and cardiovascular manifestations, without the specific passage detailing the full characteristic scope of LCPS, the inclusion of cancer susceptibility can not be verified and remains uncertain in this context. Therefore, I lean towards marking the statement as 'TRUE' given the information about cutaneous and cardiovascular symptoms typically associated with progeria syndromes.\n5. FALSE [correction]: The mutation that commonly causes Hutchinson-Gilford progeria syndrome, a type of progeria, is a heterozygous c.1824C>T (p.G608G) mutation in the LMNA gene. Without specifics about LCPS mutations in the passage, we cannot verify the exact mutation for LCPS.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the common variants at 12q14 and 12q24 are associated with lung cancer risk. Specifically, the variant marked by rs1051730 on 15q24-25.1 is associated with an increased risk of lung cancer, while the variant marked by rs481134 on the same region is associated with a reduced risk of lung cancer. The second variant, rs481134, explains an additional 13.2% of population attributable risk for lung cancer.",
    "llama-2-13b-chat-hf_fact_raw": "1. Common variants at 12q14 and 12q24 are associated with lung cancer risk.\n2. The variant marked by rs1051730 on 15q24-25.1 is associated with an increased risk of lung cancer.\n3. The variant marked by rs481134 on 15q24-25.1 is associated with a reduced risk of lung cancer.\n4. The variant rs481134 explains an additional 13.2% of population attributable risk for lung cancer.",
    "llama-2-13b-chat-hf_fact": [
      "Common variants at 12q14 and 12q24 are associated with lung cancer risk.",
      "The variant marked by rs1051730 on 15q24-25.1 is associated with an increased risk of lung cancer.",
      "The variant marked by rs481134 on 15q24-25.1 is associated with a reduced risk of lung cancer.",
      "The variant rs481134 explains an additional 13.2% of population attributable risk for lung cancer."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nExplanation:\nStatement 1 references specific chromosomal locations (12q14 and 12q24) associated with lung cancer risk, but without specific study results or scientific consensus to confirm the truth of this statement, it remains unknown.\n\nStatement 2 is consistent with genetic research findings that have identified the variant marked by rs1051730 on 15q24-25.1 as being associated with an increased risk for lung cancer. Unless contradictory information is provided, this statement is considered true.\n\nStatement 3 and 4 involve specific claims about genetic variants (rs481134) and their effects on lung cancer risk and population attributable risk, respectively. Without specific data or references to scientific studies to confirm these claims, the truthfulness of these statements cannot be determined. Therefore, they are both labeled as unknown.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the ligands of the Roundabout (Robo) receptors are not explicitly mentioned. However, the study suggests that Robo4 mediates attraction-signaling mechanisms through Rho GTPases in vertebrate vascular guidance. Therefore, the ligands of Robo4 are likely to be molecules that activate Rho GTPases, such as Cdc42 and Rac1. These ligands could be other proteins or molecules that interact with Robo4 and trigger its activation of Rho GTPases, leading to attraction-signaling mechanisms in vascular development.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, there is no direct role for TFII-I in megakaryopoiesis. The information provided is related to the function of TFIIIC in transcription initiation in yeast, and specifically discusses the role of the tau131 subunit of TFIIIC in recruiting the transcription factor B\". There is no mention of TFII-I in the provided information. Therefore, I cannot provide an answer to the question of whether there is a role for TFII-I in megakaryopoiesis.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, atenolol is not metabolized by CYP2D6. The study found that CYP2D6 activity increased during pregnancy, but this increase was only observed in homozygous and heterozygous extensive metabolizers, and poor metabolizers showed an increased metabolic ratio during pregnancy. Since atenolol is not a CYP2D6 substrate, it is not metabolized by this enzyme.",
    "llama-2-13b-chat-hf_fact_raw": "1. Atenolol is not metabolized by CYP2D6.\n2. CYP2D6 activity increases during pregnancy.\n3. The increase in CYP2D6 activity during pregnancy is observed in homozygous and heterozygous extensive metabolizers.\n4. Poor metabolizers show an increased metabolic ratio during pregnancy.",
    "llama-2-13b-chat-hf_fact": [
      "Atenolol is not metabolized by CYP2D6.",
      "CYP2D6 activity increases during pregnancy.",
      "The increase in CYP2D6 activity during pregnancy is observed in homozygous and heterozygous extensive metabolizers.",
      "Poor metabolizers show an increased metabolic ratio during pregnancy."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Poor metabolizers would not show an increased metabolic ratio during pregnancy as their CYP2D6 enzyme activity is low or absent, so their metabolic ratio for drugs metabolized by CYP2D6 would remain unchanged or possibly even decrease due to physiological changes in pregnancy that affect drug metabolism.",
    "llama-2-13b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-13b-chat-hf_response": "Sure, I'd be happy to help! Based on the information provided, here are the versions of ExpansionHunter:\n1. PROLANG: This is an improved version of the PROSOFT program, with new commands and improvements to the old ones. It is an open software that allows users with BASIC programming experience to easily expand its functionality.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, ADAMTS18 plays a role in hormone receptor signaling by suppressing epithelial-mesenchymal transition (EMT), migration, and invasion of breast cancer cells, and inhibiting the phosphorylation of AKT and p65. This suggests that ADAMTS18 may be involved in regulating the signaling pathways that are activated by hormone receptors in breast cancer cells. Additionally, the methylation of ADAMTS18 has been found to be a potential tumor biomarker for breast cancer.",
    "llama-2-13b-chat-hf_fact_raw": "1. ADAMTS18 is involved in suppressing epithelial-mesenchymal transition (EMT) in breast cancer cells.\n2. ADAMTS18 plays a role in inhibiting the migration and invasion of breast cancer cells.\n3. ADAMTS18 is involved in the inhibition of the phosphorylation of AKT and p65.\n4. ADAMTS18 may help regulate signaling pathways activated by hormone receptors in breast cancer cells.\n5. The methylation of ADAMTS18 has been identified as a potential tumor biomarker for breast cancer.",
    "llama-2-13b-chat-hf_fact": [
      "ADAMTS18 is involved in suppressing epithelial-mesenchymal transition (EMT) in breast cancer cells.",
      "ADAMTS18 plays a role in inhibiting the migration and invasion of breast cancer cells.",
      "ADAMTS18 is involved in the inhibition of the phosphorylation of AKT and p65.",
      "ADAMTS18 may help regulate signaling pathways activated by hormone receptors in breast cancer cells.",
      "The methylation of ADAMTS18 has been identified as a potential tumor biomarker for breast cancer."
    ],
    "llama-2-13b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nRationale:\n1-4: The statements provided about ADAMTS18 require specific scientific knowledge or data from research studies which are not included in the provided context. Without specific information or citation from relevant research, it's difficult to confirm the accuracy of these claims related to the function of ADAMTS18 in breast cancer cells.\n\n5: This statement is true because the methylation of certain genes, including ADAMTS18, has been studied and identified as potential biomarkers for cancer, including breast cancer. DNA methylation is a common epigenetic mechanism that can lead to gene silencing, and the methylation status of genes like ADAMTS18 can serve as a potential biomarker for diagnosis or prognosis of the disease.",
    "llama-2-13b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-13b-chat-hf_response": "Based on the information provided, the mode of action of Thiazovivin is not directly related to its ability to inhibit NAD-dependent oxidations, but rather it exhibits depression of central nervous system (CNS) activity, which can be associated with an increase in respiration. Additionally, Thiazovivin potentiates pentobarbital sleeping time in mice at a dose of 100 mg/kg.",
    "llama-2-13b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-13b-chat-hf_fact": [],
    "llama-2-13b-chat-hf_judge": []
  }
]